1	Seizure	NN	O	seizure	_	0	SENT_1	[p1l9t153r216b202],
2	(	CD	NUMBER	(	num	3	SENT_1	[p1l245t153r418b214],
3	2006	CD	DATE	2006	dep	1	SENT_1	[p1l245t153r418b214],
4	)	CD	NUMBER	)	number	5	SENT_1	[p1l245t153r418b214],
5	15	CD	NUMBER	15	dep	3	SENT_1	[p1l452t154r536b212],
6	,	,	O	,	_	0	SENT_1	[p1l452t154r536b212],
7	344-347	CD	NUMBER	344-347	num	8	SENT_1	[p1l568t153r815b202],
8	ELSEVIER	NN	O	elsevier	appos	3	SENT_1	[p1l15t687r444b753],

1	CASE	NN	O	case	nn	2	SENT_2	[p1l10t900r218b973],
2	REPORT	NN	O	report	_	0	SENT_2	[p1l261t900r590b973],

1	Lack	NN	O	lack	_	0	SENT_3	[p1l18t1120r355b1244],
2	of	IN	O	of	_	0	SENT_3	[p1l414t1121r565b1244],
3	association	NN	O	association	prep_of	1	SENT_3	[p1l619t1123r1440b1244],
4	between	IN	O	between	_	0	SENT_3	[p1l1512t1120r2154b1244],
5	MDR1	NN	O	mdr1	nn	7	SENT_3	[p1l8t1318r395b1438],
6	genetic	JJ	O	genetic	amod	7	SENT_3	[p1l482t1318r1032b1470],
7	polymorphism	NN	O	polymorphism	prep_between	3	SENT_3	[p1l1101t1314r2146b1470],
8	multidrug-resistant	JJ	O	multidrug-resistant	amod	9	SENT_3	[p1l17t1509r1456b1664],
9	epilepsy	NN	O	epilepsy	dep	1	SENT_3	[p1l1520t1509r2139b1664],

1	SEIZURE	NN	O	seizure	_	0	SENT_4	[p1l1370t2100r2018b2231],

1	www.elsevier.com	NNP	O	www.elsevier.com	_	0	SENT_5	[p1l969t2510r1684b2573],
2	/	:	O	/	punct	3	SENT_5	[p1l969t2510r1684b2573],
3	locate/yseiz	NN	O	locate/yseiz	dep	1	SENT_5	[p1l1697t2510r2152b2590],

1	C3435T	NN	O	c3435t	nn	2	SENT_6	[p1l16t2785r757b2942],
2	nucleotide	NN	O	nucleotide	_	0	SENT_6	[p1l842t2781r1869b2942],
3	and	CC	O	and	advmod	2	SENT_6	[p1l6t3035r347b3196],

1	Dong	NNP	PERSON	Dong	nn	3	SENT_7	[p1l99t3282r227b3336],
2	Wook	NNP	PERSON	Wook	nn	3	SENT_7	[p1l247t3280r394b3325],
3	Kim	NNP	PERSON	Kim	nsubj	32	SENT_7	[p1l417t3281r531b3335],
4	,	,	O	,	_	0	SENT_7	[p1l417t3281r531b3335],
5	Manho	NNP	PERSON	Manho	nn	6	SENT_7	[p1l556t3280r729b3325],
6	Kim	NNP	PERSON	Kim	appos	3	SENT_7	[p1l754t3281r868b3335],
7	,	,	O	,	_	0	SENT_7	[p1l754t3281r868b3335],
8	Sang	NNP	PERSON	Sang	nn	11	SENT_7	[p1l895t3281r1015b3336],
9	Kun	NNP	PERSON	Kun	nn	11	SENT_7	[p1l1039t3282r1136b3325],
10	Lee	NNP	PERSON	Lee	nn	11	SENT_7	[p1l1162t3282r1255b3325],
11	*	NNP	O	*	appos	3	SENT_7	[p1l1268t3271r1307b3335],
12	,	,	O	,	_	0	SENT_7	[p1l1268t3271r1307b3335],
13	Rami	NNP	PERSON	Rami	nn	14	SENT_7	[p1l1336t3281r1461b3325],
14	Kang	NNP	PERSON	Kang	appos	3	SENT_7	[p1l1488t3282r1629b3336],
15	,	,	O	,	_	0	SENT_7	[p1l1488t3282r1629b3336],
16	Seo-Young	NNP	ORGANIZATION	Seo-Young	nn	18	SENT_7	[p1l1656t3281r1930b3336],
17	Lee	NNP	ORGANIZATION	Lee	nn	18	SENT_7	[p1l1954t3282r2047b3325],
18	Department	NNP	ORGANIZATION	Department	appos	3	SENT_7	[p1l96t3412r317b3451],
19	of	IN	ORGANIZATION	of	_	0	SENT_7	[p1l332t3411r372b3451],
20	Neurology	NNP	ORGANIZATION	Neurology	prep_of	18	SENT_7	[p1l384t3411r576b3451],
21	,	,	O	,	_	0	SENT_7	[p1l384t3411r576b3451],
22	Seoul	NNP	ORGANIZATION	Seoul	nn	25	SENT_7	[p1l596t3411r694b3443],
23	National	NNP	ORGANIZATION	National	nn	25	SENT_7	[p1l709t3411r864b3443],
24	University	NNP	ORGANIZATION	University	nn	25	SENT_7	[p1l882t3412r1069b3451],
25	College	NNP	ORGANIZATION	College	appos	3	SENT_7	[p1l1084t3411r1219b3451],
26	of	IN	ORGANIZATION	of	_	0	SENT_7	[p1l1234t3411r1274b3451],
27	Medicine	NNP	ORGANIZATION	Medicine	prep_of	25	SENT_7	[p1l1285t3411r1462b3449],
28	,	,	O	,	_	0	SENT_7	[p1l1285t3411r1462b3449],
29	Seoul	NNP	LOCATION	Seoul	nn	31	SENT_7	[p1l1482t3411r1591b3449],
30	,	,	O	,	_	0	SENT_7	[p1l1482t3411r1591b3449],
31	Korea	NNP	LOCATION	Korea	appos	3	SENT_7	[p1l1610t3412r1715b3443],
32	Received	VBD	O	receive	_	0	SENT_7	[p1l97t3526r241b3555],
33	21	CD	DATE	21	nsubj	45	SENT_7	[p1l257t3526r288b3554],
34	June	NNP	DATE	June	tmod	33	SENT_7	[p1l308t3527r385b3555],
35	2005	CD	DATE	2005	num	34	SENT_7	[p1l399t3526r485b3561],
36	;	:	O	;	_	0	SENT_7	[p1l399t3526r485b3561],
37	received	VBN	O	receive	partmod	33	SENT_7	[p1l504t3526r643b3555],
38	in	IN	O	in	_	0	SENT_7	[p1l658t3527r686b3554],
39	revised	JJ	O	revised	amod	40	SENT_7	[p1l703t3526r817b3555],
40	form	NN	O	form	prep_in	37	SENT_7	[p1l833t3526r909b3555],
41	13	CD	DATE	13	num	40	SENT_7	[p1l926t3526r960b3555],
42	February	NNP	DATE	February	tmod	40	SENT_7	[p1l977t3526r1121b3562],
43	2006	CD	DATE	2006	num	42	SENT_7	[p1l1135t3526r1221b3561],
44	;	:	O	;	_	0	SENT_7	[p1l1135t3526r1221b3561],
45	accepted	VBN	O	accept	ccomp	32	SENT_7	[p1l1239t3526r1388b3562],
46	17	CD	DATE	17	dobj	45	SENT_7	[p1l1406t3527r1441b3554],
47	February	NNP	DATE	February	tmod	45	SENT_7	[p1l1457t3526r1601b3562],
48	2006	CD	DATE	2006	num	47	SENT_7	[p1l1615t3526r1690b3555],

1	KEYWORDS	NNPS	O	KEYWORDS	nn	2	SENT_8	[p2l137t25r345b56],
2	Summary	NNP	O	Summary	_	0	SENT_8	[p2l669t31r828b66],
3	The	DT	O	the	det	4	SENT_8	[p2l878t30r939b59],
4	variability	NN	O	variability	nsubjpass	13	SENT_8	[p2l952t30r1119b66],
5	of	IN	O	of	_	0	SENT_8	[p2l1132t30r1165b59],
6	P	NN	O	p	nn	9	SENT_8	[p2l1179t30r1415b66],
7	—	CD	NUMBER	—	num	9	SENT_8	[p2l1179t30r1415b66],
8	glycoprotein	NN	O	glycoprotein	nn	9	SENT_8	[p2l1179t30r1415b66],
9	expression	NN	O	expression	prep_of	4	SENT_8	[p2l1430t31r1601b66],
10	in	IN	O	in	_	0	SENT_8	[p2l1617t31r1644b58],
11	individuals	NNS	O	individual	prep_in	9	SENT_8	[p2l1660t30r1834b59],
12	is	VBZ	O	be	auxpass	13	SENT_8	[p2l1848t31r1872b59],
13	linked	VBN	O	link	rcmod	2	SENT_8	[p2l1886t30r1983b59],
14	to	TO	O	to	_	0	SENT_8	[p2l1998t33r2031b59],
15	a	DT	O	a	det	17	SENT_8	[p2l2045t38r2062b59],
16	Multidrug	JJ	MISC	multidrug	amod	17	SENT_8	[p2l134t76r290b112],
17	resistance	NN	O	resistance	prep_to	13	SENT_8	[p2l306t77r481b111],
18	;	:	O	;	_	0	SENT_8	[p2l306t77r481b111],
19	C3435T	NN	O	c3435t	nn	20	SENT_8	[p2l669t75r789b103],
20	polymorphism	NN	O	polymorphism	nsubjpass	41	SENT_8	[p2l803t75r1030b111],
21	of	IN	O	of	_	0	SENT_8	[p2l1045t75r1078b103],
22	the	DT	O	the	det	28	SENT_8	[p2l1090t75r1144b103],
23	multidrug-resistance	JJ	O	multidrug-resistance	amod	28	SENT_8	[p2l1159t75r1498b111],
24	1	CD	NUMBER	1	number	25	SENT_8	[p2l1514t76r1524b103],
25	(	CD	NUMBER	(	num	28	SENT_8	[p2l1545t76r1657b110],
26	MDR1	NN	O	mdr1	nn	28	SENT_8	[p2l1545t76r1657b110],
27	)	NN	O	)	nn	28	SENT_8	[p2l1545t76r1657b110],
28	gene	NN	O	gene	prep_of	20	SENT_8	[p2l1672t82r1760b111],
29	,	,	O	,	_	0	SENT_8	[p2l1672t82r1760b111],
30	and	CC	O	and	_	0	SENT_8	[p2l1776t75r1833b103],
31	the	DT	O	the	det	33	SENT_8	[p2l1848t75r1902b103],
32	CC	NN	O	cc	nn	33	SENT_8	[p2l1915t75r1957b103],
33	genoEpilepsy	NN	O	genoepilepsy	conj_and	28	SENT_8	[p2l1972t82r2060b111, p2l137t121r280b157],
34	;	:	O	;	_	0	SENT_8	[p2l1972t82r2060b111, p2l137t121r280b157],
35	type	NN	O	type	dep	33	SENT_8	[p2l669t123r741b156],
36	at	IN	O	at	_	0	SENT_8	[p2l760t123r793b149],
37	the	DT	O	the	det	39	SENT_8	[p2l811t120r865b149],
38	C3435T	NN	O	c3435t	nn	39	SENT_8	[p2l884t120r1004b149],
39	polymorphism	NN	O	polymorphism	prep_at	35	SENT_8	[p2l1024t120r1251b156],
40	was	VBD	O	be	auxpass	41	SENT_8	[p2l1270t128r1331b149],
41	reported	VBN	O	report	parataxis	13	SENT_8	[p2l1352t120r1492b156],
42	to	TO	O	to	aux	44	SENT_8	[p2l1513t123r1545b149],
43	be	VB	O	be	auxpass	44	SENT_8	[p2l1566t120r1604b149],
44	associated	VBN	O	associate	xcomp	41	SENT_8	[p2l1623t120r1792b149],
45	with	IN	O	with	_	0	SENT_8	[p2l1811t120r1882b149],
46	multidrug	JJ	O	multidrug	amod	48	SENT_8	[p2l1904t120r2062b156],
47	C3435T	NN	O	c3435t	nn	48	SENT_8	[p2l136t166r256b195],
48	polymorphism	NN	O	polymorphism	prep_with	44	SENT_8	[p2l270t166r509b202],
49	;	:	O	;	_	0	SENT_8	[p2l270t166r509b202],
50	resistance	NN	O	resistance	dep	2	SENT_8	[p2l670t166r834b194],
51	in	IN	O	in	_	0	SENT_8	[p2l850t166r878b193],
52	epilepsy	NN	O	epilepsy	nn	53	SENT_8	[p2l894t165r1029b201],
53	patients	NNS	O	patient	prep_in	50	SENT_8	[p2l1045t166r1188b201],
54	.	.	O	.	_	0	SENT_8	[p2l1045t166r1188b201],

1	Since	IN	O	since	mark	10	SENT_9	[p2l1207t165r1292b194],
2	population	NN	O	population	nn	3	SENT_9	[p2l1309t165r1481b201],
3	frequencies	NNS	O	frequency	nsubj	10	SENT_9	[p2l1498t165r1690b201],
4	of	IN	O	of	_	0	SENT_9	[p2l1705t165r1738b194],
5	polymorphic	JJ	O	polymorphic	amod	6	SENT_9	[p2l1753t165r1954b201],
6	genes	NNS	O	gene	prep_of	3	SENT_9	[p2l1970t172r2062b201],
7	MDR1	NN	O	mdr1	nn	8	SENT_9	[p2l135t212r218b240],
8	gene	NN	O	gene	dep	3	SENT_9	[p2l238t218r326b247],
9	;	:	O	;	_	0	SENT_9	[p2l238t218r326b247],
10	depend	VB	O	depend	advcl	16	SENT_9	[p2l669t210r788b246],
11	on	IN	O	on	_	0	SENT_9	[p2l804t218r841b239],
12	ethnic	JJ	O	ethnic	amod	13	SENT_9	[p2l857t210r960b239],
13	speciﬁcity	NN	O	speciﬁcity	prep_on	10	SENT_9	[p2l975t210r1147b246],
14	,	,	O	,	_	0	SENT_9	[p2l975t210r1147b246],
15	we	PRP	O	we	nsubj	16	SENT_9	[p2l1164t218r1211b239],
16	investigated	VBD	O	investigate	_	0	SENT_9	[p2l1226t210r1425b246],
17	functional	JJ	O	functional	amod	18	SENT_9	[p2l1441t210r1607b239],
18	signiﬁcance	NN	O	signiﬁcance	dobj	16	SENT_9	[p2l1623t210r1813b246],
19	of	IN	O	of	_	0	SENT_9	[p2l1828t210r1861b239],
20	the	DT	O	the	det	24	SENT_9	[p2l1874t210r1928b239],
21	C3435T	NNP	MISC	C3435T	nn	24	SENT_9	[p2l1943t210r2063b239],
22	Korean	NNP	MISC	Korean	nn	24	SENT_9	[p2l137t258r247b286],
23	population	NN	O	population	nn	24	SENT_9	[p2l263t257r436b293],
24	polymorphism	NN	O	polymorphism	prep_of	18	SENT_9	[p2l670t256r897b292],
25	of	IN	O	of	_	0	SENT_9	[p2l911t256r944b285],
26	the	DT	O	the	det	28	SENT_9	[p2l955t256r1008b285],
27	MDR1	NN	O	mdr1	nn	28	SENT_9	[p2l1020t256r1103b285],
28	gene	NN	O	gene	prep_of	24	SENT_9	[p2l1122t263r1199b292],
29	in	IN	O	in	_	0	SENT_9	[p2l1212t257r1239b284],
30	Korean	JJ	MISC	korean	amod	32	SENT_9	[p2l1255t257r1365b285],
31	epilepsy	NN	O	epilepsy	nn	32	SENT_9	[p2l1378t256r1513b292],
32	patients	NNS	O	patient	prep_in	16	SENT_9	[p2l1526t257r1669b292],
33	.	.	O	.	_	0	SENT_9	[p2l1526t257r1669b292],

1	One	CD	NUMBER	one	num	2	SENT_10	[p2l1685t256r1748b285],
2	hundred	CD	NUMBER	hundred	nsubjpass	22	SENT_10	[p2l1762t256r1895b285],
3	and	CC	NUMBER	and	_	0	SENT_10	[p2l1909t256r1966b285],
4	eight	CD	NUMBER	eight	num	5	SENT_10	[p2l1979t256r2062b292],
5	patients	NNS	O	patient	conj_and	2	SENT_10	[p2l670t302r802b337],
6	with	IN	O	with	_	0	SENT_10	[p2l814t301r885b330],
7	drug-responsive	JJ	O	drug-responsive	amod	8	SENT_10	[p2l899t301r1158b337],
8	epilepsy	NN	O	epilepsy	prep_with	2	SENT_10	[p2l1170t301r1311b337],
9	,	,	O	,	_	0	SENT_10	[p2l1170t301r1311b337],
10	63	CD	NUMBER	63	num	11	SENT_10	[p2l1327t301r1362b330],
11	patients	NNS	O	patient	conj_and	2	SENT_10	[p2l1377t302r1510b337],
12	with	IN	O	with	_	0	SENT_10	[p2l1521t301r1592b330],
13	drug-resistant	JJ	O	drug-resistant	amod	14	SENT_10	[p2l1606t301r1835b337],
14	epilepsy	NN	O	epilepsy	prep_with	11	SENT_10	[p2l1848t301r1988b337],
15	,	,	O	,	_	0	SENT_10	[p2l1848t301r1988b337],
16	and	CC	O	and	_	0	SENT_10	[p2l2004t301r2061b330],
17	219	CD	NUMBER	219	num	18	SENT_10	[p2l669t346r725b375],
18	control	NN	O	control	nsubjpass	22	SENT_10	[p2l735t346r851b375],
19	migraine	JJ	O	migraine	amod	20	SENT_10	[p2l863t347r1005b382],
20	subjects	NNS	O	subject	dep	18	SENT_10	[p2l1015t346r1150b382],
21	were	VBD	O	be	auxpass	22	SENT_10	[p2l1159t354r1241b375],
22	studied	VBN	O	study	_	0	SENT_10	[p2l1251t346r1381b381],
23	,	,	O	,	_	0	SENT_10	[p2l1251t346r1381b381],
24	but	CC	O	but	_	0	SENT_10	[p2l1396t346r1449b375],
25	the	DT	O	the	det	26	SENT_10	[p2l1459t346r1512b375],
26	analysis	NN	O	analysis	nsubj	29	SENT_10	[p2l1522t346r1648b382],
27	for	IN	O	for	_	0	SENT_10	[p2l1658t346r1705b375],
28	C3435Tallele	NN	O	c3435tallele	prep_for	26	SENT_10	[p2l1715t346r1930b375],
29	showed	VBD	O	show	conj_but	22	SENT_10	[p2l1941t346r2061b375],
30	no	DT	O	no	det	32	SENT_10	[p2l670t399r707b420],
31	signiﬁcant	JJ	O	signiﬁcant	amod	32	SENT_10	[p2l728t391r895b427],
32	association	NN	O	association	dobj	29	SENT_10	[p2l916t392r1095b420],
33	between	IN	O	between	_	0	SENT_10	[p2l1119t391r1259b420],
34	the	DT	O	the	det	36	SENT_10	[p2l1281t391r1334b420],
35	CC	NN	O	cc	nn	36	SENT_10	[p2l1356t392r1398b420],
36	genotype	NN	O	genotype	prep_between	32	SENT_10	[p2l1419t394r1570b427],
37	and	CC	O	and	_	0	SENT_10	[p2l1591t391r1648b420],
38	the	DT	O	the	det	40	SENT_10	[p2l1671t391r1724b420],
39	multidrug-resistant	JJ	O	multidrug-resistant	amod	40	SENT_10	[p2l1747t391r2062b427],
40	epilepsy	NN	O	epilepsy	conj_and	36	SENT_10	[p2l669t436r809b472],
41	.	.	O	.	_	0	SENT_10	[p2l669t436r809b472],

1	We	PRP	O	we	nsubj	2	SENT_11	[p2l827t437r877b465],
2	suggest	VBP	O	suggest	_	0	SENT_11	[p2l892t439r1013b472],
3	that	IN	O	that	complm	16	SENT_11	[p2l1029t436r1096b465],
4	inﬂuence	NN	O	inﬂuence	nsubj	16	SENT_11	[p2l1112t436r1262b465],
5	of	IN	O	of	_	0	SENT_11	[p2l1278t436r1311b465],
6	the	DT	O	the	det	8	SENT_11	[p2l1325t436r1378b465],
7	C3435T	NN	O	c3435t	nn	8	SENT_11	[p2l1395t436r1515b465],
8	polymorphism	NN	O	polymorphism	prep_of	4	SENT_11	[p2l1531t436r1758b472],
9	in	IN	O	in	_	0	SENT_11	[p2l1776t437r1803b464],
10	the	DT	O	the	det	12	SENT_11	[p2l1820t436r1873b465],
11	multidrugresistant	JJ	O	multidrugresistant	amod	12	SENT_11	[p2l1890t436r2060b472, p2l670t482r811b510],
12	epilepsy	NN	O	epilepsy	prep_in	8	SENT_11	[p2l822t481r957b517],
13	may	MD	O	may	aux	16	SENT_11	[p2l969t489r1036b517],
14	not	RB	O	not	neg	16	SENT_11	[p2l1048t484r1100b510],
15	be	VB	O	be	cop	16	SENT_11	[p2l1112t481r1150b510],
16	signiﬁcant	JJ	O	signiﬁcant	ccomp	2	SENT_11	[p2l1161t481r1328b517],
17	in	IN	O	in	_	0	SENT_11	[p2l1340t482r1367b509],
18	Korean	JJ	LOCATION	korean	amod	19	SENT_11	[p2l1381t482r1491b510],
19	populations	NNS	O	population	prep_in	16	SENT_11	[p2l1505t481r1694b517],
20	and	CC	O	and	_	0	SENT_11	[p2l1706t481r1763b510],
21	further	JJ	O	further	amod	22	SENT_11	[p2l1775t481r1892b510],
22	investigations	NNS	O	investigation	nsubj	29	SENT_11	[p2l1903t482r2060b517, p2l669t527r747b555],
23	in	IN	O	in	_	0	SENT_11	[p2l758t527r786b555],
24	various	JJ	O	various	amod	26	SENT_11	[p2l797t527r914b555],
25	ethnic	JJ	O	ethnic	amod	26	SENT_11	[p2l925t526r1027b555],
26	populations	NNS	O	population	prep_in	22	SENT_11	[p2l1039t526r1228b562],
27	would	MD	O	would	aux	29	SENT_11	[p2l1238t526r1335b555],
28	be	VB	O	be	cop	29	SENT_11	[p2l1349t526r1386b555],
29	necessary	JJ	O	necessary	conj_and	16	SENT_11	[p2l1399t534r1557b562],
30	to	TO	O	to	aux	31	SENT_11	[p2l1568t529r1600b555],
31	clarify	VB	O	clarify	xcomp	29	SENT_11	[p2l1611t526r1715b562],
32	the	DT	O	the	det	33	SENT_11	[p2l1726t526r1779b555],
33	effect	NN	O	effect	dobj	31	SENT_11	[p2l1790t526r1889b555],
34	of	IN	O	of	_	0	SENT_11	[p2l1900t526r1933b555],
35	C3435T	NN	O	c3435t	nn	36	SENT_11	[p2l1943t527r2063b555],
36	polymorphism	NN	O	polymorphism	prep_of	33	SENT_11	[p2l670t571r897b607],
37	on	IN	O	on	_	0	SENT_11	[p2l913t579r950b600],
38	the	DT	O	the	det	40	SENT_11	[p2l965t571r1019b600],
39	mutidrug	NN	O	mutidrug	nn	40	SENT_11	[p2l1034t571r1181b607],
40	resistance	NN	O	resistance	prep_on	31	SENT_11	[p2l1197t572r1361b600],
41	in	IN	O	in	_	0	SENT_11	[p2l1376t572r1404b599],
42	epilepsy	NN	O	epilepsy	nn	43	SENT_11	[p2l1419t571r1554b607],
43	patients	NNS	O	patient	prep_in	40	SENT_11	[p2l1569t572r1711b607],
44	.	.	O	.	_	0	SENT_11	[p2l1569t572r1711b607],

1	©	RB	O	©	advmod	2	SENT_12	[p2l671t618r702b651],
2	2006	CD	DATE	2006	_	0	SENT_12	[p2l719t616r794b645],
3	British	JJ	O	british	dep	2	SENT_12	[p2l810t616r912b645],
4	Epilepsy	NNP	ORGANIZATION	Epilepsy	nn	5	SENT_12	[p2l929t616r1062b652],
5	Association	NNP	ORGANIZATION	Association	dep	3	SENT_12	[p2l1075t617r1269b645],
6	.	.	O	.	_	0	SENT_12	[p2l1075t617r1269b645],

1	Published	VBN	O	publish	_	0	SENT_13	[p2l1288t616r1443b645],
2	by	IN	O	by	_	0	SENT_13	[p2l1459t616r1496b652],
3	Elsevier	NNP	ORGANIZATION	Elsevier	nn	4	SENT_13	[p2l1511t616r1638b645],
4	Ltd.	NNP	ORGANIZATION	Ltd.	prep_by	1	SENT_13	[p2l1652t616r1713b645],
5	.	.	O	.	_	0	SENT_13	[p2l1652t616r1713b645],

1	All	DT	O	all	det	2	SENT_14	[p2l1730t616r1773b645],
2	rights	NNS	O	rights	nsubj	3	SENT_14	[p2l1789t616r1879b652],
3	reserved	VBN	O	reserve	_	0	SENT_14	[p2l1895t616r2045b645],
4	.	.	O	.	_	0	SENT_14	[p2l1895t616r2045b645],

1	Introduction	NN	O	introduction	_	0	SENT_15	[p2l14t885r615b966],

1	Resistance	NN	O	resistance	nsubj	5	SENT_16	[p2l13t1114r419b1180],
2	to	TO	O	to	_	0	SENT_16	[p2l483t1119r561b1180],
3	antiepileptic	JJ	O	antiepileptic	amod	4	SENT_16	[p2l623t1113r1124b1198],
4	drugs	NNS	O	drug	prep_to	1	SENT_16	[p2l1188t1113r1395b1198],
5	(	VBP	O	(	_	0	SENT_16	[p2l1463t1114r1704b1198],
6	AEDs	NNS	MISC	aed	dobj	5	SENT_16	[p2l1463t1114r1704b1198],
7	)	CD	NUMBER	)	nsubj	8	SENT_16	[p2l1463t1114r1704b1198],
8	affects	VBZ	O	affect	rcmod	6	SENT_16	[p2l1770t1113r2039b1180],
9	approximately	RB	O	approximately	quantmod	10	SENT_16	[p2l10t1221r577b1305],
10	30	CD	PERCENT	30	num	11	SENT_16	[p2l635t1222r774b1288],
11	%	NN	PERCENT	%	dobj	8	SENT_16	[p2l635t1222r774b1288],
12	of	IN	O	of	_	0	SENT_16	[p2l832t1221r910b1288],
13	patients	NNS	O	patient	prep_of	11	SENT_16	[p2l968t1222r1285b1305],
14	with	IN	O	with	_	0	SENT_16	[p2l1341t1221r1509b1288],
15	epilepsy	NN	O	epilepsy	prep_with	13	SENT_16	[p2l1570t1221r1906b1305],
16	.	.	O	.	_	0	SENT_16	[p2l1570t1221r1906b1305],

1	In	IN	O	in	_	0	SENT_17	[p2l1976t1223r2036b1287],
2	addition	NN	O	addition	pobj	1	SENT_17	[p2l10t1327r328b1395],
3	to	TO	O	to	_	0	SENT_17	[p2l364t1334r442b1395],
4	potential	JJ	O	potential	amod	5	SENT_17	[p2l477t1327r831b1412],
5	causes	NNS	O	cause	prep_to	2	SENT_17	[p2l864t1346r1117b1395],
6	of	IN	O	of	_	0	SENT_17	[p2l1149t1327r1227b1395],
7	apparent	JJ	O	apparent	amod	8	SENT_17	[p2l1257t1334r1610b1412],
8	resistance	NN	O	resistance	prep_of	5	SENT_17	[p2l1646t1329r2039b1395],
9	such	JJ	O	such	_	0	SENT_17	[p2l9t1434r177b1501],
10	as	IN	O	as	_	0	SENT_17	[p2l210t1452r286b1501],
11	poor	JJ	O	poor	amod	13	SENT_17	[p2l318t1452r491b1519],
12	drug	NN	O	drug	nn	13	SENT_17	[p2l518t1434r689b1519],
13	compliance	NN	O	compliance	prep_such_as	8	SENT_17	[p2l718t1434r1166b1519],
14	or	CC	O	or	_	0	SENT_17	[p2l1195t1452r1274b1501],
15	suboptimal	JJ	O	suboptimal	amod	16	SENT_17	[p2l1300t1434r1731b1519],
16	dosing	NN	O	dosing	prep_such_as	8	SENT_17	[p2l1761t1434r2032b1519],
17	,	,	O	,	_	0	SENT_17	[p2l1761t1434r2032b1519],
18	several	JJ	O	several	amod	20	SENT_17	[p2l9t1542r287b1609],
19	clinical	JJ	O	clinical	amod	20	SENT_17	[p2l336t1542r616b1609],
20	features	NNS	O	feature	conj_or	8	SENT_17	[p2l665t1542r990b1609],
21	like	IN	O	like	_	0	SENT_17	[p2l1042t1542r1178b1609],
22	early	JJ	O	early	amod	24	SENT_17	[p2l1227t1542r1423b1626],
23	seizure	NN	O	seizure	nn	24	SENT_17	[p2l1471t1543r1747b1609],
24	onset	NN	O	onset	prep_like	20	SENT_17	[p2l1797t1548r2031b1624],
25	,	,	O	,	_	0	SENT_17	[p2l1797t1548r2031b1624],
26	length	NN	O	length	conj_or	8	SENT_17	[p2l13t1649r252b1734],
27	of	IN	O	of	_	0	SENT_17	[p2l291t1649r369b1716],
28	seizure	NN	O	seizure	nn	29	SENT_17	[p2l401t1651r677b1716],
29	history	NN	O	history	prep_of	26	SENT_17	[p2l715t1649r980b1734],
30	before	IN	O	before	_	0	SENT_17	[p2l1016t1649r1268b1716],
31	treatment	NN	O	treatment	prep_before	29	SENT_17	[p2l1304t1655r1729b1731],
32	,	,	O	,	_	0	SENT_17	[p2l1304t1655r1729b1731],
33	or	CC	O	or	_	0	SENT_17	[p2l1772t1667r1852b1716],
34	several	JJ	O	several	amod	36	SENT_17	[p2l1884t1667r2035b1716, p2l9t1756r159b1823],
35	pathologic	JJ	O	pathologic	amod	36	SENT_17	[p2l192t1756r598b1840],
36	characteristics	NNS	O	characteristic	conj_or	8	SENT_17	[p2l627t1756r1205b1823],
37	such	JJ	O	such	_	0	SENT_17	[p2l1233t1756r1401b1823],
38	as	IN	O	as	_	0	SENT_17	[p2l1434t1774r1510b1823],
39	hippocampal	NN	O	hippocampal	prep_such_as	36	SENT_17	[p2l1541t1756r2039b1840],

1	*	NN	O	*	nn	2	SENT_18	[p2l53t2036r76b2058],
2	Correspondence	NN	O	correspondence	_	0	SENT_18	[p2l117t2035r620b2103],
3	to	TO	O	to	_	0	SENT_18	[p2l643t2040r724b2089],
4	:	:	O	:	_	0	SENT_18	[p2l643t2040r724b2089],
5	Department	NNP	ORGANIZATION	Department	prep_to	2	SENT_18	[p2l757t2036r1129b2103],
6	of	IN	ORGANIZATION	of	_	0	SENT_18	[p2l1151t2035r1214b2089],
7	Neurology	NNP	ORGANIZATION	Neurology	prep_of	5	SENT_18	[p2l1238t2035r1560b2103],
8	,	,	O	,	_	0	SENT_18	[p2l1238t2035r1560b2103],
9	Seoul	NNP	ORGANIZATION	Seoul	nn	12	SENT_18	[p2l1590t2035r1755b2089],
10	National	NNP	ORGANIZATION	National	nn	12	SENT_18	[p2l1782t2035r2039b2089],
11	University	NNP	ORGANIZATION	University	nn	12	SENT_18	[p2l11t2125r324b2192],
12	Hospital	NNP	ORGANIZATION	Hospital	appos	5	SENT_18	[p2l354t2124r625b2192],
13	,	,	O	,	_	0	SENT_18	[p2l354t2124r625b2192],
14	28	CD	NUMBER	28	num	16	SENT_18	[p2l661t2124r731b2178],
15	Yongkeun	NN	PERSON	yongkeun	nn	16	SENT_18	[p2l760t2124r1051b2192],
16	dong	NN	O	dong	appos	12	SENT_18	[p2l1083t2124r1250b2192],
17	,	,	O	,	_	0	SENT_18	[p2l1083t2124r1250b2192],
18	Chongno	NNP	PERSON	Chongno	nn	19	SENT_18	[p2l1286t2124r1552b2192],
19	Ku	NNP	PERSON	Ku	appos	12	SENT_18	[p2l1584t2125r1675b2189],
20	,	,	O	,	_	0	SENT_18	[p2l1584t2125r1675b2189],
21	Seoul	NNP	LOCATION	Seoul	appos	12	SENT_18	[p2l1711t2124r1877b2178],
22	110744	CD	NUMBER	110744	num	21	SENT_18	[p2l1911t2124r2036b2178, p2l9t2214r136b2279],
23	,	,	O	,	_	0	SENT_18	[p2l1911t2124r2036b2178, p2l9t2214r136b2279],
24	Korea	NNP	LOCATION	Korea	appos	12	SENT_18	[p2l172t2214r365b2267],
25	.	.	O	.	_	0	SENT_18	[p2l172t2214r365b2267],

1	Tel.	NNP	O	Tel.	_	0	SENT_19	[p2l397t2213r533b2267],
2	:	:	O	:	_	0	SENT_19	[p2l397t2213r533b2267],
3	+82	CD	NUMBER	+82	number	4	SENT_19	[p2l568t2213r673b2267],
4	2	CD	NUMBER	2	dep	1	SENT_19	[p2l701t2213r734b2266],
5	20722923	CD	NUMBER	20722923	dep	4	SENT_19	[p2l763t2213r1076b2279],
6	;	:	O	;	_	0	SENT_19	[p2l763t2213r1076b2279],
7	fax	NN	O	fax	dep	1	SENT_19	[p2l1109t2213r1223b2267],
8	:	:	O	:	_	0	SENT_19	[p2l1109t2213r1223b2267],
9	+82	CD	NUMBER	+82	number	10	SENT_19	[p2l1259t2213r1364b2267],
10	2	CD	NUMBER	2	dep	7	SENT_19	[p2l1392t2213r1424b2266],
11	36727553	CD	NUMBER	36727553	dep	10	SENT_19	[p2l1455t2213r1766b2267],
12	.	.	O	.	_	0	SENT_19	[p2l1455t2213r1766b2267],

1	E-mail	NN	O	e-mail	nn	2	SENT_20	[p2l115t2302r316b2356],
2	address	NN	O	address	_	0	SENT_20	[p2l343t2302r601b2356],
3	:	:	O	:	_	0	SENT_20	[p2l343t2302r601b2356],
4	sangunlee@dreamwiz.com	FW	O	sangunlee@dreamwiz.com	nn	5	SENT_20	[p2l632t2302r1458b2370],
5	(	FW	O	(	dep	2	SENT_20	[p2l1493t2303r1631b2370],
6	S.K.	NNP	PERSON	S.K.	nn	8	SENT_20	[p2l1493t2303r1631b2370],
7	Lee	NNP	PERSON	Lee	nn	8	SENT_20	[p2l1667t2303r1819b2370],
8	)	NNP	O	)	dep	5	SENT_20	[p2l1667t2303r1819b2370],
9	.	.	O	.	_	0	SENT_20	[p2l1667t2303r1819b2370],

1	sclerosis	NN	O	sclerosis	nsubjpass	8	SENT_21	[p2l60t2699r397b2768],
2	and	CC	O	and	_	0	SENT_21	[p2l443t2699r583b2768],
3	severe	JJ	O	severe	amod	5	SENT_21	[p2l633t2718r894b2768],
4	brain	NN	O	brain	nn	5	SENT_21	[p2l944t2699r1144b2768],
5	injury	NN	O	injury	nsubjpass	8	SENT_21	[p2l1193t2701r1429b2786],
6	have	VBP	O	have	aux	8	SENT_21	[p2l1477t2699r1662b2768],
7	been	VBN	O	be	auxpass	8	SENT_21	[p2l1712t2699r1901b2768],
8	associated	VBN	O	associate	_	0	SENT_21	[p2l1952t2718r2144b2768, p2l59t2809r307b2878],
9	with	IN	O	with	_	0	SENT_21	[p2l344t2809r519b2879],
10	a	DT	O	a	det	12	SENT_21	[p2l558t2828r599b2879],
11	high	JJ	O	high	amod	12	SENT_21	[p2l639t2809r799b2896],
12	rate	NN	O	rate	prep_with	8	SENT_21	[p2l841t2816r1002b2878],
13	of	IN	O	of	_	0	SENT_21	[p2l1038t2809r1119b2878],
14	drug	NN	O	drug	nn	15	SENT_21	[p2l1151t2809r1329b2896],
15	resistance	NN	O	resistance	prep_of	12	SENT_21	[p2l1368t2792r1832b2879],
16	.	.	O	.	_	0	SENT_21	[p2l1368t2792r1832b2879],

1	‘	NN	O	‘	_	0	SENT_22	[p2l1368t2792r1832b2879],

1	Progress	NNP	O	Progress	nsubj	6	SENT_23	[p2l174t2920r494b3005],
2	in	IN	O	in	_	0	SENT_23	[p2l559t2920r625b2987],
3	epilepsy	NN	O	epilepsy	nn	4	SENT_23	[p2l693t2919r1020b3005],
4	research	NN	O	research	prep_in	1	SENT_23	[p2l1085t2919r1417b2988],
5	has	VBZ	O	have	aux	6	SENT_23	[p2l1488t2919r1614b2987],
6	shown	VBN	O	show	_	0	SENT_23	[p2l1677t2919r1919b2987],
7	that	IN	O	that	complm	11	SENT_23	[p2l1987t2919r2151b2987],
8	genetic	JJ	O	genetic	amod	9	SENT_23	[p2l60t3029r353b3114],
9	variations	NNS	O	variation	nsubj	11	SENT_23	[p2l375t3029r765b3096],
10	can	MD	O	can	aux	11	SENT_23	[p2l790t3046r923b3096],
11	affect	VB	O	affect	ccomp	6	SENT_23	[p2l952t3027r1190b3096],
12	responsiveness	NN	O	responsiveness	dobj	11	SENT_23	[p2l1218t3029r1800b3114],
13	to	TO	O	to	_	0	SENT_23	[p2l1825t3034r1905b3096],
14	AEDs	NNS	MISC	aed	prep_to	11	SENT_23	[p2l1927t3028r2142b3096],
15	.	.	O	.	_	0	SENT_23	[p2l1927t3028r2142b3096],

1	The	DT	O	the	det	9	SENT_24	[p2l57t3136r205b3205],
2	multidrug-resistance	JJ	O	multidrug-resistance	amod	9	SENT_24	[p2l246t3136r1064b3223],
3	1	CD	NUMBER	1	number	4	SENT_24	[p2l1108t3138r1132b3204],
4	(	CD	NUMBER	(	dep	2	SENT_24	[p2l1189t3137r1459b3223],
5	MDR1	NN	O	mdr1	nn	9	SENT_24	[p2l1189t3137r1459b3223],
6	)	NN	O	)	nn	9	SENT_24	[p2l1189t3137r1459b3223],
7	gene	NN	O	gene	nn	9	SENT_24	[p2l1501t3153r1688b3223],
8	product	NN	O	product	nn	9	SENT_24	[p2l1729t3136r2033b3223],
9	Pglycoprotein	NN	PERSON	pglycoprotein	nsubj	10	SENT_24	[p2l2074t3137r2144b3204, p2l60t3246r551b3332],
10	is	VBZ	O	be	_	0	SENT_24	[p2l596t3247r653b3314],
11	of	IN	O	of	_	0	SENT_24	[p2l693t3246r774b3314],
12	particular	JJ	O	particular	amod	13	SENT_24	[p2l815t3246r1203b3332],
13	interest	NN	O	interest	prep_of	10	SENT_24	[p2l1242t3247r1575b3330],
14	,	,	O	,	_	0	SENT_24	[p2l1242t3247r1575b3330],
15	and	CC	O	and	_	0	SENT_24	[p2l1625t3246r1764b3314],
16	was	VBD	O	be	cop	17	SENT_24	[p2l1806t3264r1955b3315],
17	ﬁrst	JJ	O	ﬁrst	conj_and	10	SENT_24	[p2l1996t3246r2151b3314],
18	identiﬁed	VBN	O	identiﬁed	dep	17	SENT_24	[p2l60t3355r437b3424],
19	in	IN	O	in	_	0	SENT_24	[p2l469t3356r536b3423],
20	cancer	NN	O	cancer	nn	21	SENT_24	[p2l568t3374r834b3424],
21	cells	NNS	O	cell	prep_in	18	SENT_24	[p2l860t3355r1037b3424],
22	as	IN	O	as	_	0	SENT_24	[p2l1066t3374r1146b3424],
23	a	DT	O	a	det	24	SENT_24	[p2l1174t3374r1216b3424],
24	protein	NN	O	protein	nn	32	SENT_24	[p2l1249t3356r1530b3441],
25	responsible	JJ	O	responsible	amod	32	SENT_24	[p2l1566t3355r2009b3441],
26	for	IN	O	for	_	0	SENT_24	[p2l2039t3355r2153b3424],
27	resistance	NN	O	resistance	prep_for	25	SENT_24	[p2l63t3466r459b3533],
28	to	TO	O	to	_	0	SENT_24	[p2l558t3471r638b3533],
29	many	JJ	O	many	amod	30	SENT_24	[p2l737t3483r948b3551],
30	drugs	NNS	O	drug	prep_to	25	SENT_24	[p2l1043t3447r1320b3551],
31	.2	NN	NUMBER	.2	nn	32	SENT_24	[p2l1043t3447r1320b3551],
32	P	NN	O	p	prep_as	21	SENT_24	[p2l1422t3464r1992b3551],
33	—	CD	NUMBER	—	num	34	SENT_24	[p2l1422t3464r1992b3551],
34	glycoprotein	NN	O	glycoprotein	nsubjpass	36	SENT_24	[p2l1422t3464r1992b3551],
35	is	VBZ	O	be	auxpass	36	SENT_24	[p2l2093t3466r2151b3533],
36	expressed	VBN	O	express	ccomp	18	SENT_24	[p2l59t3573r450b3660],
37	in	IN	O	in	_	0	SENT_24	[p2l504t3575r572b3641],
38	normal	JJ	O	normal	amod	39	SENT_24	[p2l628t3573r900b3642],
39	tissues	NNS	O	tissue	prep_in	36	SENT_24	[p2l952t3575r1238b3657],
40	,	,	O	,	_	0	SENT_24	[p2l952t3575r1238b3657],
41	where	WRB	O	where	advmod	43	SENT_24	[p2l1295t3573r1541b3642],
42	it	PRP	O	it	nsubj	43	SENT_24	[p2l1594t3575r1651b3642],
43	performs	VBZ	O	perform	rcmod	39	SENT_24	[p2l1703t3573r2056b3660],
44	a	DT	O	a	det	46	SENT_24	[p2l2107t3592r2149b3642],
45	defensive	JJ	O	defensive	amod	46	SENT_24	[p2l60t3682r439b3751],
46	role	NN	O	role	dobj	43	SENT_24	[p2l488t3682r638b3751],
47	against	IN	O	against	_	0	SENT_24	[p2l683t3683r964b3769],
48	potentially	RB	O	potentially	advmod	49	SENT_24	[p2l1011t3682r1441b3769],
49	toxic	JJ	O	toxic	amod	50	SENT_24	[p2l1485t3684r1678b3751],
50	substances	NNS	O	substance	prep_against	46	SENT_24	[p2l1723t3682r2151b3751],
51	in	IN	O	in	_	0	SENT_24	[p3l60t19r127b85],
52	intestinal	JJ	O	intestinal	amod	53	SENT_24	[p3l171t18r542b87],
53	cells	NNS	O	cell	prep_in	50	SENT_24	[p3l583t18r785b101],
54	,	,	O	,	_	0	SENT_24	[p3l583t18r785b101],
55	renal	JJ	O	renal	amod	58	SENT_24	[p3l837t18r1034b87],
56	proximal	JJ	O	proximal	amod	58	SENT_24	[p3l1078t18r1421b104],
57	tubule	NN	O	tubule	nn	58	SENT_24	[p3l1463t18r1717b87],
58	cells	NNS	O	cell	appos	53	SENT_24	[p3l1758t18r1959b102],
59	,	,	O	,	_	0	SENT_24	[p3l1758t18r1959b102],
60	and	CC	O	and	_	0	SENT_24	[p3l2008t18r2146b86],
61	in	IN	O	in	_	0	SENT_24	[p3l60t128r127b194],
62	the	DT	O	the	det	64	SENT_24	[p3l150t126r279b195],
63	endothelial	JJ	O	endothelial	amod	64	SENT_24	[p3l299t126r748b195],
64	cells	NNS	O	cell	prep_in	74	SENT_24	[p3l768t126r945b195],
65	of	IN	O	of	_	0	SENT_24	[p3l964t126r1045b195],
66	the	DT	O	the	det	67	SENT_24	[p3l1062t126r1190b195],
67	brain	NN	O	brain	prep_of	64	SENT_24	[p3l1213t126r1409b195],
68	capillary	JJ	O	capillary	amod	71	SENT_24	[p3l1432t126r1774b213],
69	endothelium	NN	O	endothelium	nn	71	SENT_24	[p3l1792t126r2144b195, p3l63t218r296b305],
70	.3	NN	NUMBER	.3	nn	71	SENT_24	[p3l1792t126r2144b195, p3l63t218r296b305],
71	MDR1	NN	O	mdr1	nsubj	74	SENT_24	[p3l314t237r516b305],
72	is	VBZ	O	be	cop	74	SENT_24	[p3l548t237r604b305],
73	highly	RB	O	highly	advmod	74	SENT_24	[p3l625t235r859b323],
74	polymorphic	JJ	O	polymorphic	conj_and	18	SENT_24	[p3l877t236r1363b323],
75	and	CC	O	and	_	0	SENT_24	[p3l1383t236r1520b304],
76	the	DT	O	the	det	77	SENT_24	[p3l1542t236r1671b305],
77	‘	NN	O	‘	nsubjpass	88	SENT_24	[p3l1696t236r2151b323],
78	apparently	RB	O	apparently	advmod	82	SENT_24	[p3l1696t236r2151b323],
79	silent	JJ	O	silent	amod	82	SENT_24	[p3l60t346r301b414],
80	’	NN	O	’	nn	82	SENT_24	[p3l60t346r301b414],
81	C3435T	NN	O	c3435t	nn	82	SENT_24	[p3l355t346r648b415],
82	polymorphism	NN	O	polymorphism	rcmod	77	SENT_24	[p3l694t346r1244b432],
83	in	IN	O	in	_	0	SENT_24	[p3l1294t347r1362b413],
84	exon	NN	O	exon	prep_in	82	SENT_24	[p3l1411t364r1596b414],
85	26	CD	NUMBER	26	num	84	SENT_24	[p3l1645t346r1734b415],
86	has	VBZ	O	have	aux	88	SENT_24	[p3l1785t346r1911b415],
87	been	VBN	O	be	auxpass	88	SENT_24	[p3l1959t346r2147b414],
88	correlated	VBN	O	correlate	dep	17	SENT_24	[p3l59t455r470b524],
89	with	IN	O	with	_	0	SENT_24	[p3l525t455r698b524],
90	the	DT	O	the	det	91	SENT_24	[p3l755t455r884b524],
91	expression	NN	O	expression	prep_with	88	SENT_24	[p3l939t456r1352b541],
92	of	IN	O	of	_	0	SENT_24	[p3l1409t455r1490b524],
93	P-glycoprotein	NN	O	p-glycoprotein	prep_of	91	SENT_24	[p3l1544t455r2141b541],
94	.	.	O	.	_	0	SENT_24	[p3l1544t455r2141b541],

1	1059-1311	CD	DATE	1059-1311	_	0	SENT_25	[p3l228t602r408b634],
2	/	:	O	/	punct	1	SENT_25	[p3l228t602r408b634],
3	S	NN	O	s	nsubj	5	SENT_25	[p3l228t602r408b634],
4	—	CD	NUMBER	—	num	3	SENT_25	[p3l422t619r443b621],
5	see	VBP	O	see	dep	1	SENT_25	[p3l457t611r504b630],
6	front	JJ	O	front	amod	7	SENT_25	[p3l516t604r589b630],
7	matter	NN	O	matter	dobj	5	SENT_25	[p3l602t607r702b630],
8	2006	CD	DATE	2006	num	7	SENT_25	[p3l758t604r825b630],
9	British	JJ	O	british	amod	11	SENT_25	[p3l839t604r930b630],
10	Epilepsy	NNP	ORGANIZATION	Epilepsy	nn	11	SENT_25	[p3l945t604r1063b636],
11	Association	NNP	ORGANIZATION	Association	dep	7	SENT_25	[p3l1074t605r1246b630],
12	.	.	O	.	_	0	SENT_25	[p3l1074t605r1246b630],

1	Published	VBN	O	publish	_	0	SENT_26	[p3l1263t604r1400b630],
2	by	IN	O	by	_	0	SENT_26	[p3l1415t604r1447b636],
3	Elsevier	NNP	ORGANIZATION	Elsevier	nn	4	SENT_26	[p3l1460t604r1573b630],
4	Ltd.	NNP	ORGANIZATION	Ltd.	prep_by	1	SENT_26	[p3l1586t604r1640b630],
5	.	.	O	.	_	0	SENT_26	[p3l1586t604r1640b630],

1	All	DT	O	all	det	2	SENT_27	[p3l1655t604r1693b630],
2	rights	NNS	O	rights	nsubj	3	SENT_27	[p3l1707t604r1787b636],
3	reserved	VBN	O	reserve	_	0	SENT_27	[p3l1801t604r1934b630],
4	.	.	O	.	_	0	SENT_27	[p3l1801t604r1934b630],

1	doi	FW	O	doi	_	0	SENT_28	[p3l226t646r680b678],
2	:10.1016	CD	NUMBER	:10.1016	dep	1	SENT_28	[p3l226t646r680b678],
3	/	:	O	/	punct	5	SENT_28	[p3l226t646r680b678],
4	j.	NN	O	j.	nn	5	SENT_28	[p3l226t646r680b678],
5	seizure	NN	O	seizure	dep	2	SENT_28	[p3l226t646r680b678],
6	.2006.02	CD	NUMBER	.2006.02	dep	2	SENT_28	[p3l226t646r680b678],
7	.	.	O	.	_	0	SENT_28	[p3l226t646r680b678],

1	MDR1	NN	O	mdr1	nn	3	SENT_29	[p3l96t754r189b785],
2	C3435T	NN	O	c3435t	nn	3	SENT_29	[p3l211t753r345b785],
3	polymorphism	NN	O	polymorphism	_	0	SENT_29	[p3l362t753r614b793],
4	345	CD	NUMBER	345	dep	3	SENT_29	[p3l2001t753r2062b785],

1	People	NNS	O	people	dep	101	SENT_30	[p3l12t920r279b1010],
2	homozygous	JJ	O	homozygous	dep	101	SENT_30	[p3l313t920r803b1010],
3	for	IN	O	for	dep	101	SENT_30	[p3l833t920r950b991],
4	the	DT	O	the	dep	101	SENT_30	[p3l980t920r1112b991],
5	C	NN	O	c	dep	101	SENT_30	[p3l1145t921r1194b991],
6	allele	NN	O	allele	dep	101	SENT_30	[p3l1227t920r1451b991],
7	have	VBP	O	have	dep	101	SENT_30	[p3l1486t920r1672b991],
8	on	IN	O	on	dep	101	SENT_30	[p3l1704t939r1797b991],
9	average	JJ	O	average	dep	101	SENT_30	[p3l1832t937r2151b1010],
10	substantially	RB	O	substantially	dep	101	SENT_30	[p3l8t1033r524b1122],
11	higher	JJR	O	higher	dep	101	SENT_30	[p3l560t1033r813b1122],
12	P-glycoprotein	NN	MISC	p-glycoprotein	dep	101	SENT_30	[p3l849t1033r1434b1122],
13	expressions	NNS	O	expression	dep	101	SENT_30	[p3l1471t1034r1935b1122],
14	than	IN	O	than	dep	101	SENT_30	[p3l1970t1033r2149b1104],
15	those	DT	O	those	dep	101	SENT_30	[p3l8t1144r226b1215],
16	homozygous	JJ	O	homozygous	dep	101	SENT_30	[p3l265t1144r755b1234],
17	for	IN	O	for	dep	101	SENT_30	[p3l790t1144r907b1215],
18	the	DT	O	the	dep	101	SENT_30	[p3l941t1144r1073b1215],
19	T	NN	O	t	dep	101	SENT_30	[p3l1106t1146r1160b1215],
20	allele	NN	O	allele	dep	101	SENT_30	[p3l1184t1127r1478b1215],
21	.4	CD	NUMBER	.4	dep	101	SENT_30	[p3l1184t1127r1478b1215],
22	With	IN	O	with	dep	101	SENT_30	[p3l1511t1144r1695b1215],
23	regards	VBZ	O	regard	dep	101	SENT_30	[p3l1738t1144r2034b1234],
24	to	TO	O	to	dep	101	SENT_30	[p3l2070t1151r2152b1215],
25	epilepsy	NN	O	epilepsy	dep	101	SENT_30	[p3l8t1259r343b1349],
26	treatment	NN	O	treatment	dep	101	SENT_30	[p3l404t1266r846b1346],
27	,	,	O	,	_	0	SENT_30	[p3l404t1266r846b1346],
28	P-glycoprotein	NN	O	p-glycoprotein	dep	101	SENT_30	[p3l922t1259r1506b1349],
29	can	MD	O	can	dep	101	SENT_30	[p3l1573t1278r1710b1330],
30	transport	VB	O	transport	dep	101	SENT_30	[p3l1776t1266r2152b1349],
31	many	JJ	O	many	dep	101	SENT_30	[p3l11t1389r227b1460],
32	AEDs	NNS	O	aed	dep	101	SENT_30	[p3l278t1371r474b1441],
33	of	IN	O	of	dep	101	SENT_30	[p3l528t1370r610b1441],
34	different	JJ	O	different	dep	101	SENT_30	[p3l663t1370r1026b1441],
35	action	NN	O	action	dep	101	SENT_30	[p3l1082t1372r1329b1441],
36	mechanisms	NNS	O	mechanism	dep	101	SENT_30	[p3l1391t1353r1948b1457],
37	,5	CD	NUMBER	,5	dep	101	SENT_30	[p3l1391t1353r1948b1457],
38	and	CC	O	and	dep	101	SENT_30	[p3l2006t1370r2148b1441],
39	the	DT	O	the	dep	101	SENT_30	[p3l8t1485r141b1556],
40	increased	VBN	O	increase	dep	101	SENT_30	[p3l166t1485r551b1556],
41	expression	NN	O	expression	dep	101	SENT_30	[p3l578t1486r1002b1574],
42	of	IN	O	of	dep	101	SENT_30	[p3l1028t1485r1111b1556],
43	P-glycoprotei	NN	MISC	p-glycoproteus	dep	101	SENT_30	[p3l1135t1485r1670b1574],
44	n	NN	O	n	dep	101	SENT_30	[p3l1681t1504r1721b1555],
45	was	VBD	O	be	dep	101	SENT_30	[p3l1745t1504r1897b1556],
46	found	VBN	O	find	dep	101	SENT_30	[p3l1920t1485r2148b1556],
47	in	IN	O	in	dep	101	SENT_30	[p3l9t1599r77b1668],
48	the	DT	O	the	dep	101	SENT_30	[p3l136t1598r268b1669],
49	brain	NN	O	brain	dep	101	SENT_30	[p3l327t1598r527b1669],
50	specimens	NNS	O	specimen	dep	101	SENT_30	[p3l587t1599r1005b1687],
51	of	IN	O	of	dep	101	SENT_30	[p3l1060t1598r1142b1669],
52	those	DT	O	those	dep	101	SENT_30	[p3l1195t1598r1413b1669],
53	with	IN	O	with	dep	101	SENT_30	[p3l1466t1598r1643b1669],
54	intractable	JJ	O	intractable	dep	101	SENT_30	[p3l1702t1598r2151b1669],
55	epilepsy	NN	O	epilepsy	dep	101	SENT_30	[p3l8t1692r461b1799],
56	.6	CD	NUMBER	.6	dep	101	SENT_30	[p3l8t1692r461b1799],
57	’	NN	O	’	dep	101	SENT_30	[p3l8t1692r461b1799],
58	7	CD	NUMBER	7	dep	101	SENT_30	[p3l8t1692r461b1799],
59	Recently	RB	DATE	recently	dep	101	SENT_30	[p3l507t1709r868b1799],
60	,	,	O	,	_	0	SENT_30	[p3l507t1709r868b1799],
61	it	PRP	O	it	dep	101	SENT_30	[p3l919t1711r978b1780],
62	has	VBZ	O	have	dep	101	SENT_30	[p3l1023t1709r1151b1780],
63	been	VBN	O	be	dep	101	SENT_30	[p3l1196t1709r1388b1780],
64	documented	VBN	O	document	dep	101	SENT_30	[p3l1434t1709r1937b1780],
65	that	IN	O	that	dep	101	SENT_30	[p3l1984t1709r2152b1780],
66	patients	NNS	O	patient	dep	101	SENT_30	[p3l11t1826r340b1914],
67	with	IN	O	with	dep	101	SENT_30	[p3l367t1824r543b1895],
68	drug-resistant	JJ	O	drug-resistant	dep	101	SENT_30	[p3l577t1824r1144b1914],
69	epilepsy	NN	O	epilepsy	dep	101	SENT_30	[p3l1174t1824r1508b1914],
70	are	VBP	O	be	dep	101	SENT_30	[p3l1538t1843r1666b1895],
71	more	RBR	O	more	dep	101	SENT_30	[p3l1700t1843r1905b1895],
72	likely	JJ	O	likely	dep	101	SENT_30	[p3l1938t1824r2152b1913],
73	to	TO	O	to	dep	101	SENT_30	[p3l8t1944r90b2008],
74	have	VB	O	have	dep	101	SENT_30	[p3l115t1937r301b2008],
75	the	DT	O	the	dep	101	SENT_30	[p3l325t1937r457b2008],
76	CC	NN	O	cc	dep	101	SENT_30	[p3l479t1937r585b2008],
77	genotype	NN	O	genotype	dep	101	SENT_30	[p3l608t1944r982b2026],
78	at	IN	O	at	dep	101	SENT_30	[p3l1005t1944r1085b2008],
79	the	DT	O	the	dep	101	SENT_30	[p3l1108t1937r1240b2008],
80	C3435T	NN	O	c3435t	dep	101	SENT_30	[p3l1263t1937r1562b2008],
81	polymorphism	NN	O	polymorphism	dep	101	SENT_30	[p3l1584t1937r2149b2026],
82	than	IN	O	than	dep	101	SENT_30	[p3l8t2048r187b2119],
83	those	DT	O	those	dep	101	SENT_30	[p3l227t2048r445b2119],
84	with	IN	O	with	dep	101	SENT_30	[p3l480t2048r657b2119],
85	drug-responsive	JJ	O	drug-responsive	dep	101	SENT_30	[p3l698t2048r1341b2138],
86	epilepsy	NN	O	epilepsy	dep	101	SENT_30	[p3l1378t2030r1769b2138],
87	,8	NN	O	,8	dep	101	SENT_30	[p3l1378t2030r1769b2138],
88	and	CC	O	and	dep	101	SENT_30	[p3l1807t2048r1949b2119],
89	several	JJ	O	several	dep	101	SENT_30	[p3l1989t2068r2146b2119, p3l8t2163r164b2234],
90	conﬂicting	VBG	O	conﬂicting	dep	101	SENT_30	[p3l232t2163r658b2253],
91	reports9	NN	O	reports9	dep	101	SENT_30	[p3l728t2145r1164b2253],
92	‘“	CD	NUMBER	‘“	dep	101	SENT_30	[p3l728t2145r1164b2253],
93	have	VBP	O	have	dep	101	SENT_30	[p3l1243t2163r1429b2234],
94	been	VBN	O	be	dep	101	SENT_30	[p3l1500t2163r1691b2234],
95	published	VBN	O	publish	dep	101	SENT_30	[p3l1765t2163r2148b2253],
96	regarding	VBG	O	regard	dep	101	SENT_30	[p3l12t2275r393b2365],
97	conﬁrmation	NN	O	conﬁrmation	dep	101	SENT_30	[p3l425t2275r938b2346],
98	of	IN	O	of	dep	101	SENT_30	[p3l973t2275r1056b2346],
99	the	DT	O	the	dep	101	SENT_30	[p3l1085t2275r1216b2346],
100	previous	JJ	O	previous	dep	101	SENT_30	[p3l1252t2277r1588b2365],
101	report	NN	O	report	_	0	SENT_30	[p3l1624t2282r1900b2365],
102	.	.	O	.	_	0	SENT_30	[p3l1624t2282r1900b2365],

1	Population	NNP	O	Population	nn	2	SENT_31	[p3l125t2389r548b2478],
2	frequencies	NNS	O	frequency	nsubj	10	SENT_31	[p3l571t2389r1045b2478],
3	of	IN	O	of	_	0	SENT_31	[p3l1065t2389r1148b2460],
4	many	JJ	O	many	amod	6	SENT_31	[p3l1167t2408r1383b2478],
5	polymorphic	JJ	O	polymorphic	amod	6	SENT_31	[p3l1403t2389r1901b2478],
6	genes	NNS	O	gene	prep_of	2	SENT_31	[p3l1922t2406r2152b2478],
7	of	IN	O	of	_	0	SENT_31	[p3l8t2502r90b2573],
8	pharmacogenetic	JJ	O	pharmacogenetic	amod	9	SENT_31	[p3l127t2502r829b2591],
9	interest	NN	O	interest	prep_of	6	SENT_31	[p3l867t2503r1184b2573],
10	depend	VB	O	depend	_	0	SENT_31	[p3l1221t2502r1519b2591],
11	on	IN	O	on	_	0	SENT_31	[p3l1559t2521r1652b2573],
12	ethnic	JJ	O	ethnic	amod	13	SENT_31	[p3l1692t2502r1947b2573],
13	speciﬁcity	NN	O	speciﬁcity	prep_on	10	SENT_31	[p3l1984t2521r2146b2591, p3l8t2614r294b2704],
14	.	.	O	.	_	0	SENT_31	[p3l1984t2521r2146b2591, p3l8t2614r294b2704],

1	Association	NNP	O	Association	nsubj	16	SENT_32	[p3l335t2615r788b2685],
2	of	IN	O	of	_	0	SENT_32	[p3l825t2614r906b2685],
3	these	DT	O	these	det	4	SENT_32	[p3l938t2614r1157b2685],
4	genes	NNS	O	gene	prep_of	1	SENT_32	[p3l1192t2632r1422b2704],
5	with	IN	O	with	_	0	SENT_32	[p3l1454t2614r1630b2685],
6	interindividual	JJ	O	interindividual	amod	7	SENT_32	[p3l1667t2614r2146b2685, p3l8t2728r179b2799],
7	differences	NNS	O	difference	prep_with	4	SENT_32	[p3l247t2728r704b2799],
8	in	IN	O	in	_	0	SENT_32	[p3l771t2730r839b2798],
9	drug	NN	O	drug	nn	10	SENT_32	[p3l909t2728r1088b2818],
10	effectiveness	NN	O	effectiveness	prep_in	7	SENT_32	[p3l1154t2728r1695b2799],
11	and	CC	O	and	_	0	SENT_32	[p3l1760t2728r1902b2799],
12	drug	NN	O	drug	nn	13	SENT_32	[p3l1972t2728r2152b2818],
13	toxicity	NN	O	toxicity	conj_and	10	SENT_32	[p3l8t2842r316b2930],
14	may	MD	O	may	aux	16	SENT_32	[p3l336t2860r501b2930],
15	also	RB	O	also	advmod	16	SENT_32	[p3l520t2841r676b2912],
16	depend	VB	O	depend	_	0	SENT_32	[p3l695t2841r992b2930],
17	on	IN	O	on	_	0	SENT_32	[p3l1014t2860r1107b2912],
18	the	DT	O	the	det	20	SENT_32	[p3l1129t2841r1262b2912],
19	ethnic	JJ	O	ethnic	amod	20	SENT_32	[p3l1281t2841r1535b2912],
20	characteristics	NNS	O	characteristic	prep_on	16	SENT_32	[p3l1555t2841r2151b2912],
21	of	IN	O	of	_	0	SENT_32	[p3l8t2952r90b3023],
22	a	DT	O	a	det	23	SENT_32	[p3l107t2972r150b3023],
23	population	NN	O	population	prep_of	20	SENT_32	[p3l174t2952r629b3042],
24	.	.	O	.	_	0	SENT_32	[p3l174t2952r629b3042],

1	12	CD	NUMBER	12	dep	8	SENT_33	[p3l646t2934r710b2981],
2	Since	IN	O	since	dep	8	SENT_33	[p3l730t2953r941b3024],
3	the	DT	O	the	det	5	SENT_33	[p3l962t2952r1093b3024],
4	C3435T	NN	O	c3435t	nn	5	SENT_33	[p3l1114t2953r1414b3024],
5	polymorphism	NN	O	polymorphism	nsubjpass	8	SENT_33	[p3l1434t2952r1998b3042],
6	has	VBZ	O	have	aux	8	SENT_33	[p3l2023t2952r2151b3024],
7	been	VBN	O	be	auxpass	8	SENT_33	[p3l11t3067r203b3138],
8	detected	VBN	O	detect	advcl	22	SENT_33	[p3l259t3067r622b3138],
9	in	IN	O	in	_	0	SENT_33	[p3l680t3069r747b3137],
10	various	JJ	O	various	amod	12	SENT_33	[p3l802t3069r1090b3138],
11	ethnic	JJ	O	ethnic	amod	12	SENT_33	[p3l1143t3067r1396b3138],
12	populations	NNS	O	population	prep_in	8	SENT_33	[p3l1454t3067r1921b3157],
13	with	IN	O	with	_	0	SENT_33	[p3l1972t3067r2149b3138],
14	considerable	JJ	O	considerable	amod	16	SENT_33	[p3l8t3178r524b3249],
15	ethnic	JJ	O	ethnic	amod	16	SENT_33	[p3l552t3178r806b3249],
16	variation	NN	O	variation	prep_with	8	SENT_33	[p3l832t3180r1192b3249],
17	in	IN	O	in	_	0	SENT_33	[p3l1225t3180r1293b3249],
18	frequency	NN	O	frequency	prep_in	16	SENT_33	[p3l1324t3160r1825b3268],
19	,	,	O	,	_	0	SENT_33	[p3l1324t3160r1825b3268],
20	”	CD	NUMBER	”	appos	18	SENT_33	[p3l1324t3160r1825b3268],
21	we	PRP	O	we	nsubj	22	SENT_33	[p3l1852t3198r1970b3249],
22	studied	VBD	O	study	_	0	SENT_33	[p3l1999t3185r2146b3249, p3l8t3293r179b3364],
23	the	DT	O	the	det	25	SENT_33	[p3l206t3293r338b3364],
24	allele	NN	O	allele	nn	25	SENT_33	[p3l362t3293r586b3364],
25	frequencies	NNS	O	frequency	dobj	22	SENT_33	[p3l609t3293r1084b3382],
26	of	IN	O	of	_	0	SENT_33	[p3l1108t3293r1190b3364],
27	the	DT	O	the	det	29	SENT_33	[p3l1211t3293r1342b3364],
28	C3435T	NN	O	c3435t	nn	29	SENT_33	[p3l1366t3294r1666b3364],
29	polymorphism	NN	O	polymorphism	prep_of	25	SENT_33	[p3l1690t3293r2146b3382, p3l9t3407r140b3477],
30	with	IN	O	with	_	0	SENT_33	[p3l174t3406r350b3477],
31	drug-responsive	JJ	O	drug-responsive	amod	34	SENT_33	[p3l385t3406r1027b3495],
32	or	CC	O	or	_	0	SENT_33	[p3l1059t3425r1143b3477],
33	drug-resistant	JJ	O	drug-resistant	amod	34	SENT_33	[p3l1173t3406r1740b3495],
34	epilepsy	NN	O	epilepsy	prep_with	22	SENT_33	[p3l1773t3406r2119b3495],
35	.	.	O	.	_	0	SENT_33	[p3l1773t3406r2119b3495],

1	Methods	NNS	O	method	_	0	SENT_34	[p3l6t3665r437b3751],

1	Subjects	NNS	O	subject	_	0	SENT_35	[p4l9t112r410b211],

1	Patients	NNS	O	patient	nsubjpass	4	SENT_36	[p4l12t348r342b417],
2	were	VBD	O	be	auxpass	4	SENT_36	[p4l380t365r586b417],
3	consecutively	RB	O	consecutively	advmod	4	SENT_36	[p4l627t346r1192b436],
4	recruited	VBN	O	recruit	_	0	SENT_36	[p4l1235t346r1611b417],
5	through	IN	O	through	_	0	SENT_36	[p4l1657t346r1972b436],
6	the	DT	O	the	det	8	SENT_36	[p4l2017t346r2150b417],
7	epilepsy	NN	O	epilepsy	nn	8	SENT_36	[p4l8t458r349b548],
8	clinic	NN	O	clinic	prep_through	4	SENT_36	[p4l372t458r591b529],
9	at	IN	O	at	_	0	SENT_36	[p4l617t465r698b529],
10	Seoul	NNP	ORGANIZATION	Seoul	nn	13	SENT_36	[p4l724t458r942b530],
11	National	NNP	ORGANIZATION	National	nn	13	SENT_36	[p4l973t458r1313b529],
12	University	NNP	ORGANIZATION	University	nn	13	SENT_36	[p4l1344t460r1757b548],
13	Hospital	NNP	ORGANIZATION	Hospital	prep_at	4	SENT_36	[p4l1784t458r2142b548],
14	.	.	O	.	_	0	SENT_36	[p4l1784t458r2142b548],

1	Drug-resistant	JJ	O	drug-resistant	nsubjpass	6	SENT_37	[p4l12t573r593b661],
2	or	CC	O	or	_	0	SENT_37	[p4l663t591r746b643],
3	drug-responsive	JJ	O	drug-responsive	amod	4	SENT_37	[p4l814t572r1469b661],
4	epilepsy	NN	O	epilepsy	nsubjpass	6	SENT_37	[p4l1539t572r1880b661],
5	were	VBD	O	be	auxpass	6	SENT_37	[p4l1945t591r2150b643],
6	determined	VBN	O	determine	_	0	SENT_37	[p4l8t684r486b756],
7	according	VBG	O	accord	_	0	SENT_37	[p4l514t684r912b774],
8	to	TO	O	to	prepc_according_to	6	SENT_37	[p4l936t691r1018b756],
9	the	DT	O	the	det	11	SENT_37	[p4l1042t684r1176b756],
10	following	VBG	O	follow	amod	11	SENT_37	[p4l1199t684r1578b774],
11	criteria	NNS	O	criterion	pobj	6	SENT_37	[p4l1601t686r1932b756],
12	.	.	O	.	_	0	SENT_37	[p4l1601t686r1932b756],

1	Drug	NN	O	drug	nn	2	SENT_38	[p4l1968t686r2150b774],
2	resistance	NN	O	resistance	nsubjpass	4	SENT_38	[p4l12t798r426b866],
3	was	VBD	O	be	auxpass	4	SENT_38	[p4l453t815r607b867],
4	deﬁned	VBN	O	deﬁned	_	0	SENT_38	[p4l636t796r938b866],
5	as	IN	O	as	_	0	SENT_38	[p4l972t815r1053b866],
6	the	DT	O	the	det	7	SENT_38	[p4l1082t796r1215b866],
7	occurrence	NN	O	occurrence	prep_as	4	SENT_38	[p4l1245t815r1705b866],
8	of	IN	O	of	_	0	SENT_38	[p4l1735t796r1817b866],
9	at	IN	O	at	quantmod	11	SENT_38	[p4l1844t803r1925b866],
10	least	JJS	O	least	mwe	9	SENT_38	[p4l1958t796r2151b866],
11	four	CD	NUMBER	four	num	12	SENT_38	[p4l8t910r177b981],
12	seizures	NNS	O	seizure	prep_of	7	SENT_38	[p4l205t911r534b981],
13	over	IN	O	over	_	0	SENT_38	[p4l564t929r745b981],
14	the	DT	DATE	the	det	15	SENT_38	[p4l774t910r907b981],
15	year	NN	DATE	year	prep_over	12	SENT_38	[p4l935t929r1117b999],
16	before	IN	DATE	before	_	0	SENT_38	[p4l1147t910r1414b981],
17	recruitment	NN	O	recruitment	prep_before	15	SENT_38	[p4l1448t911r1941b981],
18	with	IN	O	with	_	0	SENT_38	[p4l1969t910r2147b981],
19	trials	NNS	O	trial	prep_with	4	SENT_38	[p4l8t1023r217b1094],
20	of	IN	O	of	_	0	SENT_38	[p4l252t1023r334b1094],
21	more	JJR	O	more	mwe	22	SENT_38	[p4l369t1042r576b1094],
22	than	IN	O	than	quantmod	23	SENT_38	[p4l612t1023r791b1094],
23	three	CD	NUMBER	three	num	25	SENT_38	[p4l830t1023r1051b1094],
24	antiepileptic	JJ	O	antiepileptic	amod	25	SENT_38	[p4l1087t1023r1616b1112],
25	medications	NNS	O	medication	prep_of	19	SENT_38	[p4l1653t1023r2151b1094],
26	at	IN	O	at	advmod	27	SENT_38	[p4l9t1141r90b1205],
27	maximal	JJ	O	maximal	amod	25	SENT_38	[p4l118t1134r464b1205],
28	tolerated	VBN	O	tolerate	partmod	25	SENT_38	[p4l492t1134r874b1205],
29	doses	NNS	O	dose	dobj	28	SENT_38	[p4l905t1134r1153b1220],
30	,	,	O	,	_	0	SENT_38	[p4l905t1134r1153b1220],
31	which	WDT	O	which	nsubjpass	33	SENT_38	[p4l1186t1134r1424b1205],
32	were	VBD	O	be	auxpass	33	SENT_38	[p4l1452t1153r1657b1205],
33	established	VBN	O	establish	rcmod	25	SENT_38	[p4l1683t1134r2147b1205],
34	by	IN	O	by	_	0	SENT_38	[p4l11t1248r103b1338],
35	the	DT	O	the	det	36	SENT_38	[p4l138t1248r272b1319],
36	occurrence	NN	O	occurrence	agent	33	SENT_38	[p4l309t1267r769b1319],
37	of	IN	O	of	_	0	SENT_38	[p4l807t1248r889b1319],
38	clinical	JJ	O	clinical	amod	40	SENT_38	[p4l923t1248r1217b1319],
39	side	JJ	O	side	amod	40	SENT_38	[p4l1255t1248r1417b1319],
40	effects	NNS	O	effect	prep_of	36	SENT_38	[p4l1454t1248r1740b1319],
41	at	IN	O	at	_	0	SENT_38	[p4l1778t1255r1859b1319],
42	supramaximal	JJ	O	supramaximal	amod	43	SENT_38	[p4l1895t1267r2145b1338, p4l11t1359r357b1429],
43	doses	NNS	O	dose	prep_at	33	SENT_38	[p4l395t1359r643b1429],
44	.	.	O	.	_	0	SENT_38	[p4l395t1359r643b1429],

1	Drug	NN	O	drug	nn	2	SENT_39	[p4l125t1474r307b1562],
2	responsiveness	NN	O	responsiveness	nsubjpass	4	SENT_39	[p4l372t1474r980b1562],
3	was	VBD	O	be	auxpass	4	SENT_39	[p4l1038t1492r1193b1544],
4	deﬁned	VBN	O	deﬁned	_	0	SENT_39	[p4l1253t1473r1556b1544],
5	as	IN	O	as	_	0	SENT_39	[p4l1621t1492r1702b1544],
6	complete	JJ	O	complete	amod	8	SENT_39	[p4l1762t1473r2150b1562],
7	seizure	NN	O	seizure	nn	8	SENT_39	[p4l8t1587r300b1657],
8	freedom	NN	O	freedom	prep_as	4	SENT_39	[p4l332t1585r676b1657],
9	for	IN	O	for	_	0	SENT_39	[p4l711t1585r829b1657],
10	at	IN	DURATION	at	advmod	13	SENT_39	[p4l859t1592r940b1657],
11	least	JJS	DURATION	least	pobj	10	SENT_39	[p4l975t1585r1168b1657],
12	an	DT	DURATION	a	det	13	SENT_39	[p4l1201t1605r1292b1657],
13	year	NN	DURATION	year	prep_for	8	SENT_39	[p4l1324t1605r1518b1675],
14	,	,	O	,	_	0	SENT_39	[p4l1324t1605r1518b1675],
15	up	RB	O	up	advmod	13	SENT_39	[p4l1560t1605r1655b1675],
16	to	TO	O	to	_	0	SENT_39	[p4l1687t1593r1769b1657],
17	the	DT	O	the	det	18	SENT_39	[p4l1801t1585r1934b1657],
18	date	NN	O	date	prep_to	15	SENT_39	[p4l1967t1585r2151b1657],
19	of	IN	O	of	_	0	SENT_39	[p4l8t1698r90b1769],
20	the	DT	O	the	det	23	SENT_39	[p4l136t1698r269b1769],
21	last	JJ	O	last	amod	23	SENT_39	[p4l322t1698r465b1769],
22	follow-up	JJ	O	follow-up	amod	23	SENT_39	[p4l513t1698r905b1788],
23	visit	NN	O	visit	prep_of	18	SENT_39	[p4l951t1700r1148b1769],
24	.	.	O	.	_	0	SENT_39	[p4l951t1700r1148b1769],

1	Control	NNP	O	Control	nn	2	SENT_40	[p4l1205t1698r1508b1770],
2	subjects	NNS	O	subject	nsubj	4	SENT_40	[p4l1557t1698r1900b1788],
3	were	VBD	O	be	cop	4	SENT_40	[p4l1945t1717r2150b1769],
4	individuals	NNS	O	individual	_	0	SENT_40	[p4l9t1812r450b1883],
5	with	IN	O	with	_	0	SENT_40	[p4l487t1812r666b1883],
6	migraine	NN	O	migraine	prep_with	4	SENT_40	[p4l712t1813r1070b1901],
7	without	IN	O	without	_	0	SENT_40	[p4l1108t1812r1428b1883],
8	a	DT	O	a	det	9	SENT_40	[p4l1469t1831r1512b1883],
9	history	NN	O	history	prep_without	4	SENT_40	[p4l1555t1812r1834b1901],
10	of	IN	O	of	_	0	SENT_40	[p4l1872t1812r1955b1883],
11	epilepsy	NN	O	epilepsy	prep_of	9	SENT_40	[p4l1992t1813r2145b1901, p4l12t1925r232b2014],
12	.	.	O	.	_	0	SENT_40	[p4l1992t1813r2145b1901, p4l12t1925r232b2014],

1	All	DT	O	all	det	5	SENT_41	[p4l272t1925r379b1996],
2	epilepsy	NN	O	epilepsy	nn	5	SENT_41	[p4l414t1925r755b2014],
3	and	CC	O	and	_	0	SENT_41	[p4l788t1925r931b1996],
4	control	NN	O	control	nn	5	SENT_41	[p4l968t1925r1261b1996],
5	patients	NNS	O	patient	nsubj	9	SENT_41	[p4l1299t1926r1633b2014],
6	were	VBD	O	be	cop	9	SENT_41	[p4l1665t1944r1870b1996],
7	ethnically	RB	O	ethnically	advmod	9	SENT_41	[p4l1904t1925r2146b1996, p4l8t2037r201b2127],
8	homogeneous	JJ	O	homogeneous	amod	9	SENT_41	[p4l284t2037r844b2127],
9	Koreans	NNPS	O	Koreans	_	0	SENT_41	[p4l927t2039r1270b2108],
10	.	.	O	.	_	0	SENT_41	[p4l927t2039r1270b2108],

1	We	PRP	O	we	nsubj	2	SENT_42	[p4l1358t2039r1481b2108],
2	analyzed	VBD	O	analyze	_	0	SENT_42	[p4l1563t2037r1925b2127],
3	108	CD	NUMBER	108	num	4	SENT_42	[p4l2014t2038r2149b2108],
4	patients	NNS	O	patient	dobj	2	SENT_42	[p4l11t2152r345b2240],
5	with	IN	O	with	_	0	SENT_42	[p4l378t2150r557b2221],
6	drug-responsive	JJ	O	drug-responsive	amod	7	SENT_42	[p4l596t2150r1251b2240],
7	epilepsy	NN	O	epilepsy	prep_with	4	SENT_42	[p4l1287t2150r1641b2240],
8	,	,	O	,	_	0	SENT_42	[p4l1287t2150r1641b2240],
9	63	CD	NUMBER	63	num	10	SENT_42	[p4l1686t2151r1774b2221],
10	patients	NNS	O	patient	conj_and	4	SENT_42	[p4l1817t2152r2151b2240],
11	with	IN	O	with	_	0	SENT_42	[p4l6t2263r184b2334],
12	drug-resistant	JJ	O	drug-resistant	amod	13	SENT_42	[p4l275t2263r855b2353],
13	epilepsy	NN	O	epilepsy	prep_with	10	SENT_42	[p4l942t2263r1297b2353],
14	,	,	O	,	_	0	SENT_42	[p4l942t2263r1297b2353],
15	and	CC	O	and	_	0	SENT_42	[p4l1394t2263r1537b2334],
16	219	CD	NUMBER	219	num	18	SENT_42	[p4l1627t2264r1767b2335],
17	control	NN	O	control	nn	18	SENT_42	[p4l1857t2263r2150b2334],
18	patients	NNS	O	patient	conj_and	4	SENT_42	[p4l11t2378r370b2466],
19	.	.	O	.	_	0	SENT_42	[p4l11t2378r370b2466],

1	The	DT	O	the	det	3	SENT_43	[p4l422t2377r576b2448],
2	demographic	JJ	O	demographic	amod	3	SENT_43	[p4l622t2377r1155b2466],
3	characteristics	NNS	O	characteristic	nsubjpass	7	SENT_43	[p4l1201t2377r1812b2448],
4	of	IN	O	of	_	0	SENT_43	[p4l1856t2377r1939b2448],
5	subjects	NNS	O	subject	prep_of	3	SENT_43	[p4l1981t2377r2145b2448, p4l6t2491r209b2579],
6	are	VBP	O	be	auxpass	7	SENT_43	[p4l247t2509r377b2561],
7	listed	VBN	O	list	_	0	SENT_43	[p4l418t2489r638b2561],
8	in	IN	O	in	_	0	SENT_43	[p4l678t2491r747b2560],
9	Table	NNP	O	Table	prep_in	7	SENT_43	[p4l784t2489r1004b2561],
10	1	CD	NUMBER	1	num	9	SENT_43	[p4l1047t2491r1111b2561],
11	.	.	O	.	_	0	SENT_43	[p4l1047t2491r1111b2561],

1	Identiﬁcation	NN	O	identiﬁcation	_	0	SENT_44	[p4l13t2749r638b2828],
2	of	IN	O	of	_	0	SENT_44	[p4l682t2750r778b2828],
3	MDR1	NN	O	mdr1	nn	4	SENT_44	[p4l810t2751r1057b2828],
4	polymorphisms	NNS	O	polymorphism	prep_of	1	SENT_44	[p4l1114t2749r1827b2848],

1	Blood	NN	O	blood	nn	2	SENT_45	[p4l12t2983r232b3054],
2	samples	NNS	O	sample	nsubj	3	SENT_45	[p4l274t2983r602b3073],
3	(	VBP	O	(	_	0	SENT_45	[p4l645t2985r715b3072],
4	5	CD	NUMBER	5	num	6	SENT_45	[p4l645t2985r715b3072],
5	ml	NN	O	ml	nn	6	SENT_45	[p4l749t2983r878b3072],
6	)	NN	O	)	nsubjpass	8	SENT_45	[p4l749t2983r878b3072],
7	were	VBD	O	be	auxpass	8	SENT_45	[p4l917t3002r1123b3054],
8	collected	VBN	O	collect	ccomp	3	SENT_45	[p4l1160t2983r1542b3054],
9	in	IN	O	in	_	0	SENT_45	[p4l1583t2985r1652b3053],
10	EDTA	NN	O	edta	nn	12	SENT_45	[p4l1697t2984r1898b3053],
11	vacutainer	NN	O	vacutainer	nn	12	SENT_45	[p4l1927t3002r2145b3054, p4l8t3097r257b3167],
12	tubes	NNS	O	tube	prep_in	8	SENT_45	[p4l288t3096r511b3167],
13	for	IN	O	for	_	0	SENT_45	[p4l544t3096r662b3167],
14	DNA	NN	O	dna	nn	15	SENT_45	[p4l696t3097r861b3167],
15	extraction	NN	O	extraction	prep_for	12	SENT_45	[p4l891t3097r1316b3167],
16	and	CC	O	and	_	0	SENT_45	[p4l1353t3096r1496b3167],
17	MDR1	NN	O	mdr1	nn	18	SENT_45	[p4l1530t3097r1739b3167],
18	genotyping	NN	O	genotyping	prep_for	12	SENT_45	[p4l1787t3103r2145b3185, p4l9t3210r153b3298],
19	.	.	O	.	_	0	SENT_45	[p4l1787t3103r2145b3185, p4l9t3210r153b3298],

1	Puriﬁed	JJ	O	puriﬁed	amod	3	SENT_46	[p4l235t3208r546b3279],
2	genomic	JJ	O	genomic	amod	3	SENT_46	[p4l619t3210r963b3298],
3	DNA	NN	MISC	dna	nsubjpass	5	SENT_46	[p4l1037t3209r1202b3279],
4	was	VBD	O	be	auxpass	5	SENT_46	[p4l1263t3227r1417b3279],
5	extracted	VBN	O	extract	_	0	SENT_46	[p4l1486t3208r1884b3279],
6	from	IN	O	from	prep	5	SENT_46	[p4l1957t3208r2148b3279],

1	Table	NNP	O	Table	_	0	SENT_47	[p4l62t3317r268b3381],
2	1	CD	NUMBER	1	num	3	SENT_47	[p4l310t3319r334b3380],
3	Characteristics	NNS	O	characteristic	dep	1	SENT_47	[p4l437t3317r991b3381],
4	of	IN	O	of	_	0	SENT_47	[p4l1024t3318r1098b3381],
5	patients	NNS	O	patient	prep_of	3	SENT_47	[p4l1131t3319r1431b3397],

1	Variable	JJ	O	variable	amod	4	SENT_48	[p4l62t3511r365b3574],
2	Drug-responsive	JJ	O	drug-responsive	amod	4	SENT_48	[p4l706t3512r1295b3591],
3	Drug-resistant	JJ	O	drug-resistant	amod	4	SENT_48	[p4l1474t3512r1995b3591],
4	epilepsy	NN	O	epilepsy	_	0	SENT_48	[p4l703t3613r1008b3693],
5	(	NN	O	(	nn	6	SENT_48	[p4l1045t3615r1123b3693],
6	N	NN	O	n	dep	4	SENT_48	[p4l1045t3615r1123b3693],
7	=	JJ	O	=	amod	15	SENT_48	[p4l1148t3639r1183b3660],
8	108	CD	NUMBER	108	number	9	SENT_48	[p4l1216t3614r1366b3693],
9	)	CD	NUMBER	)	dep	10	SENT_48	[p4l1216t3614r1366b3693],
10	epilepsy	NN	O	epilepsy	dep	15	SENT_48	[p4l1470t3613r1776b3693],
11	(	NN	O	(	nn	15	SENT_48	[p4l1812t3615r1890b3693],
12	N	NN	O	n	nn	15	SENT_48	[p4l1812t3615r1890b3693],
13	=	JJ	O	=	amod	15	SENT_48	[p4l1915t3639r1950b3660],
14	63	CD	NUMBER	63	num	15	SENT_48	[p4l1979t3614r2090b3693],
15	)	NN	O	)	dep	6	SENT_48	[p4l1979t3614r2090b3693],

1	Sex	NN	O	sex	_	0	SENT_49	[p5l65t22r190b85],

1	Male	JJ	O	male	_	0	SENT_50	[p5l147t123r320b186],
2	66	CD	NUMBER	66	number	3	SENT_50	[p5l703t123r785b186],
3	31	CD	NUMBER	31	dep	1	SENT_50	[p5l1472t123r1541b186],
4	Female	JJ	O	female	dep	1	SENT_50	[p5l153t225r419b290],
5	42	CD	NUMBER	42	number	6	SENT_50	[p5l701t226r785b289],
6	32	CD	NUMBER	32	dep	4	SENT_50	[p5l1472t226r1552b289],

1	Age	NNP	O	Age	_	0	SENT_51	[p5l62t377r198b456],
2	(	CD	NUMBER	(	num	3	SENT_51	[p5l236t378r448b456],
3	year	NN	NUMBER	year	dep	1	SENT_51	[p5l236t378r448b456],
4	)	IN	O	)	amod	3	SENT_51	[p5l236t378r448b456],

1	Mean	NN	O	mean	_	0	SENT_52	[p5l148t479r338b541],
2	1	CD	NUMBER	1	num	1	SENT_52	[p5l369t483r425b540],
3	:	:	O	:	_	0	SENT_52	[p5l369t483r425b540],
4	S.D.	NNP	O	S.D.	dep	1	SENT_52	[p5l453t478r594b541],
5	32.9	CD	NUMBER	32.9	dep	4	SENT_52	[p5l705t478r860b541],
6	i	FW	O	i	dep	9	SENT_52	[p5l889t483r946b540],
7	9.6	CD	NUMBER	9.6	dep	6	SENT_52	[p5l973t478r1087b541],
8	34.1	CD	NUMBER	34.1	dep	9	SENT_52	[p5l1472t478r1616b540],
9	i	FW	O	i	dep	1	SENT_52	[p5l1656t483r1713b540],
10	9.0	CD	NUMBER	9.0	dep	9	SENT_52	[p5l1741t478r1856b541],

1	Range	NNP	O	Range	_	0	SENT_53	[p5l153t581r371b660],
2	17-56	CD	NUMBER	17-56	num	3	SENT_53	[p5l708t581r935b643],
3	18-64	CD	NUMBER	18-64	dep	1	SENT_53	[p5l1475t581r1704b643],

1	peripheral	JJ	O	peripheral	amod	3	SENT_54	[p5l11t910r431b1000],
2	blood	NN	O	blood	nn	3	SENT_54	[p5l509t910r728b982],
3	leukocytes	NNS	O	leukocyte	_	0	SENT_54	[p5l810t910r1242b1000],
4	using	VBG	O	use	partmod	3	SENT_54	[p5l1319t912r1523b1000],
5	the	DT	O	the	det	8	SENT_54	[p5l1598t910r1731b982],
6	phenolchloroform	NN	O	phenolchloroform	nn	8	SENT_54	[p5l1809t910r2147b1000, p5l8t1024r455b1095],
7	extraction	NN	O	extraction	nn	8	SENT_54	[p5l484t1026r903b1095],
8	method	NN	O	method	dobj	4	SENT_54	[p5l936t1024r1270b1095],
9	.	.	O	.	_	0	SENT_54	[p5l936t1024r1270b1095],

1	Genotyping	VBG	O	genotype	_	0	SENT_55	[p5l1306t1025r1771b1114],
2	was	VBD	O	be	auxpass	3	SENT_55	[p5l1795t1043r1948b1095],
3	conducted	VBN	O	conduct	aux	1	SENT_55	[p5l1974t1043r2144b1095, p5l9t1136r288b1206],
4	using	VBG	O	use	xcomp	3	SENT_55	[p5l313t1137r516b1224],
5	an	DT	O	a	det	10	SENT_55	[p5l537t1155r628b1206],
6	ABI	NNP	O	ABI	nn	10	SENT_55	[p5l649t1137r773b1205],
7	7700	CD	NUMBER	7700	num	10	SENT_55	[p5l799t1137r988b1206],
8	sequence	NN	O	sequence	nn	10	SENT_55	[p5l1009t1155r1390b1224],
9	Detection	NN	O	detection	nn	10	SENT_55	[p5l1414t1137r1805b1206],
10	System	NN	O	system	dobj	4	SENT_55	[p5l1829t1137r2142b1224],
11	,	,	O	,	_	0	SENT_55	[p5l1829t1137r2142b1224],
12	or	CC	O	or	_	0	SENT_55	[p5l8t1267r92b1319],
13	"	``	O	"	punct	10	SENT_55	[p5l119t1230r635b1337],
14	Taqman	NNP	O	Taqman	dobj	4	SENT_55	[p5l119t1230r635b1337],
15	”	CD	NUMBER	”	num	17	SENT_55	[p5l119t1230r635b1337],
16	TM	NN	O	tm	nn	17	SENT_55	[p5l119t1230r635b1337],
17	assay	NN	O	assay	dep	14	SENT_55	[p5l656t1267r869b1337],
18	(	CD	NUMBER	(	num	21	SENT_55	[p5l895t1247r1228b1337],
19	Applied	NNP	O	Applied	nn	21	SENT_55	[p5l895t1247r1228b1337],
20	Biosystems	NNP	O	Biosystems	nn	21	SENT_55	[p5l1257t1249r1756b1337],
21	)	NN	O	)	nsubj	1	SENT_55	[p5l1257t1249r1756b1337],
22	.	.	O	.	_	0	SENT_55	[p5l1257t1249r1756b1337],

1	Polymerase	NN	MISC	polymerase	nn	6	SENT_56	[p5l1791t1247r2144b1337, p5l9t1380r139b1431],
2	chain	NN	O	chain	nn	6	SENT_56	[p5l183t1361r397b1431],
3	reaction	NN	O	reaction	nn	6	SENT_56	[p5l447t1362r778b1431],
4	(	CD	NUMBER	(	num	6	SENT_56	[p5l831t1361r1045b1449],
5	PCR	NN	O	pcr	nn	6	SENT_56	[p5l831t1361r1045b1449],
6	)	NN	O	)	nsubjpass	11	SENT_56	[p5l831t1361r1045b1449],
7	primers	NNS	O	primer	dep	6	SENT_56	[p5l1095t1362r1401b1449],
8	and	CC	O	and	_	0	SENT_56	[p5l1444t1361r1588b1431],
9	probes	NNS	O	probe	dep	6	SENT_56	[p5l1636t1361r1905b1449],
10	were	VBD	O	be	auxpass	11	SENT_56	[p5l1945t1380r2149b1431],
11	designed	VBN	O	design	_	0	SENT_56	[p5l9t1472r365b1562],
12	using	VBG	O	use	xcomp	11	SENT_56	[p5l414t1474r617b1562],
13	Primer	NN	O	primer	nn	14	SENT_56	[p5l664t1474r931b1543],
14	Express	NN	O	express	nsubj	16	SENT_56	[p5l976t1455r1367b1562],
15	”	CD	NUMBER	”	num	16	SENT_56	[p5l976t1455r1367b1562],
16	software	NN	O	software	xcomp	12	SENT_56	[p5l1408t1472r1764b1543],
17	(	CD	NUMBER	(	num	20	SENT_56	[p5l1813t1472r2146b1562],
18	Applied	NNP	O	Applied	nn	20	SENT_56	[p5l1813t1472r2146b1562],
19	Biosystems	NNP	O	Biosystems	nn	20	SENT_56	[p5l13t1587r512b1676],
20	)	NN	O	)	dep	16	SENT_56	[p5l13t1587r512b1676],
21	.	.	O	.	_	0	SENT_56	[p5l13t1587r512b1676],

1	Assay	NN	O	assay	nn	2	SENT_57	[p5l543t1587r765b1676],
2	design	NN	O	design	nsubjpass	6	SENT_57	[p5l789t1586r1043b1676],
3	and	CC	O	and	_	0	SENT_57	[p5l1073t1586r1216b1657],
4	conditions	NNS	O	condition	nsubjpass	6	SENT_57	[p5l1244t1586r1662b1657],
5	were	VBD	O	be	auxpass	6	SENT_57	[p5l1685t1605r1890b1657],
6	based	VBN	O	base	_	0	SENT_57	[p5l1918t1586r2146b1657],
7	on	IN	O	on	_	0	SENT_57	[p5l8t1718r101b1769],
8	the	DT	O	the	det	11	SENT_57	[p5l156t1699r290b1769],
9	allelic	JJ	O	allelic	amod	11	SENT_57	[p5l341t1699r587b1769],
10	discrimination	NN	O	discrimination	nn	11	SENT_57	[p5l639t1699r1218b1769],
11	protocol	NN	O	protocol	prep_on	6	SENT_57	[p5l1275t1699r1612b1787],
12	supplied	VBN	O	supply	partmod	11	SENT_57	[p5l1664t1699r2002b1787],
13	by	IN	O	by	_	0	SENT_57	[p5l2060t1699r2151b1787],
14	Applied	NNP	ORGANIZATION	Applied	nn	15	SENT_57	[p5l6t1811r313b1901],
15	Biosystems	NNPS	ORGANIZATION	Biosystems	agent	12	SENT_57	[p5l369t1813r833b1901],
16	.	.	O	.	_	0	SENT_57	[p5l369t1813r833b1901],

1	The	DT	O	the	det	5	SENT_58	[p5l888t1811r1041b1883],
2	cDNA	NN	O	cdna	nn	5	SENT_58	[p5l1088t1812r1302b1883],
3	3435C	NN	O	3435c	nn	5	SENT_58	[p5l1349t1812r1592b1883],
4	allele	NN	O	allele	nn	5	SENT_58	[p5l1642t1811r1867b1883],
5	probe	NN	O	probe	nsubjpass	19	SENT_58	[p5l1918t1811r2149b1901],
6	was	VBD	O	be	auxpass	7	SENT_58	[p5l6t1944r159b1996],
7	labeled	VBN	O	label	_	0	SENT_58	[p5l210t1925r505b1996],
8	on	IN	O	on	_	0	SENT_58	[p5l555t1944r648b1996],
9	the	DT	O	the	det	12	SENT_58	[p5l698t1925r832b1996],
10	5	CD	NUMBER	5	num	12	SENT_58	[p5l882t1924r943b1996],
11	’	NN	O	’	nn	12	SENT_58	[p5l882t1924r943b1996],
12	end	NN	O	end	prep_on	7	SENT_58	[p5l993t1925r1139b1996],
13	with	IN	O	with	_	0	SENT_58	[p5l1187t1925r1364b1996],
14	the	DT	O	the	det	16	SENT_58	[p5l1415t1925r1548b1996],
15	FAM	NN	O	fam	nn	16	SENT_58	[p5l1599t1926r1752b1996],
16	receptor	NN	O	receptor	prep_with	7	SENT_58	[p5l1801t1932r2152b2015],
17	dye	VB	O	dye	ccomp	7	SENT_58	[p5l9t2037r151b2125],
18	and	CC	O	and	_	0	SENT_58	[p5l172t2037r315b2107],
19	contained	VBD	O	contain	conj_and	7	SENT_58	[p5l339t2037r741b2107],
20	the	DT	O	the	det	22	SENT_58	[p5l764t2037r898b2107],
21	following	VBG	O	follow	amod	22	SENT_58	[p5l917t2037r1293b2125],
22	nucleotide	NN	O	nucleotide	dobj	19	SENT_58	[p5l1316t2037r1747b2107],
23	sequence	NN	O	sequence	dobj	7	SENT_58	[p5l1767t2056r2149b2125],
24	5	CD	NUMBER	5	dep	23	SENT_58	[p5l12t2147r1168b2234],
25	’	SYM	O	’	dep	28	SENT_58	[p5l12t2147r1168b2234],
26	-	:	O	-	_	0	SENT_58	[p5l12t2147r1168b2234],
27	CAAGATCCATQCCGACC-3	NN	O	caagatccatqccgacc-3	nn	28	SENT_58	[p5l12t2147r1168b2234],
28	’	NN	O	’	dep	23	SENT_58	[p5l12t2147r1168b2234],
29	.	.	O	.	_	0	SENT_58	[p5l12t2147r1168b2234],

1	The	DT	O	the	det	5	SENT_59	[p5l1213t2148r1365b2219],
2	cDNA	NN	O	cdna	nn	5	SENT_59	[p5l1403t2149r1617b2219],
3	3435T	NN	O	3435t	nn	5	SENT_59	[p5l1655t2149r1898b2219],
4	allele	NN	O	allele	nn	5	SENT_59	[p5l1924t2148r2149b2219],
5	probe	NN	O	probe	nsubjpass	19	SENT_59	[p5l11t2262r243b2351],
6	was	VBD	O	be	auxpass	7	SENT_59	[p5l262t2281r415b2333],
7	labeled	VBN	O	label	_	0	SENT_59	[p5l440t2262r735b2333],
8	on	IN	O	on	_	0	SENT_59	[p5l760t2281r853b2333],
9	the	DT	O	the	det	12	SENT_59	[p5l878t2262r1012b2333],
10	5	CD	NUMBER	5	num	12	SENT_59	[p5l1035t2261r1096b2333],
11	’	NN	O	’	nn	12	SENT_59	[p5l1035t2261r1096b2333],
12	end	NN	O	end	prep_on	7	SENT_59	[p5l1121t2262r1266b2333],
13	with	IN	O	with	_	0	SENT_59	[p5l1289t2262r1466b2333],
14	the	DT	O	the	det	16	SENT_59	[p5l1491t2262r1624b2333],
15	VIC	NN	O	vic	nn	16	SENT_59	[p5l1644t2263r1775b2333],
16	receptor	NN	O	receptor	prep_with	7	SENT_59	[p5l1801t2269r2152b2351],
17	dye	VB	O	dye	ccomp	7	SENT_59	[p5l9t2374r151b2464],
18	and	CC	O	and	_	0	SENT_59	[p5l172t2374r315b2446],
19	contained	VBD	O	contain	conj_and	7	SENT_59	[p5l339t2374r740b2446],
20	the	DT	O	the	det	22	SENT_59	[p5l764t2374r898b2446],
21	following	VBG	O	follow	amod	22	SENT_59	[p5l917t2374r1293b2464],
22	nucleotide	NN	O	nucleotide	dobj	19	SENT_59	[p5l1316t2374r1747b2446],
23	sequence	NN	O	sequence	dobj	7	SENT_59	[p5l1767t2394r2149b2464],
24	5	CD	NUMBER	5	dep	23	SENT_59	[p5l12t2485r1167b2572],
25	’	SYM	O	’	dep	28	SENT_59	[p5l12t2485r1167b2572],
26	-	:	O	-	_	0	SENT_59	[p5l12t2485r1167b2572],
27	CAAGATCCATICCGACC-3	NN	O	caagatccaticcgacc-3	nn	28	SENT_59	[p5l12t2485r1167b2572],
28	’	NN	O	’	dep	23	SENT_59	[p5l12t2485r1167b2572],
29	.	.	O	.	_	0	SENT_59	[p5l12t2485r1167b2572],

1	Forward	RB	O	forward	advmod	3	SENT_60	[p5l1243t2486r1570b2556],
2	and	CC	O	and	advmod	3	SENT_60	[p5l1639t2486r1780b2556],
3	reverse	VB	O	reverse	_	0	SENT_60	[p5l1852t2505r2149b2556],
4	primers	NNS	O	primer	dobj	3	SENT_60	[p5l11t2600r317b2687],
5	were	VBD	O	be	auxpass	6	SENT_60	[p5l343t2618r546b2669],
6	used	VBN	O	use	rcmod	4	SENT_60	[p5l576t2599r755b2669],
7	to	TO	O	to	aux	8	SENT_60	[p5l786t2606r868b2669],
8	amplify	VB	O	amplify	xcomp	6	SENT_60	[p5l896t2599r1202b2687],
9	the	DT	O	the	det	10	SENT_60	[p5l1228t2599r1361b2669],
10	region	NN	O	region	dobj	8	SENT_60	[p5l1392t2600r1640b2687],
11	surrounding	VBG	O	surround	partmod	10	SENT_60	[p5l1670t2599r2150b2687],
12	the	DT	O	the	det	14	SENT_60	[p5l9t2711r142b2783],
13	C3435T	NN	O	c3435t	nn	14	SENT_60	[p5l170t2712r471b2783],
14	polymorphism	NN	O	polymorphism	dobj	11	SENT_60	[p5l498t2711r1093b2801],
15	.	.	O	.	_	0	SENT_60	[p5l498t2711r1093b2801],

1	The	DT	O	the	det	3	SENT_61	[p5l1126t2711r1279b2783],
2	nucleotide	NN	O	nucleotide	nn	3	SENT_61	[p5l1309t2711r1739b2783],
3	sequence	NN	O	sequence	nsubj	12	SENT_61	[p5l1767t2731r2149b2801],
4	of	IN	O	of	_	0	SENT_61	[p5l8t2823r91b2894],
5	the	DT	O	the	det	7	SENT_61	[p5l146t2823r280b2894],
6	forward	JJ	O	forward	amod	7	SENT_61	[p5l338t2823r655b2894],
7	primer	NN	O	primer	prep_of	3	SENT_61	[p5l720t2825r992b2913],
8	was	VBD	O	be	cop	12	SENT_61	[p5l1046t2842r1198b2894],
9	5	CD	NUMBER	5	number	10	SENT_61	[p5l1260t2822r2144b2894, p5l9t2935r486b3008],
10	’	CD	NUMBER	’	num	12	SENT_61	[p5l1260t2822r2144b2894, p5l9t2935r486b3008],
11	TCTTCTTTGCTCCTCCATTGC-3	NN	O	tcttctttgctcctccattgc-3	nn	12	SENT_61	[p5l1260t2822r2144b2894, p5l9t2935r486b3008],
12	’	NN	O	’	_	0	SENT_61	[p5l1260t2822r2144b2894, p5l9t2935r486b3008],
13	and	CC	O	and	_	0	SENT_61	[p5l558t2937r701b3008],
14	of	IN	O	of	_	0	SENT_61	[p5l772t2937r855b3008],
15	the	DT	O	the	det	17	SENT_61	[p5l920t2937r1053b3008],
16	reverse	JJ	O	reverse	amod	17	SENT_61	[p5l1125t2956r1421b3008],
17	primer	NN	O	primer	prep_of	22	SENT_61	[p5l1493t2938r1765b3026],
18	was	VBD	O	be	cop	22	SENT_61	[p5l1829t2956r1981b3008],
19	5	CD	NUMBER	5	number	20	SENT_61	[p5l2052t2935r2144b3008, p5l6t3048r1259b3121],
20	’	CD	NUMBER	’	num	22	SENT_61	[p5l2052t2935r2144b3008, p5l6t3048r1259b3121],
21	TGAGCTGCGGTTTCTCTTCA-3	NN	O	tgagctgcggtttctcttca-3	nn	22	SENT_61	[p5l2052t2935r2144b3008, p5l6t3048r1259b3121],
22	’	NN	O	’	conj_and	12	SENT_61	[p5l2052t2935r2144b3008, p5l6t3048r1259b3121],
23	.	.	O	.	_	0	SENT_61	[p5l2052t2935r2144b3008, p5l6t3048r1259b3121],

1	PCR	NN	O	pcr	nn	2	SENT_62	[p5l1321t3050r1477b3121],
2	reactions	NNS	O	reaction	nsubjpass	4	SENT_62	[p5l1526t3051r1899b3121],
3	were	VBD	O	be	auxpass	4	SENT_62	[p5l1945t3069r2149b3121],
4	performed	VBN	O	perform	_	0	SENT_62	[p5l11t3164r437b3253],
5	in	IN	O	in	_	0	SENT_62	[p5l488t3165r556b3234],
6	a	DT	O	a	det	10	SENT_62	[p5l607t3183r650b3235],
7	reaction	NN	O	reaction	nn	10	SENT_62	[p5l702t3165r1034b3235],
8	volume	NN	O	volume	nn	10	SENT_62	[p5l1082t3164r1380b3235],
9	15.0	CD	NUMBER	15.0	num	10	SENT_62	[p5l1433t3164r1603b3235],
10	pll	NN	O	pll	prep_in	4	SENT_62	[p5l1635t3164r1714b3253],
11	using	VBG	O	use	xcomp	4	SENT_62	[p5l1765t3165r1968b3253],
12	the	DT	O	the	det	16	SENT_62	[p5l2016t3164r2150b3235],
13	hot	JJ	O	hot	amod	16	SENT_62	[p5l11t3276r369b3348],
14	—	NN	O	—	nn	16	SENT_62	[p5l11t3276r369b3348],
15	start	NN	O	start	nn	16	SENT_62	[p5l11t3276r369b3348],
16	format	NN	O	format	dobj	11	SENT_62	[p5l403t3276r706b3348],
17	.	.	O	.	_	0	SENT_62	[p5l403t3276r706b3348],

1	The	DT	O	the	det	3	SENT_63	[p5l746t3276r898b3348],
2	reaction	NN	O	reaction	nn	3	SENT_63	[p5l936t3278r1268b3348],
3	components	NNS	O	component	nsubj	4	SENT_63	[p5l1305t3284r1800b3366],
4	were	VBD	O	be	_	0	SENT_63	[p5l1831t3296r2035b3348],
5	as	IN	O	as	mark	6	SENT_63	[p5l2069t3296r2150b3348],
6	follows	VBZ	O	follow	advcl	4	SENT_63	[p5l8t3389r322b3460],
7	:	:	O	:	_	0	SENT_63	[p5l8t3389r322b3460],
8	2X	NN	O	2x	dobj	6	SENT_63	[p5l353t3390r450b3459],
9	Taqman	NNP	O	Taqman	nn	13	SENT_63	[p5l468t3391r783b3479],
10	Universal	NNP	O	Universal	nn	13	SENT_63	[p5l811t3389r1183b3460],
11	PCR	NN	O	pcr	nn	13	SENT_63	[p5l1210t3390r1365b3460],
12	Master	NN	O	master	nn	13	SENT_63	[p5l1383t3391r1658b3460],
13	Mix	NNP	O	Mix	dep	8	SENT_63	[p5l1675t3391r1837b3476],
14	,	,	O	,	_	0	SENT_63	[p5l1675t3391r1837b3476],
15	600	CD	NUMBER	600	num	16	SENT_63	[p5l1868t3390r2009b3460],
16	nM	NN	O	nm	dobj	6	SENT_63	[p5l2040t3391r2152b3460],
17	of	IN	O	of	_	0	SENT_63	[p5l8t3502r91b3572],
18	each	DT	O	each	det	19	SENT_63	[p5l123t3502r310b3572],
19	primer	NN	O	primer	prep_of	16	SENT_63	[p5l352t3503r634b3590],
20	,	,	O	,	_	0	SENT_63	[p5l352t3503r634b3590],
21	100	CD	NUMBER	100	num	22	SENT_63	[p5l684t3502r820b3572],
22	nM	NN	O	nm	conj_and	8	SENT_63	[p5l850t3504r962b3572],
23	of	IN	O	of	_	0	SENT_63	[p5l995t3502r1077b3572],
24	each	DT	O	each	det	25	SENT_63	[p5l1109t3502r1297b3572],
25	probe	NN	O	probe	prep_of	22	SENT_63	[p5l1339t3502r1597b3590],
26	,	,	O	,	_	0	SENT_63	[p5l1339t3502r1597b3590],
27	and	CC	O	and	_	0	SENT_63	[p5l1640t3502r1783b3572],
28	20	CD	NUMBER	20	num	29	SENT_63	[p5l1821t3502r1914b3572],
29	ng	NN	O	ng	conj_and	8	SENT_63	[p5l1945t3519r2034b3590],
30	of	IN	O	of	_	0	SENT_63	[p5l2070t3502r2153b3572],
31	genomic	JJ	O	genomic	amod	32	SENT_63	[p6l9t21r350b109],
32	DNA	NN	O	dna	prep_of	29	SENT_63	[p6l409t20r596b91],
33	.	.	O	.	_	0	SENT_63	[p6l409t20r596b91],

1	PCRs	NNS	O	pcr	nsubjpass	3	SENT_64	[p6l664t20r853b91],
2	were	VBD	O	be	auxpass	3	SENT_64	[p6l907t39r1110b91],
3	run	VBN	O	run	dep	9	SENT_64	[p6l1170t39r1296b91],
4	on	IN	O	on	_	0	SENT_64	[p6l1354t39r1447b91],
5	a	DT	O	a	det	8	SENT_64	[p6l1507t39r1549b91],
6	Perkin	NNP	ORGANIZATION	Perkin	nn	8	SENT_64	[p6l1609t19r1855b91],
7	Elmer	NNP	ORGANIZATION	Elmer	nn	8	SENT_64	[p6l1918t19r2152b91],
8	GenAmp	NNP	ORGANIZATION	GenAmp	prep_on	3	SENT_64	[p6l9t117r418b221],
9	®	VBD	O	®	_	0	SENT_64	[p6l9t117r418b221],
10	9700	CD	NUMBER	9700	num	11	SENT_64	[p6l461t133r650b202],
11	thermocycler	NN	O	thermocycler	dobj	9	SENT_64	[p6l691t131r1238b221],
12	using	VBG	O	use	partmod	11	SENT_64	[p6l1279t134r1482b221],
13	the	DT	O	the	det	15	SENT_64	[p6l1522t132r1656b202],
14	9600	CD	DATE	9600	num	15	SENT_64	[p6l1696t133r1886b203],
15	mode	NN	O	mode	dobj	12	SENT_64	[p6l1928t131r2149b202],
16	under	IN	O	under	_	0	SENT_64	[p6l11t244r245b314],
17	the	DT	O	the	det	19	SENT_64	[p6l311t244r444b314],
18	following	JJ	O	following	amod	19	SENT_64	[p6l510t244r885b332],
19	conditions	NNS	O	condition	prep_under	12	SENT_64	[p6l952t244r1396b314],
20	:	:	O	:	_	0	SENT_64	[p6l952t244r1396b314],
21	50	CD	NUMBER	50	number	22	SENT_64	[p6l1475t245r1565b314],
22	°	CD	NUMBER	°	num	23	SENT_64	[p6l1594t245r1678b314],
23	C	NN	O	c	conj_and	11	SENT_64	[p6l1594t245r1678b314],
24	for	IN	O	for	_	0	SENT_64	[p6l1746t244r1864b314],
25	2min	JJ	O	2min	amod	31	SENT_64	[p6l1927t245r2145b313],
26	(	NN	O	(	nn	31	SENT_64	[p6l14t340r509b444],
27	AmpErase	NN	O	amperase	nn	31	SENT_64	[p6l14t340r509b444],
28	®	CD	NUMBER	®	num	31	SENT_64	[p6l14t340r509b444],
29	UNG	NN	O	ung	nn	31	SENT_64	[p6l594t356r765b426],
30	activation	NN	O	activation	nn	31	SENT_64	[p6l847t357r1315b444],
31	)	NN	O	)	prep_for	23	SENT_64	[p6l847t357r1315b444],
32	,	,	O	,	_	0	SENT_64	[p6l847t357r1315b444],
33	95	CD	NUMBER	95	num	35	SENT_64	[p6l1401t356r1491b426],
34	°	NN	O	°	nn	35	SENT_64	[p6l1524t356r1607b426],
35	C	NN	O	c	appos	31	SENT_64	[p6l1524t356r1607b426],
36	for	IN	O	for	_	0	SENT_64	[p6l1686t355r1804b426],
37	10	CD	DURATION	10	num	38	SENT_64	[p6l1885t356r1973b426],
38	min	NN	DURATION	min	prep_for	35	SENT_64	[p6l2003t357r2145b425],
39	(	CD	NUMBER	(	num	43	SENT_64	[p6l14t468r414b556],
40	AmpliTaq	NNP	ORGANIZATION	AmpliTaq	nn	43	SENT_64	[p6l14t468r414b556],
41	Gold	NNP	ORGANIZATION	Gold	nn	43	SENT_64	[p6l463t468r646b538],
42	Activation	NN	ORGANIZATION	activation	nn	43	SENT_64	[p6l692t469r1170b556],
43	)	NN	O	)	dep	35	SENT_64	[p6l692t469r1170b556],
44	,	,	O	,	_	0	SENT_64	[p6l692t469r1170b556],
45	followed	VBN	O	follow	partmod	23	SENT_64	[p6l1224t468r1575b538],
46	by	IN	O	by	_	0	SENT_64	[p6l1627t468r1719b556],
47	50	CD	NUMBER	50	num	48	SENT_64	[p6l1766t468r1856b538],
48	cycles	NNS	O	cycle	agent	45	SENT_64	[p6l1902t468r2150b556],
49	of	IN	O	of	_	0	SENT_64	[p6l8t580r91b652],
50	92	CD	NUMBER	92	num	51	SENT_64	[p6l125t581r216b652],
51	CC	NN	O	cc	prep_of	48	SENT_64	[p6l247t581r331b652],
52	for	IN	O	for	_	0	SENT_64	[p6l370t580r487b652],
53	15	CD	NUMBER	15	num	54	SENT_64	[p6l527t582r612b652],
54	s	NNS	O	s	prep_for	51	SENT_64	[p6l642t600r675b652],
55	(	CD	NUMBER	(	num	57	SENT_64	[p6l718t580r1308b670],
56	denaturation	NN	O	denaturation	nn	57	SENT_64	[p6l718t580r1308b670],
57	)	NN	O	)	dep	11	SENT_64	[p6l718t580r1308b670],
58	and	CC	O	and	_	0	SENT_64	[p6l1348t580r1491b652],
59	60	CD	NUMBER	60	num	61	SENT_64	[p6l1532t581r1624b652],
60	°	NN	O	°	nn	61	SENT_64	[p6l1654t581r1737b652],
61	C	NN	O	c	dobj	9	SENT_64	[p6l1654t581r1737b652],
62	for	IN	O	for	_	0	SENT_64	[p6l1775t580r1894b652],
63	1	CD	DURATION	1	num	64	SENT_64	[p6l1934t582r1957b651],
64	min	NN	DURATION	min	prep_for	61	SENT_64	[p6l2003t582r2145b651],
65	(	CD	NUMBER	(	num	67	SENT_64	[p6l14t693r941b783],
66	annealing/extension	NN	O	annealing/extension	nn	67	SENT_64	[p6l14t693r941b783],
67	)	NN	O	)	nsubj	9	SENT_64	[p6l14t693r941b783],
68	.	.	O	.	_	0	SENT_64	[p6l14t693r941b783],

1	Samples	NNS	O	sample	nsubjpass	8	SENT_65	[p6l1001t693r1332b783],
2	that	WDT	O	that	nsubjpass	6	SENT_65	[p6l1382t693r1550b764],
3	could	MD	O	could	aux	6	SENT_65	[p6l1600t693r1816b764],
4	not	RB	O	not	neg	6	SENT_65	[p6l1873t700r2001b764],
5	be	VB	O	be	auxpass	6	SENT_65	[p6l2054t693r2149b764],
6	scored	VBN	O	score	rcmod	1	SENT_65	[p6l9t806r271b876],
7	were	VBD	O	be	auxpass	8	SENT_65	[p6l322t825r525b876],
8	repeated	VBN	O	repeat	_	0	SENT_65	[p6l579t806r972b894],
9	.	.	O	.	_	0	SENT_65	[p6l579t806r972b894],

1	Unreadable	JJ	O	unreadable	amod	2	SENT_66	[p6l1034t806r1500b876],
2	results	NNS	O	result	nsubjpass	8	SENT_66	[p6l1554t806r1820b876],
3	on	IN	O	on	_	0	SENT_66	[p6l1870t825r1963b876],
4	the	DT	O	the	det	6	SENT_66	[p6l2016t806r2150b876],
5	second	JJ	ORDINAL	second	amod	6	SENT_66	[p6l9t918r286b990],
6	run	NN	O	run	prep_on	2	SENT_66	[p6l341t938r468b990],
7	were	VBD	O	be	auxpass	8	SENT_66	[p6l518t938r721b990],
8	scored	VBN	O	score	_	0	SENT_66	[p6l771t918r1033b990],
9	as	IN	O	as	_	0	SENT_66	[p6l1086t938r1167b990],
10	undetermined	JJ	O	undetermined	amod	12	SENT_66	[p6l1219t918r1790b990],
11	(	NN	O	(	nn	12	SENT_66	[p6l1848t920r1992b1008],
12	n	NN	O	n	prep_as	8	SENT_66	[p6l1848t920r1992b1008],
13	=	JJ	O	=	amod	12	SENT_66	[p6l1848t920r1992b1008],
14	17	CD	NUMBER	17	tmod	13	SENT_66	[p6l2029t920r2140b990],
15	:	:	O	:	_	0	SENT_66	[p6l2029t920r2140b990],
16	11	CD	NUMBER	11	num	17	SENT_66	[p6l15t1034r87b1102],
17	cases	NNS	O	case	dep	12	SENT_66	[p6l132t1051r372b1119],
18	,	,	O	,	_	0	SENT_66	[p6l132t1051r372b1119],
19	6	CD	NUMBER	6	num	20	SENT_66	[p6l411t1033r453b1103],
20	controls	NNS	O	control	appos	17	SENT_66	[p6l485t1032r871b1121],
21	)	RB	O	)	advmod	8	SENT_66	[p6l485t1032r871b1121],
22	.	.	O	.	_	0	SENT_66	[p6l485t1032r871b1121],

1	We	PRP	O	we	nsubj	2	SENT_67	[p6l908t1034r1031b1103],
2	repeated	VBD	O	repeat	_	0	SENT_67	[p6l1066t1032r1430b1122],
3	the	DT	O	the	det	7	SENT_67	[p6l1465t1032r1597b1103],
4	"	``	O	"	punct	7	SENT_67	[p6l1636t1015r2152b1122],
5	Taqman	NNP	O	Taqman	nn	7	SENT_67	[p6l1636t1015r2152b1122],
6	”	CD	NUMBER	”	num	7	SENT_67	[p6l1636t1015r2152b1122],
7	T	NN	O	t	dobj	2	SENT_67	[p6l1636t1015r2152b1122],
8	"	''	O	"	punct	2	SENT_67	[p6l1636t1015r2152b1122],
9	"	``	O	"	punct	10	SENT_67	[p6l1636t1015r2152b1122],
10	assay	NN	O	assay	npadvmod	2	SENT_67	[p6l9t1163r223b1232],
11	on	IN	O	on	_	0	SENT_67	[p6l253t1163r345b1214],
12	10	CD	PERCENT	10	num	13	SENT_67	[p6l387t1145r529b1214],
13	%	NN	PERCENT	%	prep_on	10	SENT_67	[p6l387t1145r529b1214],
14	of	IN	O	of	_	0	SENT_67	[p6l561t1144r644b1214],
15	the	DT	O	the	det	16	SENT_67	[p6l674t1144r808b1214],
16	samples	NNS	O	sample	prep_of	2	SENT_67	[p6l840t1144r1189b1232],
17	.	.	O	.	_	0	SENT_67	[p6l840t1144r1189b1232],

1	Results	NNS	O	result	_	0	SENT_68	[p6l14t1402r375b1487],

1	Demographic	JJ	O	demographic	amod	2	SENT_69	[p6l13t1642r541b1732],
2	characteristics	NNS	O	characteristic	nsubj	3	SENT_69	[p6l562t1642r1164b1714],
3	showed	VBD	O	show	_	0	SENT_69	[p6l1184t1642r1483b1714],
4	that	IN	O	that	complm	15	SENT_69	[p6l1508t1642r1675b1714],
5	the	DT	O	the	det	10	SENT_69	[p6l1695t1642r1829b1714],
6	male	NN	O	male	amod	10	SENT_69	[p6l1851t1642r2047b1714],
7	to	TO	O	to	_	0	SENT_69	[p6l2068t1650r2149b1714],
8	female	JJ	O	female	amod	9	SENT_69	[p6l8t1756r291b1827],
9	sex	NN	O	sex	prep_to	6	SENT_69	[p6l335t1775r466b1827],
10	ratio	NN	O	ratio	nsubj	15	SENT_69	[p6l511t1758r700b1827],
11	in	IN	O	in	_	0	SENT_69	[p6l744t1758r812b1827],
12	the	DT	O	the	det	14	SENT_69	[p6l859t1756r992b1827],
13	drug-responsive	JJ	O	drug-responsive	amod	14	SENT_69	[p6l1036t1756r1683b1846],
14	group	NN	O	group	prep_in	10	SENT_69	[p6l1727t1773r1955b1846],
15	was	VBD	O	be	ccomp	3	SENT_69	[p6l1997t1775r2150b1827],
16	higher	JJR	O	higher	dep	17	SENT_69	[p6l11t1868r266b1956],
17	than	IN	O	than	advmod	15	SENT_69	[p6l283t1868r461b1938],
18	in	IN	O	in	_	0	SENT_69	[p6l484t1869r553b1937],
19	the	DT	O	the	det	21	SENT_69	[p6l575t1868r708b1938],
20	drug-resistant	JJ	O	drug-resistant	amod	21	SENT_69	[p6l727t1868r1299b1956],
21	group	NN	O	group	prep_in	15	SENT_69	[p6l1317t1885r1573b1956],
22	,	,	O	,	_	0	SENT_69	[p6l1317t1885r1573b1956],
23	but	CC	O	but	_	0	SENT_69	[p6l1602t1868r1733b1938],
24	this	DT	O	this	det	25	SENT_69	[p6l1753t1868r1898b1938],
25	result	NN	O	result	nsubj	26	SENT_69	[p6l1920t1868r2150b1938],
26	failed	VBD	O	fail	conj_but	3	SENT_69	[p6l8t1980r239b2051],
27	to	TO	O	to	aux	28	SENT_69	[p6l262t1987r344b2051],
28	achieve	VB	O	achieve	xcomp	26	SENT_69	[p6l365t1980r677b2051],
29	statistical	JJ	O	statistical	amod	32	SENT_69	[p6l697t1980r1098b2051],
30	signiﬁcance	NN	O	signiﬁcance	nn	32	SENT_69	[p6l1120t1980r1594b2070],
31	(	NN	O	(	nn	32	SENT_69	[p6l1621t1982r1713b2070],
32	p	NN	O	p	dobj	28	SENT_69	[p6l1621t1982r1713b2070],
33	=	JJ	O	=	amod	32	SENT_69	[p6l1743t2009r1782b2032],
34	0.130	CD	NUMBER	0.130	tmod	33	SENT_69	[p6l1812t1981r2036b2051],
35	by	IN	O	by	_	0	SENT_69	[p6l2060t1980r2151b2070],
36	X2	NN	O	x2	nn	38	SENT_69	[p6l11t2075r94b2181],
37	test	NN	O	test	nn	38	SENT_69	[p6l132t2095r347b2182],
38	)	NN	O	)	prep_by	28	SENT_69	[p6l132t2095r347b2182],
39	.	.	O	.	_	0	SENT_69	[p6l132t2095r347b2182],

1	There	EX	O	there	expl	2	SENT_70	[p6l390t2093r629b2164],
2	was	VBD	O	be	_	0	SENT_70	[p6l663t2112r817b2164],
3	no	DT	O	no	det	5	SENT_70	[p6l855t2112r948b2164],
4	age	NN	O	age	nn	5	SENT_70	[p6l985t2110r1126b2182],
5	difference	NN	O	difference	nsubj	2	SENT_70	[p6l1163t2093r1587b2164],
6	between	IN	O	between	_	0	SENT_70	[p6l1627t2093r1975b2164],
7	the	DT	O	the	det	11	SENT_70	[p6l2016t2093r2150b2164],
8	drug-responsive	JJ	O	drug-responsive	amod	11	SENT_70	[p6l9t2206r655b2296],
9	and	CC	O	and	_	0	SENT_70	[p6l688t2206r831b2277],
10	drug-resistant	JJ	O	drug-resistant	amod	11	SENT_70	[p6l867t2206r1440b2296],
11	groups	NNS	O	group	prep_between	5	SENT_70	[p6l1472t2224r1764b2296],
12	.	.	O	.	_	0	SENT_70	[p6l1472t2224r1764b2296],

1	346	CD	NUMBER	346	num	3	SENT_71	[p6l98t2371r159b2403],
2	D.W.	NNP	PERSON	D.W.	nn	3	SENT_71	[p6l1782t2372r1861b2403],
3	Kim	NNP	PERSON	Kim	_	0	SENT_71	[p6l1883t2372r1946b2403],
4	et	FW	O	et	nn	5	SENT_71	[p6l1963t2374r2000b2403],
5	al.	FW	O	al.	dep	3	SENT_71	[p6l2016t2371r2059b2403],
6	.	.	O	.	_	0	SENT_71	[p6l2016t2371r2059b2403],

1	Table	NNP	O	Table	_	0	SENT_72	[p6l121t2469r212b2498],
2	2	CD	NUMBER	2	num	1	SENT_72	[p6l228t2469r246b2498],
3	Genotype	NN	O	genotype	nn	6	SENT_72	[p6l286t2470r443b2505],
4	and	CC	O	and	_	0	SENT_72	[p6l458t2469r515b2498],
5	allele	NN	O	allele	conj_and	3	SENT_72	[p6l531t2469r621b2498],
6	distribution	NN	O	distribution	dep	1	SENT_72	[p6l636t2469r824b2498],
7	of	IN	O	of	_	0	SENT_72	[p6l840t2469r873b2498],
8	the	DT	O	the	det	10	SENT_72	[p6l886t2469r940b2498],
9	C3435T	NN	O	c3435t	nn	10	SENT_72	[p6l955t2469r1075b2498],
10	polymorphism	NN	O	polymorphism	prep_of	6	SENT_72	[p6l1089t2469r1317b2505],
11	of	IN	O	of	_	0	SENT_72	[p6l1332t2469r1366b2498],
12	the	DT	O	the	det	14	SENT_72	[p6l1379t2469r1432b2498],
13	ABCB1	NN	O	abcb1	nn	14	SENT_72	[p6l1446t2470r1544b2498],
14	gene	NN	O	gene	prep_of	10	SENT_72	[p6l1565t2476r1642b2505],
15	in	IN	O	in	_	0	SENT_72	[p6l1657t2470r1684b2498],
16	epilepsy	NN	O	epilepsy	nn	19	SENT_72	[p6l1700t2469r1835b2505],
17	and	CC	O	and	_	0	SENT_72	[p6l1849t2469r1906b2498],
18	control	JJ	O	control	nn	19	SENT_72	[p6l1921t2469r2038b2498],
19	subjects	NNS	O	subject	prep_in	14	SENT_72	[p6l122t2515r257b2551],

1	Genotypesl	NN	MISC	genotypesl	_	0	SENT_73	[p6l122t2609r311b2645],
2	Drug-responsive	JJ	MISC	drug-responsive	amod	20	SENT_73	[p6l500t2610r760b2645],
3	Drug-resistant	JJ	MISC	drug-resistant	amod	20	SENT_73	[p6l980t2610r1210b2645],
4	p	NN	O	p	nn	20	SENT_73	[p6l1437t2617r1458b2645],
5	value	NN	O	value	nn	20	SENT_73	[p6l1471t2609r1559b2638],
6	Migraine	NN	O	migraine	nn	20	SENT_73	[p6l1744t2610r1883b2645],
7	alleles	NNS	O	allele	nn	20	SENT_73	[p6l122t2654r227b2683],
8	epilepsy	NN	O	epilepsy	nn	20	SENT_73	[p6l499t2654r634b2690],
9	(	NN	O	(	nn	20	SENT_73	[p6l650t2655r684b2690],
10	N	NN	O	n	nn	20	SENT_73	[p6l650t2655r684b2690],
11	=	JJ	O	=	amod	20	SENT_73	[p6l695t2666r711b2675],
12	101	CD	NUMBER	101	number	13	SENT_73	[p6l725t2654r792b2690],
13	)	CD	NUMBER	)	dep	14	SENT_73	[p6l725t2654r792b2690],
14	epilepsy	NN	O	epilepsy	dep	20	SENT_73	[p6l979t2654r1114b2690],
15	(	NN	O	(	nn	20	SENT_73	[p6l1130t2655r1164b2690],
16	N	NN	O	n	nn	20	SENT_73	[p6l1130t2655r1164b2690],
17	=	JJ	O	=	amod	20	SENT_73	[p6l1175t2666r1191b2675],
18	59	CD	NUMBER	59	number	19	SENT_73	[p6l1204t2655r1252b2690],
19	)	CD	NUMBER	)	num	20	SENT_73	[p6l1204t2655r1252b2690],
20	patients	NNS	O	patient	dep	1	SENT_73	[p6l1746t2655r1878b2690],
21	(	CD	NUMBER	(	num	22	SENT_73	[p6l1895t2655r1930b2690],
22	N	NN	O	n	npadvmod	23	SENT_73	[p6l1895t2655r1930b2690],
23	=	JJ	O	=	amod	20	SENT_73	[p6l1940t2666r1956b2675],
24	213	CD	NUMBER	213	num	25	SENT_73	[p6l1968t2654r2037b2690],
25	)	NN	O	)	dep	1	SENT_73	[p6l1968t2654r2037b2690],

1	Genotypes	NNS	O	genotype	dep	101	SENT_74	[p6l122t2748r294b2784],
2	CC	NN	O	cc	dep	101	SENT_74	[p6l159t2794r201b2822],
3	48	CD	NUMBER	48	dep	101	SENT_74	[p6l517t2794r555b2822],
4	(	CD	NUMBER	(	dep	101	SENT_74	[p6l572t2794r666b2829],
5	47.5	CD	NUMBER	47.5	dep	101	SENT_74	[p6l572t2794r666b2829],
6	)	NN	O	)	dep	101	SENT_74	[p6l572t2794r666b2829],
7	19	CD	NUMBER	19	dep	101	SENT_74	[p6l981t2794r1015b2822],
8	(	CD	NUMBER	(	dep	101	SENT_74	[p6l1032t2794r1126b2829],
9	32.2	CD	NUMBER	32.2	dep	101	SENT_74	[p6l1032t2794r1126b2829],
10	)	NN	O	)	dep	101	SENT_74	[p6l1032t2794r1126b2829],
11	0.09	CD	NUMBER	0.09	dep	101	SENT_74	[p6l1439t2787r1524b2822],
12	*	CD	NUMBER	*	dep	101	SENT_74	[p6l1439t2787r1524b2822],
13	88	CD	NUMBER	88	dep	101	SENT_74	[p6l1764t2794r1801b2822],
14	(	NN	O	(	dep	101	SENT_74	[p6l1818t2794r1912b2829],
15	41.5	CD	NUMBER	41.5	dep	101	SENT_74	[p6l1818t2794r1912b2829],
16	)	CD	NUMBER	)	dep	101	SENT_74	[p6l1818t2794r1912b2829],
17	CT	NN	O	ct	dep	101	SENT_74	[p6l159t2839r202b2867],
18	30	CD	NUMBER	30	dep	101	SENT_74	[p6l519t2839r555b2867],
19	(	CD	NUMBER	(	dep	101	SENT_74	[p6l572t2839r666b2874],
20	29.7	CD	NUMBER	29.7	dep	101	SENT_74	[p6l572t2839r666b2874],
21	)	NN	O	)	dep	101	SENT_74	[p6l572t2839r666b2874],
22	27	CD	NUMBER	27	dep	101	SENT_74	[p6l979t2839r1016b2867],
23	(	CD	NUMBER	(	dep	101	SENT_74	[p6l1032t2839r1126b2874],
24	45.8	CD	NUMBER	45.8	dep	101	SENT_74	[p6l1032t2839r1126b2874],
25	)	NN	O	)	dep	101	SENT_74	[p6l1032t2839r1126b2874],
26	92	CD	NUMBER	92	dep	101	SENT_74	[p6l1764t2839r1800b2867],
27	(	CD	NUMBER	(	dep	101	SENT_74	[p6l1818t2839r1912b2874],
28	43.4	CD	NUMBER	43.4	dep	101	SENT_74	[p6l1818t2839r1912b2874],
29	)	NN	O	)	dep	101	SENT_74	[p6l1818t2839r1912b2874],
30	‘	CD	NUMBER	‘	dep	101	SENT_74	[p6l158t2885r201b2912],
31	IT	PRP	O	it	dep	101	SENT_74	[p6l158t2885r201b2912],
32	23	CD	NUMBER	23	dep	101	SENT_74	[p6l518t2884r554b2912],
33	(	NN	O	(	dep	101	SENT_74	[p6l572t2884r666b2919],
34	22.8	CD	NUMBER	22.8	dep	101	SENT_74	[p6l572t2884r666b2919],
35	)	CD	NUMBER	)	dep	101	SENT_74	[p6l572t2884r666b2919],
36	13	CD	NUMBER	13	dep	101	SENT_74	[p6l981t2884r1014b2912],
37	(	NN	O	(	dep	101	SENT_74	[p6l1032t2884r1126b2919],
38	30.1	CD	NUMBER	30.1	dep	101	SENT_74	[p6l1032t2884r1126b2919],
39	)	CD	NUMBER	)	dep	101	SENT_74	[p6l1032t2884r1126b2919],
40	32	CD	NUMBER	32	dep	101	SENT_74	[p6l1765t2884r1800b2912],
41	(	NN	O	(	dep	101	SENT_74	[p6l1818t2884r1912b2919],
42	15.1	CD	NUMBER	15.1	dep	101	SENT_74	[p6l1818t2884r1912b2919],
43	)	CD	NUMBER	)	dep	101	SENT_74	[p6l1818t2884r1912b2919],
44	Alleles	NNS	O	allele	dep	101	SENT_74	[p6l121t2950r230b2978],
45	C	NN	O	c	dep	101	SENT_74	[p6l159t2995r179b3024],
46	allele	NN	O	allele	dep	101	SENT_74	[p6l194t2995r284b3024],
47	126	CD	NUMBER	126	dep	101	SENT_74	[p6l501t2995r555b3024],
48	(	NN	O	(	dep	101	SENT_74	[p6l572t2995r666b3031],
49	62.4	CD	NUMBER	62.4	dep	101	SENT_74	[p6l572t2995r666b3031],
50	)	CD	NUMBER	)	dep	101	SENT_74	[p6l572t2995r666b3031],
51	65	CD	NUMBER	65	dep	101	SENT_74	[p6l979t2995r1015b3024],
52	(	NN	O	(	dep	101	SENT_74	[p6l1032t2996r1126b3031],
53	55.1	CD	NUMBER	55.1	dep	101	SENT_74	[p6l1032t2996r1126b3031],
54	)	CD	NUMBER	)	dep	101	SENT_74	[p6l1032t2996r1126b3031],
55	0.20	CD	NUMBER	0.20	dep	101	SENT_74	[p6l1439t2995r1509b3024],
56	268	CD	NUMBER	268	dep	101	SENT_74	[p6l1745t2995r1801b3024],
57	(	NN	O	(	dep	101	SENT_74	[p6l1818t2995r1912b3031],
58	63.2	CD	NUMBER	63.2	dep	101	SENT_74	[p6l1818t2995r1912b3031],
59	)	CD	NUMBER	)	dep	101	SENT_74	[p6l1818t2995r1912b3031],
60	Tallele	NNP	ORGANIZATION	Tallele	dep	101	SENT_74	[p6l158t3040r279b3069],
61	76	CD	NUMBER	76	dep	101	SENT_74	[p6l518t3040r555b3069],
62	(	CD	NUMBER	(	dep	101	SENT_74	[p6l572t3040r666b3076],
63	37.6	CD	NUMBER	37.6	dep	101	SENT_74	[p6l572t3040r666b3076],
64	)	NN	O	)	dep	101	SENT_74	[p6l572t3040r666b3076],
65	53	CD	NUMBER	53	dep	101	SENT_74	[p6l980t3040r1014b3069],
66	(	CD	NUMBER	(	dep	101	SENT_74	[p6l1032t3040r1126b3076],
67	44.9	CD	NUMBER	44.9	dep	101	SENT_74	[p6l1032t3040r1126b3076],
68	)	NN	O	)	dep	101	SENT_74	[p6l1032t3040r1126b3076],
69	156	CD	NUMBER	156	dep	101	SENT_74	[p6l1747t3040r1801b3069],
70	(	NN	O	(	dep	101	SENT_74	[p6l1818t3040r1912b3076],
71	36.8	CD	NUMBER	36.8	dep	101	SENT_74	[p6l1818t3040r1912b3076],
72	)	CD	NUMBER	)	dep	101	SENT_74	[p6l1818t3040r1912b3076],
73	Values	NNS	O	value	dep	101	SENT_74	[p6l121t3132r213b3158],
74	expressed	VBN	O	express	dep	101	SENT_74	[p6l225t3132r369b3164],
75	as	IN	O	as	dep	101	SENT_74	[p6l383t3139r412b3158],
76	N	NN	O	n	dep	101	SENT_74	[p6l424t3133r445b3158],
77	(	CD	PERCENT	(	dep	101	SENT_74	[p6l458t3132r508b3164],
78	%	NN	PERCENT	%	dep	101	SENT_74	[p6l458t3132r508b3164],
79	)	CD	NUMBER	)	dep	101	SENT_74	[p6l458t3132r508b3164],
80	;	:	O	;	_	0	SENT_74	[p6l458t3132r508b3164],
81	comparing	VBG	O	compare	dep	101	SENT_74	[p6l523t3133r675b3164],
82	only	RB	O	only	dep	101	SENT_74	[p6l687t3132r748b3164],
83	CC	NN	O	cc	dep	101	SENT_74	[p6l760t3132r797b3158],
84	vs.	CC	O	vs.	dep	101	SENT_74	[p6l809t3139r847b3158],
85	'	''	O	'	_	0	SENT_74	[p6l862t3133r900b3157],
86	I	PRP	O	I	dep	101	SENT_74	[p6l862t3133r900b3157],
87	'	''	O	'	_	0	SENT_74	[p6l862t3133r900b3157],
88	I	PRP	O	I	dep	101	SENT_74	[p6l862t3133r900b3157],
89	'	''	O	'	_	0	SENT_74	[p6l862t3133r900b3157],
90	genotypes	NNS	O	genotype	dep	101	SENT_74	[p6l912t3126r1068b3164],
91	’	RB	O	’	dep	101	SENT_74	[p6l912t3126r1068b3164],
92	in	IN	O	in	dep	101	SENT_74	[p6l1081t3133r1105b3157],
93	2	CD	NUMBER	2	dep	101	SENT_74	[p6l1119t3132r1134b3157],
94	>	JJR	O	>	dep	101	SENT_74	[p6l1148t3140r1164b3157],
95	<	JJR	O	<	dep	101	SENT_74	[p6l1148t3140r1164b3157],
96	2	CD	NUMBER	2	dep	101	SENT_74	[p6l1178t3132r1193b3157],
97	table	NN	O	table	dep	101	SENT_74	[p6l1207t3132r1291b3163],
98	,	,	O	,	_	0	SENT_74	[p6l1207t3132r1291b3163],
99	p	NN	O	p	dep	101	SENT_74	[p6l1305t3139r1323b3164],
100	=	JJ	O	=	dep	101	SENT_74	[p6l1333t3142r1347b3151],
101	0.42	CD	NUMBER	0.42	_	0	SENT_74	[p6l1358t3132r1429b3158],
102	.	.	O	.	_	0	SENT_74	[p6l1358t3132r1429b3158],

1	In	IN	O	in	_	0	SENT_75	[p6l128t3336r191b3403],
2	patients	NNS	O	patient	prep_in	17	SENT_75	[p6l312t3335r643b3422],
3	with	IN	O	with	_	0	SENT_75	[p6l756t3334r932b3404],
4	drug-responsive	JJ	O	drug-responsive	amod	7	SENT_75	[p6l1052t3334r1698b3422],
5	epilepsy	NN	O	epilepsy	nn	7	SENT_75	[p6l1814t3334r2152b3422],
6	(	NN	O	(	nn	7	SENT_75	[p6l15t3447r101b3534],
7	N	NN	O	n	prep_with	2	SENT_75	[p6l15t3447r101b3534],
8	=	JJ	O	=	amod	7	SENT_75	[p6l128t3474r168b3497],
9	101	CD	NUMBER	101	num	10	SENT_75	[p6l204t3446r399b3534],
10	)	NN	O	)	dep	8	SENT_75	[p6l204t3446r399b3534],
11	,	,	O	,	_	0	SENT_75	[p6l204t3446r399b3534],
12	genotypic	JJ	O	genotypic	amod	13	SENT_75	[p6l467t3447r863b3534],
13	frequencies	NNS	O	frequency	nsubj	17	SENT_75	[p6l922t3446r1401b3534],
14	were	VBD	O	be	cop	17	SENT_75	[p6l1457t3465r1660b3516],
15	47.5	CD	PERCENT	47.5	number	16	SENT_75	[p6l1718t3446r1951b3516],
16	%	NN	PERCENT	%	amod	17	SENT_75	[p6l1718t3446r1951b3516],
17	CC	NN	O	cc	_	0	SENT_75	[p6l2009t3446r2142b3532],
18	,	,	O	,	_	0	SENT_75	[p6l2009t3446r2142b3532],
19	29.7	CD	PERCENT	29.7	number	20	SENT_75	[p6l9t3559r240b3630],
20	%	NN	PERCENT	%	amod	21	SENT_75	[p6l9t3559r240b3630],
21	CT	NN	O	ct	appos	17	SENT_75	[p6l274t3559r389b3645],
22	,	,	O	,	_	0	SENT_75	[p6l274t3559r389b3645],
23	and	CC	O	and	_	0	SENT_75	[p6l432t3558r575b3629],
24	22.8	CD	PERCENT	22.8	number	25	SENT_75	[p6l612t3559r842b3629],
25	%	NN	PERCENT	%	amod	26	SENT_75	[p6l612t3559r842b3629],
26	TT	NN	O	tt	conj_and	21	SENT_75	[p6l874t3560r989b3629],
27	.	.	O	.	_	0	SENT_75	[p6l874t3560r989b3629],

1	In	IN	O	in	dep	10	SENT_76	[p6l1037t3560r1100b3629],
2	patients	NNS	O	patient	pobj	1	SENT_76	[p6l1140t3560r1471b3648],
3	with	IN	O	with	_	0	SENT_76	[p6l1502t3558r1679b3629],
4	drugresistant	JJ	O	drugresistant	amod	7	SENT_76	[p6l1717t3558r2145b3648, p6l10t3678r178b3742],
5	epilepsy	NN	O	epilepsy	nn	7	SENT_76	[p6l201t3671r538b3761],
6	(	NN	O	(	nn	7	SENT_76	[p6l565t3673r651b3760],
7	N	NN	O	n	prep_with	2	SENT_76	[p6l565t3673r651b3760],
8	=	JJ	O	=	amod	7	SENT_76	[p6l678t3700r718b3723],
9	59	CD	NUMBER	59	tmod	8	SENT_76	[p6l750t3672r900b3760],
10	)	NN	O	)	_	0	SENT_76	[p6l750t3672r900b3760],
11	,	,	O	,	_	0	SENT_76	[p6l750t3672r900b3760],
12	32.2	CD	PERCENT	32.2	num	14	SENT_76	[p6l934t3672r1162b3742],
13	%	NN	PERCENT	%	nn	14	SENT_76	[p6l934t3672r1162b3742],
14	CC	NN	O	cc	conj_and	10	SENT_76	[p6l1185t3672r1318b3758],
15	,	,	O	,	_	0	SENT_76	[p6l1185t3672r1318b3758],
16	45.8	CD	PERCENT	45.8	num	18	SENT_76	[p6l1346t3672r1580b3742],
17	%	NN	PERCENT	%	nn	18	SENT_76	[p6l1346t3672r1580b3742],
18	CT	NN	O	ct	conj_and	10	SENT_76	[p6l1603t3672r1718b3758],
19	,	,	O	,	_	0	SENT_76	[p6l1603t3672r1718b3758],
20	and	CC	O	and	_	0	SENT_76	[p6l1750t3671r1893b3742],
21	30.1	CD	PERCENT	30.1	num	22	SENT_76	[p6l1921t3672r2150b3742],
22	%	NN	PERCENT	%	conj_and	10	SENT_76	[p6l1921t3672r2150b3742],

1	TT	NN	O	tt	_	0	SENT_77	[p7l7t19r122b88],
2	.	.	O	.	_	0	SENT_77	[p7l7t19r122b88],

1	In	IN	O	in	_	0	SENT_78	[p7l159t19r221b87],
2	control	JJ	O	control	amod	3	SENT_78	[p7l247t18r536b88],
3	subjects	NNS	O	subject	pobj	1	SENT_78	[p7l560t18r898b106],
4	with	IN	O	with	_	0	SENT_78	[p7l918t18r1095b88],
5	migraine	NN	O	migraine	nn	7	SENT_78	[p7l1123t19r1476b106],
6	(	CD	NUMBER	(	num	7	SENT_78	[p7l1505t19r1591b106],
7	N	NN	O	n	prep_with	3	SENT_78	[p7l1505t19r1591b106],
8	=	JJ	O	=	amod	14	SENT_78	[p7l1618t46r1657b69],
9	213	CD	NUMBER	213	num	10	SENT_78	[p7l1687t18r1889b106],
10	)	NN	O	)	tmod	8	SENT_78	[p7l1687t18r1889b106],
11	,	,	O	,	_	0	SENT_78	[p7l1687t18r1889b106],
12	41.5	CD	PERCENT	41.5	num	13	SENT_78	[p7l1917t18r2150b88],
13	%	NN	PERCENT	%	appos	10	SENT_78	[p7l1917t18r2150b88],
14	CC	NN	O	cc	dep	7	SENT_78	[p7l10t131r142b217],
15	,	,	O	,	_	0	SENT_78	[p7l10t131r142b217],
16	43.4	CD	PERCENT	43.4	num	17	SENT_78	[p7l176t131r408b201],
17	%	NN	PERCENT	%	conj_and	7	SENT_78	[p7l176t131r408b201],
18	CT	NN	O	ct	dep	17	SENT_78	[p7l436t131r551b217],
19	,	,	O	,	_	0	SENT_78	[p7l436t131r551b217],
20	and	CC	O	and	_	0	SENT_78	[p7l588t130r730b201],
21	15.1	CD	PERCENT	15.1	num	22	SENT_78	[p7l766t131r991b201],
22	%	NN	PERCENT	%	prep_with	3	SENT_78	[p7l766t131r991b201],
23	T	NN	O	t	nn	25	SENT_78	[p7l1016t132r1132b201],
24	'	''	O	'	_	0	SENT_78	[p7l1016t132r1132b201],
25	|	NN	O	|	dep	22	SENT_78	[p7l1016t132r1132b201],
26	'	''	O	'	_	0	SENT_78	[p7l1016t132r1132b201],
27	.	.	O	.	_	0	SENT_78	[p7l1016t132r1132b201],

1	There	EX	O	there	expl	2	SENT_79	[p7l1165t130r1404b201],
2	was	VBD	O	be	_	0	SENT_79	[p7l1430t149r1582b201],
3	no	DT	O	no	det	5	SENT_79	[p7l1613t149r1706b201],
4	signiﬁcant	NN	O	signiﬁcant	nn	5	SENT_79	[p7l1733t130r2149b220],
5	difference	NN	O	difference	npadvmod	15	SENT_79	[p7l10t244r433b315],
6	in	IN	O	in	_	0	SENT_79	[p7l455t246r524b314],
7	genotype	NN	O	genotype	nn	10	SENT_79	[p7l548t251r925b334],
8	or	CC	O	or	_	0	SENT_79	[p7l946t263r1030b315],
9	allele	NN	O	allele	nn	10	SENT_79	[p7l1049t244r1275b315],
10	frequencies	NNS	O	frequency	prep_in	5	SENT_79	[p7l1295t244r1774b334],
11	between	IN	O	between	_	0	SENT_79	[p7l1797t244r2146b315],
12	groups	NNS	O	group	prep_between	10	SENT_79	[p7l10t373r277b445],
13	(	CD	NUMBER	(	num	14	SENT_79	[p7l314t358r406b445],
14	p	NN	O	p	dep	12	SENT_79	[p7l314t358r406b445],
15	>	JJR	O	>	acomp	2	SENT_79	[p7l437t374r496b429],
16	0.05	CD	NUMBER	0.05	advmod	2	SENT_79	[p7l528t356r730b442],
17	,	,	O	,	_	0	SENT_79	[p7l528t356r730b442],
18	by	IN	O	by	_	0	SENT_79	[p7l773t356r865b445],
19	X2	NN	O	x2	nn	20	SENT_79	[p7l898t337r981b444],
20	test	NN	O	test	prep_by	2	SENT_79	[p7l1014t363r1197b442],
21	,	,	O	,	_	0	SENT_79	[p7l1014t363r1197b442],
22	Table	NNP	O	Table	appos	20	SENT_79	[p7l1235t356r1452b427],
23	2	CD	NUMBER	2	number	24	SENT_79	[p7l1485t357r1589b445],
24	)	CD	NUMBER	)	dep	22	SENT_79	[p7l1485t357r1589b445],
25	.	.	O	.	_	0	SENT_79	[p7l1485t357r1589b445],

1	Discussion	NN	O	discussion	_	0	SENT_80	[p7l15t615r535b698],

1	The	DT	O	the	det	2	SENT_81	[p7l7t853r160b925],
2	mechanisms	NNS	O	mechanism	nsubjpass	11	SENT_81	[p7l193t853r689b925],
3	of	IN	O	of	_	0	SENT_81	[p7l719t853r801b925],
4	drug	NN	O	drug	nn	5	SENT_81	[p7l828t853r1010b943],
5	resistance	NN	O	resistance	prep_of	2	SENT_81	[p7l1043t855r1457b925],
6	in	IN	O	in	_	0	SENT_81	[p7l1488t855r1556b924],
7	epilepsy	NN	O	epilepsy	prep_in	5	SENT_81	[p7l1589t853r1929b943],
8	have	VBP	O	have	aux	11	SENT_81	[p7l1960t853r2149b925],
9	not	RB	O	not	neg	11	SENT_81	[p7l12t974r143b1038],
10	been	VBN	O	be	auxpass	11	SENT_81	[p7l181t967r374b1038],
11	established	VBN	O	establish	_	0	SENT_81	[p7l414t967r907b1038],
12	.	.	O	.	_	0	SENT_81	[p7l414t967r907b1038],

1	Hippocampal	JJ	O	hippocampal	amod	2	SENT_82	[p7l954t967r1487b1057],
2	sclerosis	NN	O	sclerosis	nsubjpass	5	SENT_82	[p7l1524t967r1869b1038],
3	is	VBZ	O	be	auxpass	5	SENT_82	[p7l1905t969r1963b1038],
4	frequently	RB	O	frequently	advmod	5	SENT_82	[p7l1998t967r2144b1038, p7l10t1079r321b1167],
5	related	VBN	O	relate	_	0	SENT_82	[p7l361t1079r654b1149],
6	to	TO	O	to	_	0	SENT_82	[p7l694t1086r775b1149],
7	drug	NN	O	drug	nn	8	SENT_82	[p7l813t1079r994b1167],
8	resistance	NN	O	resistance	prep_to	5	SENT_82	[p7l1035t1080r1449b1149],
9	in	IN	O	in	_	0	SENT_82	[p7l1487t1080r1555b1148],
10	patients	NNS	O	patient	prep_in	5	SENT_82	[p7l1599t1080r1933b1167],
11	with	IN	O	with	_	0	SENT_82	[p7l1968t1079r2145b1149],
12	mesial	JJ	O	mesial	amod	14	SENT_82	[p7l12t1191r271b1261],
13	temporal	JJ	O	temporal	amod	14	SENT_82	[p7l304t1191r679b1279],
14	epilepsy	NN	O	epilepsy	prep_with	10	SENT_82	[p7l710t1191r1064b1279],
15	.	.	O	.	_	0	SENT_82	[p7l710t1191r1064b1279],

1	However	RB	O	however	advmod	20	SENT_83	[p7l1107t1193r1476b1277],
2	,	,	O	,	_	0	SENT_83	[p7l1107t1193r1476b1277],
3	whether	IN	O	whether	dep	8	SENT_83	[p7l1513t1191r1859b1261],
4	hippocampal	JJ	O	hippocampal	amod	5	SENT_83	[p7l1891t1191r2144b1279, p7l9t1303r305b1391],
5	sclerosis	NN	O	sclerosis	nsubj	8	SENT_83	[p7l337t1303r681b1373],
6	is	VBZ	O	be	cop	8	SENT_83	[p7l713t1304r771b1373],
7	the	DT	O	the	det	8	SENT_83	[p7l803t1303r936b1373],
8	cause	NN	O	cause	csubj	20	SENT_83	[p7l968t1322r1196b1373],
9	or	CC	O	or	_	0	SENT_83	[p7l1228t1322r1312b1373],
10	the	DT	O	the	det	11	SENT_83	[p7l1341t1303r1474b1373],
11	consequence	NN	O	consequence	csubj	20	SENT_83	[p7l1506t1322r2038b1391],
12	of	IN	O	of	_	0	SENT_83	[p7l2070t1303r2152b1373],
13	chronic	JJ	O	chronic	amod	15	SENT_83	[p7l9t1415r311b1486],
14	epileptic	JJ	O	epileptic	amod	15	SENT_83	[p7l368t1415r732b1505],
15	seizures	NNS	O	seizure	prep_of	11	SENT_83	[p7l790t1417r1119b1486],
16	and	CC	O	and	_	0	SENT_83	[p7l1175t1415r1319b1486],
17	drug	NN	O	drug	nn	18	SENT_83	[p7l1378t1415r1560b1505],
18	resistance	NN	O	resistance	prep_of	11	SENT_83	[p7l1619t1417r2033b1486],
19	is	VBZ	O	be	cop	20	SENT_83	[p7l2091t1417r2149b1486],
20	unknown	JJ	O	unknown	_	0	SENT_83	[p7l12t1528r401b1599],
21	.	.	O	.	_	0	SENT_83	[p7l12t1528r401b1599],

1	Channelopathy	NNP	PERSON	Channelopathy	nsubjpass	4	SENT_84	[p7l487t1528r1106b1618],
2	has	VBZ	O	have	aux	4	SENT_84	[p7l1184t1528r1313b1599],
3	been	VBN	O	be	auxpass	4	SENT_84	[p7l1393t1528r1586b1599],
4	considered	VBN	O	consider	_	0	SENT_84	[p7l1666t1528r2141b1615],
5	,	,	O	,	_	0	SENT_84	[p7l1666t1528r2141b1615],
6	but	CC	O	but	_	0	SENT_84	[p7l12t1641r144b1711],
7	has	VBZ	O	have	aux	9	SENT_84	[p7l199t1641r329b1711],
8	been	VBN	O	be	auxpass	9	SENT_84	[p7l383t1641r577b1711],
9	found	VBN	O	find	conj_but	4	SENT_84	[p7l632t1641r863b1711],
10	in	IN	O	in	_	0	SENT_84	[p7l918t1642r987b1710],
11	only	RB	O	only	advmod	14	SENT_84	[p7l1042t1641r1213b1729],
12	a	DT	O	a	det	14	SENT_84	[p7l1263t1660r1306b1711],
13	limited	JJ	O	limited	amod	14	SENT_84	[p7l1362t1641r1648b1711],
14	number	NN	O	number	prep_in	9	SENT_84	[p7l1707t1641r2020b1711],
15	of	IN	O	of	_	0	SENT_84	[p7l2070t1641r2152b1711],
16	cases	NNS	O	case	prep_of	14	SENT_84	[p7l9t1773r225b1825],
17	with	IN	O	with	_	0	SENT_84	[p7l249t1753r428b1825],
18	a	DT	O	a	det	21	SENT_84	[p7l458t1773r501b1825],
19	strong	JJ	O	strong	amod	21	SENT_84	[p7l528t1761r782b1843],
20	familial	JJ	O	familial	amod	21	SENT_84	[p7l808t1753r1120b1825],
21	tendency	NN	O	tendency	prep_with	16	SENT_84	[p7l1148t1753r1544b1843],
22	.	.	O	.	_	0	SENT_84	[p7l1148t1753r1544b1843],

1	Many	JJ	O	many	amod	2	SENT_85	[p7l1576t1755r1788b1843],
2	patients	NNS	O	patient	nsubj	8	SENT_85	[p7l1815t1755r2149b1843],
3	resistant	JJ	O	resistant	amod	2	SENT_85	[p7l13t1867r368b1935],
4	to	TO	O	to	_	0	SENT_85	[p7l401t1872r483b1935],
5	AED	NN	O	aed	nn	6	SENT_85	[p7l514t1866r674b1935],
6	treatment	NN	O	treatment	prep_to	3	SENT_85	[p7l708t1872r1130b1935],
7	are	VBP	O	be	cop	8	SENT_85	[p7l1165t1884r1295b1935],
8	resistant	JJ	O	resistant	_	0	SENT_85	[p7l1333t1867r1688b1935],
9	to	TO	O	to	_	0	SENT_85	[p7l1721t1872r1803b1935],
10	a	DT	O	a	det	12	SENT_85	[p7l1838t1884r1880b1935],
11	broad	JJ	O	broad	amod	12	SENT_85	[p7l1917t1865r2145b1935],
12	range	NN	O	range	prep_to	8	SENT_85	[p7l13t1995r238b2066],
13	of	IN	O	of	_	0	SENT_85	[p7l266t1978r349b2048],
14	AEDs	NNS	MISC	aed	prep_of	12	SENT_85	[p7l372t1979r568b2048],
15	with	IN	O	with	_	0	SENT_85	[p7l595t1978r772b2048],
16	different	JJ	O	different	amod	17	SENT_85	[p7l805t1978r1173b2048],
17	actions	NNS	O	action	prep_with	14	SENT_85	[p7l1201t1979r1520b2063],
18	,	,	O	,	_	0	SENT_85	[p7l1201t1979r1520b2063],
19	and	CC	O	and	_	0	SENT_85	[p7l1557t1978r1699b2048],
20	resistance	NN	O	resistance	nsubj	21	SENT_85	[p7l1735t1979r2149b2048],
21	occurs	VBZ	O	occur	conj_and	8	SENT_85	[p7l9t2109r271b2160],
22	across	IN	O	across	_	0	SENT_85	[p7l307t2109r558b2160],
23	a	DT	O	a	det	25	SENT_85	[p7l593t2109r636b2160],
24	wide	JJ	O	wide	amod	25	SENT_85	[p7l669t2090r865b2160],
25	variety	NN	O	variety	prep_across	21	SENT_85	[p7l898t2091r1190b2178],
26	of	IN	O	of	_	0	SENT_85	[p7l1223t2090r1305b2160],
27	epilepsy	NN	O	epilepsy	nn	28	SENT_85	[p7l1337t2090r1676b2178],
28	types	NNS	O	type	prep_of	25	SENT_85	[p7l1711t2097r1955b2178],
29	.	.	O	.	_	0	SENT_85	[p7l1711t2097r1955b2178],

1	The	DT	O	the	det	3	SENT_86	[p7l1996t2090r2149b2160],
2	functional	JJ	O	functional	amod	3	SENT_86	[p7l9t2202r427b2272],
3	characteristics	NNS	O	characteristic	nsubj	10	SENT_86	[p7l451t2202r1061b2272],
4	of	IN	O	of	_	0	SENT_86	[p7l1083t2202r1166b2272],
5	non-speciﬁc	JJ	O	non-speciﬁc	amod	8	SENT_86	[p7l1189t2202r1681b2290],
6	drug	NN	O	drug	nn	8	SENT_86	[p7l1704t2202r1885b2290],
7	transporter	NN	O	transporter	nn	8	SENT_86	[p7l1909t2209r2144b2272, p7l12t2321r270b2404],
8	proteins	NNS	O	protein	prep_of	3	SENT_86	[p7l327t2316r661b2404],
9	could	MD	O	could	aux	10	SENT_86	[p7l717t2314r936b2385],
10	explain	VB	O	explain	conj_and	10	SENT_86	[p7l996t2314r1292b2404],
11	broader	JJR	O	broader	amod	12	SENT_86	[p7l1355t2314r1677b2385],
12	resistance	NN	O	resistance	dobj	10	SENT_86	[p7l1735t2316r2149b2385],
13	across	IN	O	across	_	0	SENT_86	[p7l10t2445r260b2497],
14	types	NNS	O	type	prep_across	10	SENT_86	[p7l301t2433r521b2516],
15	of	IN	O	of	_	0	SENT_86	[p7l561t2426r643b2497],
16	epilepsy	NN	O	epilepsy	prep_of	14	SENT_86	[p7l681t2426r1022b2516],
17	and	CC	O	and	_	0	SENT_86	[p7l1062t2426r1204b2497],
18	to	TO	O	to	_	0	SENT_86	[p7l1249t2433r1331b2497],
19	a	DT	O	a	det	20	SENT_86	[p7l1372t2445r1415b2497],
20	range	NN	O	range	prep_to	10	SENT_86	[p7l1460t2443r1685b2516],
21	of	IN	O	of	_	0	SENT_86	[p7l1727t2426r1809b2497],
22	AEDs	NNS	MISC	aed	prep_of	20	SENT_86	[p7l1845t2409r2150b2497],
23	.	.	O	.	_	0	SENT_86	[p7l1845t2409r2150b2497],

1	‘	NN	O	‘	_	0	SENT_87	[p7l1845t2409r2150b2497],
2	4	CD	NUMBER	4	num	3	SENT_87	[p7l1845t2409r2150b2497],
3	Polymorphisms	NNS	O	polymorphism	nsubj	7	SENT_87	[p7l13t2540r622b2628],
4	of	IN	O	of	_	0	SENT_87	[p7l653t2540r736b2610],
5	MDR1	NN	O	mdr1	nn	6	SENT_87	[p7l761t2541r970b2610],
6	gene	NN	O	gene	prep_of	3	SENT_87	[p7l1016t2557r1211b2628],
7	alter	VBP	O	alter	rcmod	1	SENT_87	[p7l1243t2540r1440b2610],
8	in	FW	O	in	nn	9	SENT_87	[p7l1470t2541r1538b2609],
9	vivo	FW	O	vivo	advmod	7	SENT_87	[p7l1571t2541r1736b2610],
10	transport	NN	O	transport	nn	11	SENT_87	[p7l1768t2547r2149b2628],
11	activity	NN	O	activity	dobj	7	SENT_87	[p7l10t2654r321b2742],
12	for	IN	O	for	_	0	SENT_87	[p7l349t2652r466b2724],
13	various	JJ	O	various	amod	14	SENT_87	[p7l492t2654r785b2724],
14	drugs	NNS	O	drug	prep_for	7	SENT_87	[p7l815t2652r1059b2742],
15	,	,	O	,	_	0	SENT_87	[p7l815t2652r1059b2742],
16	and	CC	O	and	_	0	SENT_87	[p7l1097t2652r1241b2724],
17	a	DT	O	a	det	19	SENT_87	[p7l1274t2672r1316b2724],
18	C3435T	NN	O	c3435t	nn	19	SENT_87	[p7l1347t2653r1650b2724],
19	polymorphism	NN	O	polymorphism	nsubjpass	24	SENT_87	[p7l1680t2652r2144b2742, p7l10t2768r142b2837],
20	has	VBZ	O	have	aux	24	SENT_87	[p7l186t2766r315b2837],
21	been	VBN	O	be	auxpass	24	SENT_87	[p7l355t2766r548b2837],
22	most	RBS	O	most	advmod	23	SENT_87	[p7l592t2773r787b2837],
23	frequently	RB	O	frequently	advmod	24	SENT_87	[p7l824t2766r1258b2856],
24	reported	VBN	O	report	rcmod	1	SENT_87	[p7l1297t2766r1651b2856],
25	to	TO	O	to	aux	27	SENT_87	[p7l1693t2773r1774b2837],
26	be	VB	O	be	auxpass	27	SENT_87	[p7l1814t2766r1909b2837],
27	associated	VBN	O	associate	xcomp	24	SENT_87	[p7l1947t2785r2144b2837, p7l9t2878r262b2948],
28	with	IN	O	with	_	0	SENT_87	[p7l322t2878r500b2948],
29	alterations	NNS	O	alteration	prep_with	27	SENT_87	[p7l561t2878r1008b2948],
30	in	IN	O	in	_	0	SENT_87	[p7l1066t2879r1135b2947],
31	disposition	NN	O	disposition	nn	32	SENT_87	[p7l1196t2878r1634b2966],
32	kinetics	NNS	O	kinetics	prep_in	29	SENT_87	[p7l1697t2878r2012b2948],
33	of	IN	O	of	_	0	SENT_87	[p7l2069t2878r2152b2948],
34	various	JJ	O	various	amod	37	SENT_87	[p7l7t2991r301b3060],
35	clinically	RB	O	clinically	advmod	36	SENT_87	[p7l337t2989r708b3079],
36	useful	JJ	O	useful	amod	37	SENT_87	[p7l746t2989r988b3060],
37	drugs	NNS	O	drug	prep_of	32	SENT_87	[p7l1027t2972r1352b3079],
38	.15	CD	NUMBER	.15	tmod	27	SENT_87	[p7l1027t2972r1352b3079],

1	However	RB	O	however	advmod	11	SENT_88	[p7l126t3104r502b3188],
2	,	,	O	,	_	0	SENT_88	[p7l126t3104r502b3188],
3	in	IN	O	in	_	0	SENT_88	[p7l543t3104r612b3172],
4	our	PRP$	O	we	poss	5	SENT_88	[p7l647t3122r785b3173],
5	study	NN	O	study	prep_in	11	SENT_88	[p7l815t3103r1053b3191],
6	,	,	O	,	_	0	SENT_88	[p7l815t3103r1053b3191],
7	no	DT	O	no	det	9	SENT_88	[p7l1097t3122r1190b3173],
8	signiﬁcant	JJ	O	signiﬁcant	amod	9	SENT_88	[p7l1223t3103r1652b3191],
9	association	NN	O	association	nsubjpass	11	SENT_88	[p7l1685t3104r2146b3173],
10	was	VBD	O	be	auxpass	11	SENT_88	[p7l7t3234r162b3286],
11	found	VBN	O	find	_	0	SENT_88	[p7l197t3215r431b3286],
12	between	IN	O	between	_	0	SENT_88	[p7l471t3215r829b3286],
13	the	DT	O	the	det	15	SENT_88	[p7l867t3215r1002b3286],
14	C3435T	NN	O	c3435t	nn	15	SENT_88	[p7l1037t3216r1345b3287],
15	polymorphism	NN	O	polymorphism	prep_between	11	SENT_88	[p7l1379t3215r1963b3305],
16	and	CC	O	and	_	0	SENT_88	[p7l2001t3215r2145b3286],
17	response	NN	O	response	prep_between	11	SENT_88	[p7l13t3347r377b3418],
18	to	TO	O	to	_	0	SENT_88	[p7l432t3335r515b3399],
19	AED	NN	O	aed	nn	20	SENT_88	[p7l567t3329r729b3398],
20	treatment	NN	O	treatment	prep_to	11	SENT_88	[p7l784t3335r1240b3399],
21	.	.	O	.	_	0	SENT_88	[p7l784t3335r1240b3399],

1	The	DT	O	the	det	2	SENT_89	[p7l1301t3328r1456b3399],
2	reason	NN	O	reason	nsubj	12	SENT_89	[p7l1515t3347r1783b3399],
3	for	IN	O	for	_	0	SENT_89	[p7l1840t3328r1960b3399],
4	the	DT	O	the	det	6	SENT_89	[p7l2014t3328r2149b3399],
5	contradictory	JJ	O	contradictory	amod	6	SENT_89	[p7l9t3441r582b3530],
6	results	NNS	O	result	prep_for	2	SENT_89	[p7l662t3441r937b3512],
7	to	TO	O	to	_	0	SENT_89	[p7l1014t3448r1097b3512],
8	the	DT	O	the	det	10	SENT_89	[p7l1175t3441r1310b3512],
9	initial	JJ	O	initial	amod	10	SENT_89	[p7l1389t3441r1633b3512],
10	report8	NN	O	report8	prep_to	6	SENT_89	[p7l1715t3423r2012b3530],
11	is	VBZ	O	be	cop	12	SENT_89	[p7l2091t3442r2150b3512],
12	unclear	JJ	O	unclear	_	0	SENT_89	[p7l12t3554r337b3626],
13	.	.	O	.	_	0	SENT_89	[p7l12t3554r337b3626],

1	The	DT	O	the	det	4	SENT_90	[p7l373t3554r527b3626],
2	small	JJ	O	small	amod	4	SENT_90	[p7l557t3554r773b3626],
3	sample	NN	O	sample	nn	4	SENT_90	[p7l804t3554r1098b3644],
4	size	NN	O	size	nsubj	11	SENT_90	[p7l1127t3556r1284b3626],
5	in	IN	O	in	_	0	SENT_90	[p7l1313t3556r1383b3625],
6	the	DT	O	the	det	8	SENT_90	[p7l1416t3554r1552b3626],
7	present	JJ	DATE	present	amod	8	SENT_90	[p7l1584t3562r1898b3644],
8	study	NN	O	study	prep_in	4	SENT_90	[p7l1926t3554r2151b3644],
9	may	MD	O	may	aux	11	SENT_90	[p7l12t3687r181b3758],
10	be	VB	O	be	cop	11	SENT_90	[p7l244t3668r339b3739],
11	responsible	JJ	O	responsible	_	0	SENT_90	[p7l405t3668r877b3758],
12	for	IN	O	for	_	0	SENT_90	[p7l939t3668r1059b3739],
13	the	DT	O	the	det	15	SENT_90	[p7l1119t3668r1255b3739],
14	negative	JJ	O	negative	amod	15	SENT_90	[p7l1319t3670r1677b3758],
15	result	NN	O	result	prep_for	11	SENT_90	[p7l1743t3668r2006b3739],
16	.	.	O	.	_	0	SENT_90	[p7l1743t3668r2006b3739],

1	In	IN	O	in	_	0	SENT_91	[p7l2082t3670r2145b3738],
2	genetic	JJ	O	genetic	amod	4	SENT_91	[p8l10t19r320b106],
3	association	NN	O	association	nn	4	SENT_91	[p8l355t19r815b88],
4	studies	NNS	O	study	prep_in	9	SENT_91	[p8l852t18r1173b103],
5	,	,	O	,	_	0	SENT_91	[p8l852t18r1173b103],
6	initial	JJ	O	initial	amod	8	SENT_91	[p8l1216t18r1459b88],
7	positive	JJ	O	positive	amod	8	SENT_91	[p8l1497t19r1821b106],
8	studies	NNS	O	study	nsubj	9	SENT_91	[p8l1856t18r2150b88],
9	tend	VBP	O	tend	_	0	SENT_91	[p8l10t130r195b201],
10	to	TO	O	to	aux	11	SENT_91	[p8l246t137r328b201],
11	overestimate	VB	O	overestimate	xcomp	9	SENT_91	[p8l374t132r930b201],
12	effect	NN	O	effect	nn	13	SENT_91	[p8l976t130r1230b201],
13	size	NN	O	size	dobj	11	SENT_91	[p8l1276t132r1432b201],
14	and	CC	O	and	_	0	SENT_91	[p8l1479t130r1624b201],
15	subsequent	JJ	O	subsequent	amod	17	SENT_91	[p8l1674t130r2149b220],
16	replication	NN	O	replication	nn	17	SENT_91	[p8l13t243r464b332],
17	attempts	NNS	O	attempt	nsubj	18	SENT_91	[p8l505t250r885b332],
18	require	VBP	O	require	conj_and	9	SENT_91	[p8l926t244r1228b332],
19	larger	JJR	O	larger	amod	21	SENT_91	[p8l1269t243r1514b332],
20	sample	NN	O	sample	nn	21	SENT_91	[p8l1550t243r1844b332],
21	size	NN	O	size	dobj	18	SENT_91	[p8l1882t225r2149b314],
22	.	.	O	.	_	0	SENT_91	[p8l1882t225r2149b314],

1	“	RB	O	“	advmod	5	SENT_92	[p8l1882t225r2149b314],
2	It	PRP	O	it	nsubj	5	SENT_92	[p8l15t358r68b427],
3	is	VBZ	O	be	cop	5	SENT_92	[p8l127t358r186b427],
4	also	RB	O	also	advmod	5	SENT_92	[p8l245t356r406b427],
5	possible	JJ	O	possible	_	0	SENT_92	[p8l467t356r799b446],
6	that	IN	O	that	complm	10	SENT_92	[p8l858t356r1030b427],
7	the	DT	O	the	det	9	SENT_92	[p8l1088t356r1224b427],
8	inconsistent	JJ	O	inconsistent	amod	9	SENT_92	[p8l1283t358r1790b427],
9	reports	NNS	O	report	nsubj	10	SENT_92	[p8l1851t363r2149b446],
10	result	VBP	O	result	ccomp	5	SENT_92	[p8l14t469r251b539],
11	from	IN	O	from	_	0	SENT_92	[p8l299t469r493b539],
12	the	DT	O	the	det	14	SENT_92	[p8l545t469r681b539],
13	ethnic	JJ	O	ethnic	amod	14	SENT_92	[p8l730t469r993b539],
14	difference	NN	O	difference	prep_from	10	SENT_92	[p8l1043t469r1480b539],
15	in	IN	O	in	_	0	SENT_92	[p8l1530t470r1599b538],
16	linkage	NN	O	linkage	nn	17	SENT_92	[p8l1656t469r1952b557],
17	disequilibrium	NN	O	disequilibrium	prep_in	14	SENT_92	[p8l2002t469r2145b539, p8l10t581r518b669],
18	.	.	O	.	_	0	SENT_92	[p8l2002t469r2145b539, p8l10t581r518b669],

1	There	EX	O	there	expl	5	SENT_93	[p8l555t581r799b651],
2	may	MD	O	may	aux	5	SENT_93	[p8l832t600r1001b669],
3	be	VB	O	be	cop	5	SENT_93	[p8l1032t581r1128b651],
4	inter-population	JJ	O	inter-population	amod	5	SENT_93	[p8l1158t581r1846b669],
5	difference	NN	O	difference	_	0	SENT_93	[p8l1880t581r2144b651, p8l10t712r207b764],
6	in	IN	O	in	_	0	SENT_93	[p8l284t695r354b764],
7	the	DT	O	the	det	8	SENT_93	[p8l435t693r570b764],
8	degree	NN	O	degree	prep_in	5	SENT_93	[p8l648t693r936b783],
9	of	IN	O	of	_	0	SENT_93	[p8l1013t693r1097b764],
10	linkage	NN	O	linkage	nn	11	SENT_93	[p8l1175t693r1471b783],
11	disequilibrium	NN	O	disequilibrium	prep_of	8	SENT_93	[p8l1549t693r2147b783],
12	between	IN	O	between	_	0	SENT_93	[p8l13t806r370b877],
13	the	DT	O	the	det	15	SENT_93	[p8l432t806r568b877],
14	C3435T	NN	O	c3435t	nn	15	SENT_93	[p8l627t807r934b877],
15	polymorphism	NN	O	polymorphism	prep_between	11	SENT_93	[p8l993t806r1576b896],
16	and	CC	O	and	_	0	SENT_93	[p8l1638t806r1783b877],
17	disease	NN	O	disease	nn	18	SENT_93	[p8l1844t806r2149b877],
18	alleles	NNS	O	allele	prep_between	11	SENT_93	[p8l10t919r309b1005],
19	,	,	O	,	_	0	SENT_93	[p8l10t919r309b1005],
20	and	CC	O	and	_	0	SENT_93	[p8l385t919r530b989],
21	studies	NNS	O	study	nsubj	27	SENT_93	[p8l601t919r894b989],
22	in	IN	O	in	_	0	SENT_93	[p8l961t920r1031b988],
23	different	JJ	O	different	amod	25	SENT_93	[p8l1102t919r1478b989],
24	ethnic	JJ	O	ethnic	amod	25	SENT_93	[p8l1545t919r1808b989],
25	groups	NNS	O	group	prep_in	21	SENT_93	[p8l1876t936r2150b1007],
26	may	MD	O	may	aux	27	SENT_93	[p8l13t1051r181b1121],
27	cause	VB	O	cause	conj_and	5	SENT_93	[p8l240t1051r473b1103],
28	different	JJ	O	different	amod	29	SENT_93	[p8l535t1031r912b1103],
29	associations	NNS	O	association	dobj	27	SENT_93	[p8l973t1033r1502b1103],
30	.	.	O	.	_	0	SENT_93	[p8l973t1033r1502b1103],

1	Nevertheless	RB	O	nevertheless	advmod	10	SENT_94	[p8l1575t1031r2141b1118],
2	,	,	O	,	_	0	SENT_94	[p8l1575t1031r2141b1118],
3	our	PRP$	O	we	poss	4	SENT_94	[p8l10t1163r147b1215],
4	study	NN	O	study	nsubj	10	SENT_94	[p8l182t1144r407b1233],
5	may	MD	O	may	aux	10	SENT_94	[p8l445t1163r614b1234],
6	be	VB	O	be	cop	10	SENT_94	[p8l653t1144r749b1215],
7	a	DT	O	a	det	10	SENT_94	[p8l787t1163r830b1215],
8	true	JJ	O	true	amod	10	SENT_94	[p8l869t1151r1042b1215],
9	negative	JJ	O	negative	amod	10	SENT_94	[p8l1083t1146r1440b1234],
10	result	NN	O	result	_	0	SENT_94	[p8l1482t1144r1718b1215],
11	and	CC	O	and	_	0	SENT_94	[p8l1757t1144r1902b1215],
12	show	VBP	O	show	conj_and	10	SENT_94	[p8l1943t1144r2151b1215],
13	that	IN	O	that	complm	24	SENT_94	[p8l10t1257r183b1327],
14	the	DT	O	the	det	15	SENT_94	[p8l249t1257r385b1327],
15	inﬂuence	NN	O	inﬂuence	nsubj	24	SENT_94	[p8l452t1257r837b1327],
16	of	IN	O	of	_	0	SENT_94	[p8l902t1257r986b1327],
17	C3435T	NN	O	c3435t	nn	18	SENT_94	[p8l1049t1257r1358b1327],
18	polymorphism	NN	O	polymorphism	prep_of	15	SENT_94	[p8l1423t1257r2007b1345],
19	in	IN	O	in	_	0	SENT_94	[p8l2076t1258r2146b1326],
20	multidrug	JJ	O	multidrug	amod	21	SENT_94	[p8l13t1369r419b1457],
21	resistance	NN	O	resistance	prep_in	18	SENT_94	[p8l476t1370r898b1439],
22	is	VBZ	O	be	cop	24	SENT_94	[p8l952t1370r1011b1439],
23	not	RB	O	not	neg	24	SENT_94	[p8l1067t1376r1200b1439],
24	signiﬁcant	JJ	O	signiﬁcant	ccomp	12	SENT_94	[p8l1253t1369r1682b1457],
25	in	IN	O	in	_	0	SENT_94	[p8l1735t1370r1805b1438],
26	Korean	JJ	LOCATION	korean	amod	27	SENT_94	[p8l1865t1371r2146b1439],
27	populations	NNS	O	population	prep_in	24	SENT_94	[p8l13t1481r525b1569],
28	,	,	O	,	_	0	SENT_94	[p8l13t1481r525b1569],
29	because	IN	O	because	mark	36	SENT_94	[p8l586t1481r920b1551],
30	the	DT	O	the	det	32	SENT_94	[p8l970t1481r1106b1551],
31	drug	NN	O	drug	nn	32	SENT_94	[p8l1156t1481r1340b1569],
32	resistance	NN	O	resistance	nsubj	36	SENT_94	[p8l1393t1482r1815b1551],
33	in	IN	O	in	_	0	SENT_94	[p8l1865t1482r1935b1550],
34	epilepsy	NN	O	epilepsy	prep_in	32	SENT_94	[p8l1987t1482r2144b1569, p8l14t1593r225b1683],
35	is	VBZ	O	be	cop	36	SENT_94	[p8l257t1595r318b1664],
36	dependent	JJ	O	dependent	advcl	24	SENT_94	[p8l352t1593r803b1683],
37	of	IN	O	of	_	0	SENT_94	[p8l837t1593r921b1664],
38	the	DT	O	the	det	39	SENT_94	[p8l953t1593r1088b1664],
39	effects	NNS	O	effect	prep_of	36	SENT_94	[p8l1123t1593r1416b1664],
40	of	IN	O	of	_	0	SENT_94	[p8l1451t1593r1534b1664],
41	many	JJ	O	many	amod	42	SENT_94	[p8l1569t1612r1789b1683],
42	biologic	JJ	O	biologic	prep_of	39	SENT_94	[p8l1825t1593r2149b1683],
43	and	CC	O	and	_	0	SENT_94	[p8l10t1707r156b1778],
44	genetic	JJ	O	genetic	amod	46	SENT_94	[p8l195t1709r506b1797],
45	risk	NN	O	risk	nn	46	SENT_94	[p8l546t1707r689b1778],
46	factors	NNS	O	factor	prep_of	39	SENT_94	[p8l722t1707r1041b1794],
47	,	,	O	,	_	0	SENT_94	[p8l722t1707r1041b1794],
48	and	CC	O	and	_	0	SENT_94	[p8l1085t1707r1231b1778],
49	the	DT	O	the	det	51	SENT_94	[p8l1270t1707r1406b1778],
50	functional	JJ	O	functional	amod	51	SENT_94	[p8l1441t1707r1868b1778],
51	implication	NN	O	implication	nsubj	60	SENT_94	[p8l1906t1707r2144b1797, p8l10t1820r266b1889],
52	of	IN	O	of	_	0	SENT_94	[p8l311t1819r395b1889],
53	one	CD	NUMBER	one	num	54	SENT_94	[p8l433t1838r582b1889],
54	factor	NN	O	factor	prep_of	51	SENT_94	[p8l623t1819r879b1889],
55	for	IN	O	for	_	0	SENT_94	[p8l918t1819r1038b1889],
56	drug	NN	O	drug	nn	57	SENT_94	[p8l1078t1819r1260b1907],
57	resistance	NN	O	resistance	prep_for	54	SENT_94	[p8l1306t1820r1728b1889],
58	might	MD	O	might	aux	60	SENT_94	[p8l1773t1819r2009b1907],
59	be	VB	O	be	cop	60	SENT_94	[p8l2053t1819r2149b1889],
60	variable	JJ	O	variable	conj_and	10	SENT_94	[p8l8t1931r349b2003],
61	in	IN	O	in	_	0	SENT_94	[p8l377t1933r447b2002],
62	different	JJ	O	different	amod	63	SENT_94	[p8l479t1931r855b2003],
63	populations	NNS	O	population	prep_in	60	SENT_94	[p8l886t1931r1398b2021],
64	.	.	O	.	_	0	SENT_94	[p8l886t1931r1398b2021],

1	It	PRP	O	it	nsubjpass	4	SENT_95	[p8l1440t1933r1493b2003],
2	may	MD	O	may	aux	4	SENT_95	[p8l1524t1951r1692b2021],
3	be	VB	O	be	auxpass	4	SENT_95	[p8l1721t1931r1817b2003],
4	related	VBN	O	relate	_	0	SENT_95	[p8l1849t1931r2146b2003],
5	with	IN	O	with	_	0	SENT_95	[p8l8t2044r189b2114],
6	the	DT	O	the	det	7	SENT_95	[p8l237t2044r372b2114],
7	fact	NN	O	fact	prep_with	4	SENT_95	[p8l417t2044r582b2114],
8	that	IN	O	that	complm	10	SENT_95	[p8l626t2044r798b2114],
9	there	EX	O	there	expl	10	SENT_95	[p8l842t2044r1067b2114],
10	are	VBP	O	be	ccomp	4	SENT_95	[p8l1112t2063r1245b2114],
11	controversies	NNS	O	controversy	nsubj	10	SENT_95	[p8l1288t2046r1852b2114],
12	in	IN	O	in	_	0	SENT_95	[p8l1897t2046r1966b2114],
13	the	DT	O	the	det	14	SENT_95	[p8l2014t2044r2150b2114],
14	effects	NNS	O	effect	prep_in	11	SENT_95	[p8l9t2156r302b2226],
15	of	IN	O	of	_	0	SENT_95	[p8l329t2156r413b2226],
16	the	DT	O	the	det	18	SENT_95	[p8l438t2156r573b2226],
17	C3435T	NN	O	c3435t	nn	18	SENT_95	[p8l602t2156r909b2226],
18	polymorphism	NN	O	polymorphism	prep_of	14	SENT_95	[p8l937t2156r1520b2244],
19	on	IN	O	on	_	0	SENT_95	[p8l1551t2175r1645b2226],
20	the	DT	O	the	det	21	SENT_95	[p8l1676t2156r1811b2226],
21	expression	NN	O	expression	prep_on	18	SENT_95	[p8l1839t2175r2144b2244, p8l10t2269r169b2339],
22	of	IN	O	of	_	0	SENT_95	[p8l223t2268r306b2339],
23	P-glycoprotein	NN	O	p-glycoprotein	prep_of	21	SENT_95	[p8l358t2250r1081b2357],
24	,	,	O	,	_	0	SENT_95	[p8l358t2250r1081b2357],
25	”	NN	O	”	appos	23	SENT_95	[p8l358t2250r1081b2357],
26	and	CC	O	and	_	0	SENT_95	[p8l1130t2268r1275b2339],
27	it	PRP	O	it	nsubj	31	SENT_95	[p8l1330t2269r1389b2339],
28	is	VBZ	O	be	cop	31	SENT_95	[p8l1440t2269r1500b2339],
29	still	RB	O	still	advmod	31	SENT_95	[p8l1550t2268r1704b2339],
30	not	RB	O	not	neg	31	SENT_95	[p8l1758t2275r1891b2339],
31	clear	JJ	O	clear	ccomp	4	SENT_95	[p8l1940t2268r2152b2339],
32	whether	IN	O	whether	complm	43	SENT_95	[p8l8t2381r360b2451],
33	some	DT	O	some	det	35	SENT_95	[p8l392t2400r605b2451],
34	important	JJ	O	important	amod	35	SENT_95	[p8l640t2382r1059b2469],
35	AEDs	NNS	MISC	aed	nsubj	43	SENT_95	[p8l1090t2382r1291b2451],
36	such	JJ	O	such	_	0	SENT_95	[p8l1325t2381r1504b2451],
37	as	IN	O	as	_	0	SENT_95	[p8l1542t2400r1624b2451],
38	carbamazepine	NN	O	carbamazepine	prep_such_as	35	SENT_95	[p8l1657t2381r2145b2451, p8l13t2495r188b2583],
39	and	CC	O	and	_	0	SENT_95	[p8l231t2493r375b2564],
40	valproate	NN	O	valproate	prep_such_as	35	SENT_95	[p8l418t2493r821b2583],
41	are	VBP	O	be	cop	43	SENT_95	[p8l863t2512r996b2564],
42	really	RB	O	really	advmod	43	SENT_95	[p8l1041t2493r1276b2583],
43	substrates	NNS	O	substrate	ccomp	31	SENT_95	[p8l1316t2493r1745b2564],
44	of	IN	O	of	_	0	SENT_95	[p8l1786t2493r1870b2564],
45	Pglycoproprotein	NN	O	pglycoproprotein	prep_of	43	SENT_95	[p8l1912t2493r2145b2583, p8l10t2589r729b2697],
46	.5	CD	NUMBER	.5	num	45	SENT_95	[p8l1912t2493r2145b2583, p8l10t2589r729b2697],
47	"	``	O	"	punct	45	SENT_95	[p8l1912t2493r2145b2583, p8l10t2589r729b2697],
48	8	CD	NUMBER	8	dep	45	SENT_95	[p8l1912t2493r2145b2583, p8l10t2589r729b2697],

1	In	IN	O	in	_	0	SENT_96	[p8l128t2720r191b2788],
2	conclusion	NN	O	conclusion	prep_in	7	SENT_96	[p8l229t2719r687b2804],
3	,	,	O	,	_	0	SENT_96	[p8l229t2719r687b2804],
4	we	PRP	O	we	nsubj	7	SENT_96	[p8l729t2738r846b2789],
5	could	MD	O	could	aux	7	SENT_96	[p8l881t2719r1099b2789],
6	not	RB	O	not	neg	7	SENT_96	[p8l1141t2726r1271b2789],
7	conﬁrm	VB	O	conﬁrm	_	0	SENT_96	[p8l1306t2719r1614b2789],
8	a	DT	O	a	det	11	SENT_96	[p8l1652t2738r1695b2789],
9	previously	RB	DATE	previously	advmod	10	SENT_96	[p8l1733t2719r2151b2807],
10	reported	VBN	O	report	amod	11	SENT_96	[p8l14t2831r368b2921],
11	association	NN	O	association	dobj	7	SENT_96	[p8l436t2833r888b2903],
12	between	IN	O	between	_	0	SENT_96	[p8l959t2831r1311b2903],
13	the	DT	O	the	det	15	SENT_96	[p8l1380t2831r1513b2903],
14	C3435T	NN	O	c3435t	nn	15	SENT_96	[p8l1579t2832r1882b2903],
15	polymorphism	NN	O	polymorphism	prep_between	11	SENT_96	[p8l1948t2831r2144b2921, p8l13t2944r410b3034],
16	and	CC	O	and	_	0	SENT_96	[p8l463t2944r606b3015],
17	the	DT	O	the	det	19	SENT_96	[p8l658t2944r792b3015],
18	multidrug-resistant	JJ	O	multidrug-resistant	amod	19	SENT_96	[p8l845t2944r1641b3034],
19	epilepsy	NN	O	epilepsy	conj_and	11	SENT_96	[p8l1690t2944r2029b3034],
20	in	IN	O	in	_	0	SENT_96	[p8l2078t2946r2146b3014],
21	Korean	JJ	LOCATION	korean	amod	22	SENT_96	[p8l14t3058r290b3127],
22	population	NN	O	population	prep_in	19	SENT_96	[p8l331t3057r795b3145],
23	.	.	O	.	_	0	SENT_96	[p8l331t3057r795b3145],

1	Ethnic	JJ	O	ethnic	amod	2	SENT_97	[p8l842t3057r1095b3127],
2	difference	NN	O	difference	nsubj	9	SENT_97	[p8l1130t3057r1557b3127],
3	or	CC	O	or	_	0	SENT_97	[p8l1592t3076r1676b3127],
4	small	JJ	O	small	amod	6	SENT_97	[p8l1709t3057r1921b3127],
5	sample	NN	O	sample	nn	6	SENT_97	[p8l1957t3076r2144b3127, p8l13t3169r135b3257],
6	size	NN	O	size	conj_or	2	SENT_97	[p8l168t3170r320b3239],
7	may	MD	O	may	aux	9	SENT_97	[p8l356t3188r522b3257],
8	be	VB	O	be	cop	9	SENT_97	[p8l555t3169r650b3239],
9	responsible	JJ	O	responsible	_	0	SENT_97	[p8l687t3169r1149b3257],
10	for	IN	O	for	_	0	SENT_97	[p8l1182t3169r1299b3239],
11	our	PRP$	O	we	poss	13	SENT_97	[p8l1329t3188r1464b3239],
12	negative	JJ	O	negative	amod	13	SENT_97	[p8l1497t3170r1848b3257],
13	result	NN	O	result	prep_for	9	SENT_97	[p8l1883t3169r2142b3255],
14	,	,	O	,	_	0	SENT_97	[p8l1883t3169r2142b3255],
15	but	CC	O	but	_	0	SENT_97	[p8l13t3281r145b3351],
16	it	PRP	O	it	nsubj	19	SENT_97	[p8l179t3282r237b3351],
17	is	VBZ	O	be	cop	19	SENT_97	[p8l271t3282r329b3351],
18	also	RB	O	also	advmod	19	SENT_97	[p8l363t3281r521b3351],
19	possible	JJ	O	possible	conj_but	9	SENT_97	[p8l558t3281r883b3369],
20	that	IN	O	that	complm	28	SENT_97	[p8l917t3281r1086b3351],
21	the	DT	O	the	det	23	SENT_97	[p8l1120t3281r1254b3351],
22	original	JJ	O	original	amod	23	SENT_97	[p8l1287t3281r1595b3369],
23	report	NN	O	report	nsubj	28	SENT_97	[p8l1633t3287r1888b3369],
24	was	VBD	O	be	cop	28	SENT_97	[p8l1920t3300r2073b3351],
25	a	DT	O	a	det	28	SENT_97	[p8l2106t3300r2149b3351],
26	false	JJ	O	false	amod	27	SENT_97	[p8l9t3393r203b3464],
27	positive	JJ	O	positive	amod	28	SENT_97	[p8l251t3395r570b3483],
28	ﬁnding	NN	O	ﬁnding	ccomp	19	SENT_97	[p8l613t3393r916b3483],
29	.	.	O	.	_	0	SENT_97	[p8l613t3393r916b3483],

1	To	TO	O	to	aux	2	SENT_98	[p8l967t3395r1057b3464],
2	clarify	VB	O	clarify	_	0	SENT_98	[p8l1101t3393r1364b3483],
3	the	DT	O	the	det	6	SENT_98	[p8l1406t3393r1540b3464],
4	exact	JJ	O	exact	amod	6	SENT_98	[p8l1585t3400r1810b3464],
5	clinical	JJ	O	clinical	amod	6	SENT_98	[p8l1854t3393r2148b3464],
6	implication	NN	O	implication	dobj	2	SENT_98	[p8l10t3506r471b3596],
7	of	IN	O	of	_	0	SENT_98	[p8l533t3506r616b3577],
8	the	DT	O	the	det	10	SENT_98	[p8l671t3506r805b3577],
9	C3435T	NN	O	c3435t	nn	10	SENT_98	[p8l865t3507r1167b3577],
10	polymorphism	NN	O	polymorphism	prep_of	6	SENT_98	[p8l1226t3506r1799b3596],
11	on	IN	O	on	_	0	SENT_98	[p8l1861t3525r1954b3577],
12	the	DT	O	the	det	14	SENT_98	[p8l2016t3506r2149b3577],
13	multidrug	JJ	O	multidrug	amod	14	SENT_98	[p8l13t3619r411b3707],
14	resistance	NN	O	resistance	prep_on	2	SENT_98	[p8l453t3620r867b3689],
15	in	IN	O	in	_	0	SENT_98	[p8l906t3620r975b3688],
16	epilepsy	NN	O	epilepsy	prep_in	14	SENT_98	[p8l1016t3619r1371b3707],
17	,	,	O	,	_	0	SENT_98	[p8l1016t3619r1371b3707],
18	further	JJ	O	further	amod	19	SENT_98	[p8l1417t3619r1712b3689],
19	investigations	NNS	O	investigation	appos	16	SENT_98	[p8l1748t3620r2144b3707, p9l10t21r207b91],

1	in	IN	O	in	_	0	SENT_99	[p9l240t21r309b90],
2	various	JJ	O	various	prep_in	7	SENT_99	[p9l344t21r637b91],
3	ethnic	JJ	O	ethnic	amod	4	SENT_99	[p9l670t19r928b91],
4	populations	NNS	O	population	nsubj	7	SENT_99	[p9l964t19r1441b109],
5	would	MD	O	would	aux	7	SENT_99	[p9l1472t19r1716b91],
6	be	VB	O	be	cop	7	SENT_99	[p9l1755t19r1850b91],
7	necessary	JJ	O	necessary	_	0	SENT_99	[p9l1887t39r2145b91, p9l10t151r188b222],
8	.	.	O	.	_	0	SENT_99	[p9l1887t39r2145b91, p9l10t151r188b222],

1	Additionally	RB	O	additionally	advmod	4	SENT_100	[p9l250t132r764b222],
2	,	,	O	,	_	0	SENT_100	[p9l250t132r764b222],
3	there	EX	O	there	expl	4	SENT_100	[p9l827t132r1048b203],
4	are	VBP	O	be	_	0	SENT_100	[p9l1105t151r1235b203],
5	other	JJ	O	other	amod	8	SENT_100	[p9l1291t132r1514b203],
6	MDR1	NN	O	mdr1	nn	8	SENT_100	[p9l1565t133r1774b203],
7	genetic	JJ	O	genetic	amod	8	SENT_100	[p9l1845t134r2149b222],
8	variations	NNS	O	variation	nsubj	4	SENT_100	[p9l8t246r414b315],
9	that	WDT	O	that	nsubjpass	11	SENT_100	[p9l445t245r614b315],
10	were	VBD	O	be	auxpass	11	SENT_100	[p9l642t264r847b315],
11	reported	VBN	O	report	rcmod	8	SENT_100	[p9l881t245r1234b333],
12	to	TO	O	to	aux	14	SENT_100	[p9l1269t252r1351b315],
13	be	VB	O	be	auxpass	14	SENT_100	[p9l1384t245r1479b315],
14	associated	VBN	O	associate	xcomp	11	SENT_100	[p9l1510t245r1937b315],
15	with	IN	O	with	_	0	SENT_100	[p9l1968t245r2146b315],
16	the	DT	O	the	det	18	SENT_100	[p9l10t357r144b427],
17	increased	VBN	O	increase	amod	18	SENT_100	[p9l187t357r579b427],
18	risk	NN	O	risk	prep_with	14	SENT_100	[p9l629t357r771b427],
19	for	IN	O	for	_	0	SENT_100	[p9l810t357r928b427],
20	multidrug	JJ	O	multidrug	amod	21	SENT_100	[p9l972t357r1371b445],
21	resistance	NN	O	resistance	prep_for	18	SENT_100	[p9l1418t358r1831b427],
22	in	IN	O	in	_	0	SENT_100	[p9l1876t358r1945b426],
23	epilepsy	NN	O	epilepsy	prep_in	21	SENT_100	[p9l1990t358r2144b445, p9l14t469r235b558],
24	,	,	O	,	_	0	SENT_100	[p9l1990t358r2144b445, p9l14t469r235b558],

1	9	CD	NUMBER	9	num	2	SENT_101	[p9l247t451r378b508],
2	”’	NN	O	”’	nsubjpass	14	SENT_101	[p9l247t451r378b508],
3	and	CC	O	and	_	0	SENT_101	[p9l441t469r584b540],
4	further	JJ	O	further	amod	6	SENT_101	[p9l649t469r943b540],
5	replication	NN	O	replication	nn	6	SENT_101	[p9l1007t469r1448b558],
6	study	NN	O	study	conj_and	2	SENT_101	[p9l1514t469r1734b558],
7	in	IN	O	in	_	0	SENT_101	[p9l1795t470r1863b539],
8	other	JJ	O	other	amod	10	SENT_101	[p9l1929t469r2151b540],
9	ethnic	JJ	O	ethnic	amod	10	SENT_101	[p9l10t582r267b653],
10	groups	NNS	O	group	prep_in	6	SENT_101	[p9l305t600r573b672],
11	would	MD	O	would	aux	14	SENT_101	[p9l607t582r851b653],
12	also	RB	O	also	advmod	14	SENT_101	[p9l892t582r1050b653],
13	be	VB	O	be	auxpass	14	SENT_101	[p9l1089t582r1184b653],
14	needed	VBN	O	need	_	0	SENT_101	[p9l1224t582r1549b653],
15	.	.	O	.	_	0	SENT_101	[p9l1224t582r1549b653],

1	Acknowledgement	NN	O	acknowledgement	_	0	SENT_102	[p9l7t842r965b950],

1	This	DT	O	this	det	2	SENT_103	[p9l7t1101r174b1172],
2	study	NN	O	study	nsubjpass	4	SENT_103	[p9l204t1101r424b1190],
3	was	VBD	O	be	auxpass	4	SENT_103	[p9l451t1120r604b1172],
4	supported	VBN	O	support	_	0	SENT_103	[p9l634t1101r1045b1191],
5	by	IN	O	by	_	0	SENT_103	[p9l1081t1101r1173b1190],
6	a	DT	O	a	det	8	SENT_103	[p9l1202t1120r1246b1172],
7	research	NN	O	research	nn	8	SENT_103	[p9l1279t1101r1625b1172],
8	grant	NN	O	grant	agent	4	SENT_103	[p9l1660t1108r1875b1191],
9	of	IN	O	of	_	0	SENT_103	[p9l1905t1101r1988b1172],
10	the	DT	O	the	det	15	SENT_103	[p9l2016t1101r2149b1172],
11	Korea	NNP	ORGANIZATION	Korea	nn	15	SENT_103	[p9l14t1214r241b1283],
12	Health	NNP	ORGANIZATION	Health	nn	15	SENT_103	[p9l284t1213r548b1283],
13	21	CD	NUMBER	21	num	15	SENT_103	[p9l590t1213r669b1282],
14	R&D	NNP	O	R&D	nn	15	SENT_103	[p9l725t1213r892b1283],
15	Project	NNP	O	Project	prep_of	8	SENT_103	[p9l934t1214r1255b1301],
16	,	,	O	,	_	0	SENT_103	[p9l934t1214r1255b1301],
17	Ministry	NNP	ORGANIZATION	Ministry	appos	8	SENT_103	[p9l1299t1214r1626b1301],
18	of	IN	ORGANIZATION	of	_	0	SENT_103	[p9l1662t1213r1744b1283],
19	Health	NNP	ORGANIZATION	Health	prep_of	17	SENT_103	[p9l1783t1213r2047b1283],
20	&	CC	ORGANIZATION	&	_	0	SENT_103	[p9l2093t1213r2148b1283],
21	Welfare	NNP	ORGANIZATION	Welfare	prep_of	17	SENT_103	[p9l8t1324r356b1410],
22	,	,	O	,	_	0	SENT_103	[p9l8t1324r356b1410],
23	Korea	NNP	LOCATION	Korea	appos	8	SENT_103	[p9l404t1326r632b1394],
24	(	CD	NUMBER	(	num	26	SENT_103	[p9l675t1325r1816b1412],
25	O3-PJ10-PG13-GD01-0002	NN	O	o3-pj10-pg13-gd01-0002	nn	26	SENT_103	[p9l675t1325r1816b1412],
26	)	NN	O	)	dep	23	SENT_103	[p9l675t1325r1816b1412],
27	.	.	O	.	_	0	SENT_103	[p9l675t1325r1816b1412],

1	MDR1	NN	O	mdr1	nn	3	SENT_104	[p9l96t1488r189b1519],
2	C3435T	NN	O	c3435t	nn	3	SENT_104	[p9l211t1487r345b1519],
3	polymorphism	NN	O	polymorphism	_	0	SENT_104	[p9l362t1487r614b1527],
4	347	CD	NUMBER	347	dep	3	SENT_104	[p9l2001t1487r2063b1519],

1	References	NNS	O	reference	_	0	SENT_105	[p9l6t1659r585b1744],

1	Regesta	NN	O	regesta	nn	2	SENT_106	[p9l146t1914r397b1985],
2	G	NN	O	g	_	0	SENT_106	[p9l422t1914r489b1983],
3	,	,	O	,	_	0	SENT_106	[p9l422t1914r489b1983],
4	Tanganelli	NNP	PERSON	Tanganelli	nn	5	SENT_106	[p9l517t1913r850b1985],
5	P.	NNP	PERSON	P.	appos	2	SENT_106	[p9l880t1914r921b1970],
6	Clinical	JJ	PERSON	clinical	amod	7	SENT_106	[p9l953t1913r1195b1970],
7	aspects	NNS	O	aspect	dep	5	SENT_106	[p9l1221t1919r1465b1985],
8	and	CC	O	and	_	0	SENT_106	[p9l1488t1913r1603b1970],
9	biological	JJ	O	biological	amod	10	SENT_106	[p9l1631t1913r1946b1985],
10	bases	NNS	O	basis	appos	2	SENT_106	[p9l1973t1913r2149b1970],
11	of	IN	O	of	_	0	SENT_106	[p9l142t2006r209b2063],
12	drug-resistant	JJ	O	drug-resistant	amod	13	SENT_106	[p9l235t2006r698b2078],
13	epilepsies	NNS	O	epilepsy	prep_of	10	SENT_106	[p9l726t2006r1073b2078],
14	.	.	O	.	_	0	SENT_106	[p9l726t2006r1073b2078],

1	Epilepsy	NNP	O	Epilepsy	nn	2	SENT_107	[p9l1108t2006r1388b2078],
2	Res	NNP	O	Res	_	0	SENT_107	[p9l1413t2007r1525b2063],
3	1999	CD	DATE	1999	num	2	SENT_107	[p9l1557t2007r2120b2076],
4	;	:	O	;	_	0	SENT_107	[p9l1557t2007r2120b2076],
5	34:109	CD	NUMBER	34:109	number	6	SENT_107	[p9l1557t2007r2120b2076],
6	—	CD	NUMBER	—	dep	2	SENT_107	[p9l1557t2007r2120b2076],
7	22	CD	NUMBER	22	dep	6	SENT_107	[p9l1557t2007r2120b2076],
8	.	.	O	.	_	0	SENT_107	[p9l1557t2007r2120b2076],

1	Ling	NNP	PERSON	Ling	nn	4	SENT_108	[p9l145t2102r276b2173],
2	V.	NNP	PERSON	V.	nn	4	SENT_108	[p9l324t2102r375b2158],
3	Multidrug	NNP	PERSON	Multidrug	nn	4	SENT_108	[p9l430t2101r744b2173],
4	resistance	NN	O	resistance	_	0	SENT_108	[p9l796t2102r1148b2158],
5	:	:	O	:	_	0	SENT_108	[p9l796t2102r1148b2158],
6	molecular	JJ	O	molecular	amod	7	SENT_108	[p9l1206t2101r1535b2158],
7	mechanisms	NNS	O	mechanism	dep	4	SENT_108	[p9l1584t2101r1981b2158],
8	and	CC	O	and	_	0	SENT_108	[p9l2031t2101r2145b2158],
9	clinical	JJ	O	clinical	amod	10	SENT_108	[p9l142t2195r378b2252],
10	relevance	NN	O	relevance	dep	4	SENT_108	[p9l422t2195r763b2252],
11	.	.	O	.	_	0	SENT_108	[p9l422t2195r763b2252],

1	Cancer	NNP	O	Cancer	nn	3	SENT_109	[p9l813t2196r1041b2252],
2	Chemother	NNP	O	Chemother	nn	3	SENT_109	[p9l1080t2195r1453b2252],
3	Pharmacol	NNP	O	Pharmacol	_	0	SENT_109	[p9l1489t2195r1839b2252],
4	1997	CD	DATE	1997	num	3	SENT_109	[p9l1885t2196r2148b2264],
5	;	:	O	;	_	0	SENT_109	[p9l1885t2196r2148b2264],
6	40	CD	NUMBER	40	number	7	SENT_109	[p9l1885t2196r2148b2264],
7	(	CD	NUMBER	(	dep	3	SENT_109	[p9l147t2287r620b2359],
8	Suppl	NNP	O	Suppl	nn	10	SENT_109	[p9l147t2287r620b2359],
9	.	.	O	.	_	0	SENT_109	[p9l147t2287r620b2359],
10	)	NN	O	)	dep	7	SENT_109	[p9l147t2287r620b2359],

1	:	:	O	:	_	0	SENT_110	[p9l147t2287r620b2359],
2	S3	NN	O	s3	_	0	SENT_110	[p9l147t2287r620b2359],
3	—	CD	NUMBER	—	num	4	SENT_110	[p9l147t2287r620b2359],
4	8	CD	NUMBER	8	dep	2	SENT_110	[p9l147t2287r620b2359],
5	.	.	O	.	_	0	SENT_110	[p9l147t2287r620b2359],

1	.	.	O	.	_	0	SENT_111	[p9l83t2427r94b2438],

1	Schinkel	NNP	PERSON	Schinkel	nn	2	SENT_112	[p9l143t2381r414b2439],
2	AH	NNP	O	AH	_	0	SENT_112	[p9l431t2382r543b2451],
3	,	,	O	,	_	0	SENT_112	[p9l431t2382r543b2451],
4	Smitt	NNP	PERSON	Smitt	nn	5	SENT_112	[p9l568t2382r744b2439],
5	JJ	NN	PERSON	jj	appos	2	SENT_112	[p9l761t2383r850b2451],
6	,	,	O	,	_	0	SENT_112	[p9l761t2383r850b2451],
7	van	NN	PERSON	van	nn	9	SENT_112	[p9l873t2397r986b2438],
8	Tellingen	NN	PERSON	tellingen	nn	9	SENT_112	[p9l1005t2381r1301b2453],
9	O	NN	PERSON	o	appos	2	SENT_112	[p9l1322t2382r1389b2451],
10	,	,	O	,	_	0	SENT_112	[p9l1322t2382r1389b2451],
11	et	FW	O	et	nn	12	SENT_112	[p9l1415t2387r1482b2438],
12	al.	FW	O	al.	appos	2	SENT_112	[p9l1501t2381r1578b2438],
13	.	.	O	.	_	0	SENT_112	[p9l1501t2381r1578b2438],

1	Disruption	NN	O	disruption	nsubj	9	SENT_113	[p9l1607t2383r1938b2453],
2	of	IN	O	of	_	0	SENT_113	[p9l1958t2381r2025b2438],
3	the	DT	O	the	det	5	SENT_113	[p9l2041t2381r2148b2438],
4	mouse	NN	O	mouse	nn	5	SENT_113	[p9l145t2492r352b2533],
5	MDR1	NN	O	mdr1	prep_of	1	SENT_113	[p9l369t2477r537b2533],
6	a	DT	O	a	det	8	SENT_113	[p9l553t2492r587b2533],
7	P-glycoprotein	NN	MISC	p-glycoprotein	nn	8	SENT_113	[p9l609t2476r1085b2548],
8	gene	NN	O	gene	dep	5	SENT_113	[p9l1107t2490r1263b2548],
9	leads	VBZ	O	lead	_	0	SENT_113	[p9l1285t2476r1452b2533],
10	to	TO	O	to	_	0	SENT_113	[p9l1471t2482r1536b2533],
11	a	DT	O	a	det	12	SENT_113	[p9l1555t2492r1590b2533],
12	deﬁciency	NN	O	deﬁciency	prep_to	9	SENT_113	[p9l1610t2476r1947b2548],
13	in	IN	O	in	_	0	SENT_113	[p9l1964t2477r2019b2532],
14	the	DT	O	the	det	16	SENT_113	[p9l2041t2476r2148b2533],
15	blood-brain	JJ	O	blood-brain	amod	16	SENT_113	[p9l145t2569r521b2626],
16	barrier	NN	O	barrier	prep_in	12	SENT_113	[p9l546t2569r772b2626],
17	and	CC	O	and	_	0	SENT_113	[p9l791t2569r906b2626],
18	to	TO	O	to	_	0	SENT_113	[p9l929t2575r995b2626],
19	increased	VBN	O	increase	amod	20	SENT_113	[p9l1016t2569r1330b2626],
20	sensitivity	NN	O	sensitivity	conj_and	12	SENT_113	[p9l1353t2570r1689b2641],
21	to	TO	O	to	_	0	SENT_113	[p9l1708t2575r1774b2626],
22	drugs	NNS	O	drug	prep_to	20	SENT_113	[p9l1795t2569r1991b2641],
23	.	.	O	.	_	0	SENT_113	[p9l1795t2569r1991b2641],

1	Cell	NN	O	cell	_	0	SENT_114	[p9l2021t2569r2147b2626],
2	1994	CD	DATE	1994	num	1	SENT_114	[p9l147t2665r748b2733],
3	;	:	O	;	_	0	SENT_114	[p9l147t2665r748b2733],
4	77:491	CD	NUMBER	77:491	number	5	SENT_114	[p9l147t2665r748b2733],
5	-502	CD	NUMBER	-502	dep	1	SENT_114	[p9l147t2665r748b2733],
6	.	.	O	.	_	0	SENT_114	[p9l147t2665r748b2733],

1	.	.	O	.	_	0	SENT_115	[p9l83t2803r94b2814],

1	Hoffmeyer	NNP	PERSON	Hoffmeyer	nn	2	SENT_116	[p9l145t2757r494b2829],
2	S	NNP	O	S	_	0	SENT_116	[p9l521t2758r573b2827],
3	,	,	O	,	_	0	SENT_116	[p9l521t2758r573b2827],
4	Burk	NNP	PERSON	Burk	nn	5	SENT_116	[p9l612t2757r757b2814],
5	o	NN	O	o	appos	2	SENT_116	[p9l784t2758r851b2827],
6	,	,	O	,	_	0	SENT_116	[p9l784t2758r851b2827],
7	von	NN	PERSON	von	nn	9	SENT_116	[p9l885t2773r998b2814],
8	Richter	NNP	PERSON	Richter	nn	9	SENT_116	[p9l1032t2757r1270b2814],
9	O	NNP	PERSON	O	appos	2	SENT_116	[p9l1297t2758r1363b2827],
10	,	,	O	,	_	0	SENT_116	[p9l1297t2758r1363b2827],
11	et	FW	O	et	nn	12	SENT_116	[p9l1399t2763r1466b2814],
12	al.	FW	O	al.	appos	2	SENT_116	[p9l1496t2757r1573b2814],
13	.	.	O	.	_	0	SENT_116	[p9l1496t2757r1573b2814],

1	Functional	JJ	O	functional	amod	2	SENT_117	[p9l1612t2757r1954b2814],
2	polymorphisms	NNS	O	polymorphism	_	0	SENT_117	[p9l1987t2757r2144b2829, p9l145t2850r495b2922],
3	of	IN	O	of	_	0	SENT_117	[p9l514t2850r580b2907],
4	the	DT	O	the	det	7	SENT_117	[p9l597t2850r705b2907],
5	human	JJ	O	human	amod	7	SENT_117	[p9l727t2850r942b2907],
6	multidrug-resistance	JJ	O	multidrug-resistance	amod	7	SENT_117	[p9l966t2850r1650b2922],
7	gene	NN	O	gene	prep_of	2	SENT_117	[p9l1670t2865r1846b2922],
8	:	:	O	:	_	0	SENT_117	[p9l1670t2865r1846b2922],
9	multiple	JJ	O	multiple	amod	11	SENT_117	[p9l1874t2850r2148b2922],
10	sequence	NN	O	sequence	nn	11	SENT_117	[p9l142t2960r451b3016],
11	variations	NNS	O	variation	dep	2	SENT_117	[p9l489t2945r814b3001],
12	and	CC	O	and	_	0	SENT_117	[p9l854t2944r969b3001],
13	correlation	NN	O	correlation	conj_and	11	SENT_117	[p9l1011t2944r1374b3001],
14	of	IN	O	of	_	0	SENT_117	[p9l1416t2944r1482b3001],
15	one	CD	NUMBER	one	num	16	SENT_117	[p9l1519t2960r1637b3001],
16	allele	NN	O	allele	prep_of	13	SENT_117	[p9l1678t2944r1860b3001],
17	with	IN	O	with	_	0	SENT_117	[p9l1897t2944r2041b3001],
18	Pglycoprotein	NN	O	pglycoprotein	nn	19	SENT_117	[p9l2086t2945r2144b3001, p9l143t3038r553b3110],
19	expression	NN	O	expression	prep_with	16	SENT_117	[p9l583t3040r928b3110],
20	and	CC	O	and	_	0	SENT_117	[p9l959t3038r1074b3095],
21	activity	NN	O	activity	conj_and	19	SENT_117	[p9l1105t3040r1354b3110],
22	in	FW	O	in	prep	13	SENT_117	[p9l1380t3040r1435b3095],
23	vivo	FW	O	vivo	pobj	22	SENT_117	[p9l1464t3040r1618b3095],
24	.	.	O	.	_	0	SENT_117	[p9l1464t3040r1618b3095],

1	Proc	NNP	ORGANIZATION	Proc	nn	7	SENT_118	[p9l1652t3039r1797b3095],
2	Natl	NNP	ORGANIZATION	Natl	nn	7	SENT_118	[p9l1823t3038r1962b3095],
3	Acad	NNP	ORGANIZATION	Acad	nn	7	SENT_118	[p9l1987t3038r2153b3095],
4	Sci	NNP	ORGANIZATION	Sci	nn	7	SENT_118	[p9l143t3134r232b3190],
5	U	NNP	ORGANIZATION	U	nn	7	SENT_118	[p9l264t3134r309b3190],
6	S	NNP	ORGANIZATION	S	nn	7	SENT_118	[p9l335t3134r368b3190],
7	A	NNP	O	A	_	0	SENT_118	[p9l392t3134r437b3189],
8	2000	CD	DATE	2000	num	7	SENT_118	[p9l467t3134r1035b3202],
9	;	:	O	;	_	0	SENT_118	[p9l467t3134r1035b3202],
10	97:3473	CD	NUMBER	97:3473	number	11	SENT_118	[p9l467t3134r1035b3202],
11	—	CD	NUMBER	—	dep	7	SENT_118	[p9l467t3134r1035b3202],
12	8	CD	NUMBER	8	dep	11	SENT_118	[p9l467t3134r1035b3202],
13	.	.	O	.	_	0	SENT_118	[p9l467t3134r1035b3202],

1	.	.	O	.	_	0	SENT_119	[p9l83t3271r94b3282],

1	Loscher	NNP	O	Loscher	nn	2	SENT_120	[p9l145t3225r396b3282],
2	W	NNP	O	W	_	0	SENT_120	[p9l429t3227r505b3295],
3	,	,	O	,	_	0	SENT_120	[p9l429t3227r505b3295],
4	Potschka	NNP	PERSON	Potschka	nn	6	SENT_120	[p9l551t3225r838b3282],
5	H.	NNP	PERSON	H.	nn	6	SENT_120	[p9l878t3227r940b3282],
6	Role	NN	PERSON	role	appos	2	SENT_120	[p9l988t3225r1124b3282],
7	of	IN	O	of	_	0	SENT_120	[p9l1162t3225r1228b3282],
8	multi-drug	JJ	O	multi-drug	amod	9	SENT_120	[p9l1265t3225r1611b3297],
9	transporters	NNS	O	transporter	prep_of	6	SENT_120	[p9l1648t3231r2053b3297],
10	in	IN	O	in	_	0	SENT_120	[p9l2090t3227r2145b3282],
11	pharmacoresistance	NN	O	pharmacoresistance	prep_in	9	SENT_120	[p9l145t3319r805b3391],
12	to	TO	O	to	_	0	SENT_120	[p9l831t3325r897b3376],
13	antiepileptic	JJ	O	antiepileptic	amod	14	SENT_120	[p9l923t3319r1345b3391],
14	drugs	NNS	O	drug	prep_to	11	SENT_120	[p9l1371t3319r1567b3391],
15	.	.	O	.	_	0	SENT_120	[p9l1371t3319r1567b3391],

1	J	NNP	O	J	nn	4	SENT_121	[p9l1596t3321r1633b3376],
2	Pharmacol	NNP	O	Pharmacol	nn	4	SENT_121	[p9l1656t3319r2007b3376],
3	Exp	NNP	O	Exp	nn	4	SENT_121	[p9l2032t3321r2150b3392],
4	Ther	NNP	O	Ther	_	0	SENT_121	[p9l146t3414r300b3470],
5	2002	CD	DATE	2002	num	4	SENT_121	[p9l325t3414r858b3483],
6	;	:	O	;	_	0	SENT_121	[p9l325t3414r858b3483],
7	301:7	CD	NUMBER	301:7	number	8	SENT_121	[p9l325t3414r858b3483],
8	—	CD	NUMBER	—	dep	4	SENT_121	[p9l325t3414r858b3483],
9	14	CD	NUMBER	14	dep	8	SENT_121	[p9l325t3414r858b3483],
10	.	.	O	.	_	0	SENT_121	[p9l325t3414r858b3483],

1	.	.	O	.	_	0	SENT_122	[p9l82t3551r94b3563],

1	Dombrowski	NNP	PERSON	Dombrowski	nn	2	SENT_123	[p9l145t3506r539b3563],
2	SM	NNP	O	SM	_	0	SENT_123	[p9l568t3507r674b3575],
3	,	,	O	,	_	0	SENT_123	[p9l568t3507r674b3575],
4	Desai	NNP	PERSON	Desai	nn	5	SENT_123	[p9l710t3507r877b3563],
5	SY	NNP	O	SY	appos	2	SENT_123	[p9l906t3507r990b3575],
6	,	,	O	,	_	0	SENT_123	[p9l906t3507r990b3575],
7	Marroni	NNP	PERSON	Marroni	nn	8	SENT_123	[p9l1021t3507r1269b3563],
8	M	NNP	O	M	appos	5	SENT_123	[p9l1297t3508r1369b3575],
9	,	,	O	,	_	0	SENT_123	[p9l1297t3508r1369b3575],
10	Cucullo	NNP	O	Cucullo	nn	11	SENT_123	[p9l1402t3506r1645b3563],
11	L	NNP	O	L	appos	5	SENT_123	[p9l1674t3508r1727b3575],
12	,	,	O	,	_	0	SENT_123	[p9l1674t3508r1727b3575],
13	Goodrich	NNP	PERSON	Goodrich	nn	14	SENT_123	[p9l1760t3506r2053b3563],
14	K	NNP	PERSON	K	appos	5	SENT_123	[p9l2084t3508r2142b3575],
15	,	,	O	,	_	0	SENT_123	[p9l2084t3508r2142b3575],
16	Bingaman	NNP	PERSON	Bingaman	nn	17	SENT_123	[p9l145t3601r460b3671],
17	W	NNP	O	W	appos	5	SENT_123	[p9l496t3601r572b3669],
18	,	,	O	,	_	0	SENT_123	[p9l496t3601r572b3669],
19	et	FW	O	et	nn	20	SENT_123	[p9l615t3605r682b3656],
20	al.	FW	O	al.	appos	5	SENT_123	[p9l719t3599r796b3656],
21	.	.	O	.	_	0	SENT_123	[p9l719t3599r796b3656],

1	Overexpression	NN	O	overexpression	_	0	SENT_124	[p9l840t3600r1341b3671],
2	of	IN	O	of	_	0	SENT_124	[p9l1380t3599r1446b3656],
3	multiple	JJ	O	multiple	amod	6	SENT_124	[p9l1482t3599r1756b3671],
4	drug	NN	O	drug	nn	6	SENT_124	[p9l1793t3599r1938b3671],
5	resistance	NN	O	resistance	nn	6	SENT_124	[p9l1977t3601r2144b3656, p9l142t3699r326b3751],
6	genes	NNS	O	gene	prep_of	1	SENT_124	[p9l346t3708r532b3766],
7	in	IN	O	in	_	0	SENT_124	[p9l551t3695r606b3750],
8	endothelial	JJ	O	endothelial	amod	9	SENT_124	[p9l628t3694r1003b3751],
9	cells	NNS	O	cell	prep_in	1	SENT_124	[p9l1022t3694r1170b3751],
10	from	IN	O	from	_	0	SENT_124	[p9l1189t3694r1341b3751],
11	patients	NNS	O	patient	prep_from	1	SENT_124	[p9l1365t3695r1633b3766],
12	with	IN	O	with	_	0	SENT_124	[p9l1649t3694r1793b3751],
13	refractory	JJ	O	refractory	amod	14	SENT_124	[p9l1817t3694r2150b3766],
14	epilepsy	NN	O	epilepsy	prep_with	11	SENT_124	[p10l142t17r425b89],
15	.	.	O	.	_	0	SENT_124	[p10l142t17r425b89],

1	Epilepsia	NNP	O	Epilepsia	_	0	SENT_125	[p10l460t17r762b89],
2	2001	CD	DATE	2001	num	1	SENT_125	[p10l789t18r931b74],
3	;	:	O	;	_	0	SENT_125	[p10l950t18r1113b87],
4	42:1	CD	NUMBER	42:1	number	5	SENT_125	[p10l950t18r1113b87],
5	501	CD	NUMBER	501	dep	1	SENT_125	[p10l1131t18r1230b74],
6	-6	CD	NUMBER	-6	dep	5	SENT_125	[p10l1247t18r1357b74],
7	.	.	O	.	_	0	SENT_125	[p10l1247t18r1357b74],

1	.	.	O	.	_	0	SENT_126	[p10l83t157r94b168],

1	Sisodiya	NNP	O	Sisodiya	nn	2	SENT_127	[p10l143t111r404b183],
2	SM	NNP	O	SM	_	0	SENT_127	[p10l437t112r543b181],
3	,	,	O	,	_	0	SENT_127	[p10l437t112r543b181],
4	Lin	NNP	PERSON	Lin	nn	5	SENT_127	[p10l583t113r673b168],
5	WR	NNP	O	WR	appos	2	SENT_127	[p10l705t112r831b181],
6	,	,	O	,	_	0	SENT_127	[p10l705t112r831b181],
7	Harding	NNP	PERSON	Harding	nn	8	SENT_127	[p10l872t111r1123b183],
8	BN	NNP	O	BN	appos	2	SENT_127	[p10l1157t113r1262b181],
9	,	,	O	,	_	0	SENT_127	[p10l1157t113r1262b181],
10	Squier	NNP	ORGANIZATION	Squier	nn	11	SENT_127	[p10l1300t112r1508b183],
11	MV	NNP	ORGANIZATION	MV	appos	2	SENT_127	[p10l1535t113r1640b181],
12	,	,	O	,	_	0	SENT_127	[p10l1535t113r1640b181],
13	Thom	NNP	PERSON	Thom	nn	16	SENT_127	[p10l1676t111r1858b168],
14	M.	NNP	PERSON	M.	nn	16	SENT_127	[p10l1889t113r1961b169],
15	Drug	NNP	PERSON	Drug	nn	16	SENT_127	[p10l2002t113r2149b183],
16	resistance	NN	O	resistance	appos	2	SENT_127	[p10l145t207r477b262],
17	in	IN	O	in	_	0	SENT_127	[p10l499t207r554b262],
18	epilepsy	NN	O	epilepsy	prep_in	16	SENT_127	[p10l579t205r871b277],
19	:	:	O	:	_	0	SENT_127	[p10l579t205r871b277],
20	expression	NN	O	expression	dep	2	SENT_127	[p10l899t207r1245b277],
21	of	IN	O	of	_	0	SENT_127	[p10l1269t205r1336b262],
22	drug	NN	O	drug	nn	24	SENT_127	[p10l1355t205r1501b277],
23	resistance	NN	O	resistance	nn	24	SENT_127	[p10l1526t207r1857b262],
24	proteins	NNS	O	protein	prep_of	20	SENT_127	[p10l1881t207r2149b277],
25	in	IN	O	in	_	0	SENT_127	[p10l143t301r198b356],
26	common	JJ	O	common	amod	27	SENT_127	[p10l218t315r494b357],
27	causes	NNS	O	cause	prep_in	20	SENT_127	[p10l514t315r728b357],
28	of	IN	O	of	_	0	SENT_127	[p10l745t300r811b357],
29	refractory	JJ	O	refractory	amod	30	SENT_127	[p10l829t300r1162b372],
30	epilepsy	NN	O	epilepsy	prep_of	27	SENT_127	[p10l1178t300r1461b372],
31	.	.	O	.	_	0	SENT_127	[p10l1178t300r1461b372],

1	Brain	NN	O	brain	_	0	SENT_128	[p10l1486t300r1658b357],
2	2002	CD	DATE	2002	num	1	SENT_128	[p10l1675t300r1850b369],
3	;	:	O	;	_	0	SENT_128	[p10l1675t300r1850b369],
4	1	CD	NUMBER	1	number	5	SENT_128	[p10l1867t301r1888b356],
5	25:2231	CD	NUMBER	25:2231	dep	1	SENT_128	[p10l1906t300r2147b357, p10l144t394r205b450],
6	.	.	O	.	_	0	SENT_128	[p10l226t439r238b450],

1	.	.	O	.	_	0	SENT_129	[p10l83t533r94b544],

1	Siddiqui	NNP	PERSON	Siddiqui	nn	2	SENT_130	[p10l143t487r402b559],
2	A	NNP	O	A	_	0	SENT_130	[p10l431t488r494b557],
3	,	,	O	,	_	0	SENT_130	[p10l431t488r494b557],
4	Kerb	NNP	O	Kerb	nn	5	SENT_130	[p10l533t487r678b545],
5	R	NNP	O	R	appos	2	SENT_130	[p10l711t488r768b557],
6	,	,	O	,	_	0	SENT_130	[p10l711t488r768b557],
7	Weale	NNP	ORGANIZATION	Weale	nn	8	SENT_130	[p10l801t487r1003b545],
8	ME	NNP	ORGANIZATION	ME	appos	5	SENT_130	[p10l1030t489r1143b557],
9	,	,	O	,	_	0	SENT_130	[p10l1030t489r1143b557],
10	Brinkmann	NNP	PERSON	Brinkmann	nn	11	SENT_130	[p10l1181t487r1526b545],
11	U	NNP	PERSON	U	appos	5	SENT_130	[p10l1560t489r1623b557],
12	,	,	O	,	_	0	SENT_130	[p10l1560t489r1623b557],
13	Smith	NNP	PERSON	Smith	nn	14	SENT_130	[p10l1659t487r1842b545],
14	A	NNP	O	A	appos	5	SENT_130	[p10l1872t488r1935b557],
15	,	,	O	,	_	0	SENT_130	[p10l1872t488r1935b557],
16	Goldstein	NNP	PERSON	Goldstein	nn	17	SENT_130	[p10l1971t487r2144b545, p10l142t583r298b639],
17	DB	NNP	O	DB	appos	5	SENT_130	[p10l323t583r424b651],
18	,	,	O	,	_	0	SENT_130	[p10l323t583r424b651],
19	et	FW	O	et	nn	20	SENT_130	[p10l450t587r517b639],
20	al.	FW	O	al.	appos	5	SENT_130	[p10l536t582r613b639],
21	.	.	O	.	_	0	SENT_130	[p10l536t582r613b639],

1	Association	NNP	O	Association	_	0	SENT_131	[p10l637t582r1005b639],
2	of	IN	O	of	_	0	SENT_131	[p10l1026t582r1093b639],
3	multidrug	JJ	O	multidrug	amod	4	SENT_131	[p10l1111t582r1429b654],
4	resistance	NN	O	resistance	prep_of	1	SENT_131	[p10l1451t583r1782b639],
5	in	IN	O	in	_	0	SENT_131	[p10l1802t583r1857b638],
6	epilepsy	NN	O	epilepsy	prep_in	1	SENT_131	[p10l1878t582r2151b654],
7	with	IN	O	with	_	0	SENT_131	[p10l140t676r284b733],
8	a	DT	O	a	det	9	SENT_131	[p10l313t692r347b733],
9	polymorphism	NN	O	polymorphism	prep_with	1	SENT_131	[p10l377t676r835b748],
10	in	IN	O	in	_	0	SENT_131	[p10l864t677r919b732],
11	the	DT	O	the	det	14	SENT_131	[p10l948t676r1055b733],
12	drug-transporter	NN	O	drug-transporter	nn	14	SENT_131	[p10l1082t676r1635b748],
13	gene	NN	O	gene	nn	14	SENT_131	[p10l1660t690r1816b748],
14	ABCB1	NN	O	abcb1	prep_in	9	SENT_131	[p10l1839t677r2071b733],
15	.	.	O	.	_	0	SENT_131	[p10l1839t677r2071b733],

1	N	NN	O	n	nn	3	SENT_132	[p10l2104t677r2151b733],
2	Engl	NNP	O	Engl	nn	3	SENT_132	[p10l142t769r280b841],
3	J	NNP	O	J	nsubj	4	SENT_132	[p10l307t771r344b826],
4	Med	VBD	O	med	_	0	SENT_132	[p10l370t769r512b827],
5	2003	CD	DATE	2003	dobj	4	SENT_132	[p10l537t770r1148b839],
6	;	:	O	;	_	0	SENT_132	[p10l537t770r1148b839],
7	348:1442	CD	NUMBER	348:1442	num	8	SENT_132	[p10l537t770r1148b839],
8	-8	CD	NUMBER	-8	dep	5	SENT_132	[p10l537t770r1148b839],
9	.	.	O	.	_	0	SENT_132	[p10l537t770r1148b839],

1	.	.	O	.	_	0	SENT_133	[p10l83t909r94b921],

1	Zimprich	NNP	O	Zimprich	nn	2	SENT_134	[p10l143t864r430b936],
2	F	NN	O	f	_	0	SENT_134	[p10l464t865r504b933],
3	,	,	O	,	_	0	SENT_134	[p10l464t865r504b933],
4	Sunder-Plassmann	NNP	PERSON	Sunder-Plassmann	nn	5	SENT_134	[p10l539t864r1134b921],
5	R	NNP	PERSON	R	appos	2	SENT_134	[p10l1168t865r1225b933],
6	,	,	O	,	_	0	SENT_134	[p10l1168t865r1225b933],
7	Stogmann	NNP	PERSON	Stogmann	nn	8	SENT_134	[p10l1261t864r1579b936],
8	E	NNP	PERSON	E	appos	5	SENT_134	[p10l1614t865r1668b933],
9	,	,	O	,	_	0	SENT_134	[p10l1614t865r1668b933],
10	Gleiss	NNP	MISC	Gleiss	nn	11	SENT_134	[p10l1704t864r1894b921],
11	A	NNP	MISC	A	appos	5	SENT_134	[p10l1920t864r1983b933],
12	,	,	O	,	_	0	SENT_134	[p10l1920t864r1983b933],
13	DalBianco	NNP	O	DalBianco	nn	14	SENT_134	[p10l2021t864r2144b921, p10l145t959r359b1015],
14	A	NNP	O	A	appos	5	SENT_134	[p10l391t959r454b1027],
15	,	,	O	,	_	0	SENT_134	[p10l391t959r454b1027],
16	Zimprich	NNP	O	Zimprich	nn	17	SENT_134	[p10l496t958r782b1030],
17	A	NNP	O	A	appos	5	SENT_134	[p10l815t959r879b1027],
18	,	,	O	,	_	0	SENT_134	[p10l815t959r879b1027],
19	et	FW	O	et	nn	20	SENT_134	[p10l919t963r986b1015],
20	al.	FW	O	al.	appos	5	SENT_134	[p10l1021t958r1098b1015],
21	.	.	O	.	_	0	SENT_134	[p10l1021t958r1098b1015],

1	Association	NNP	O	Association	_	0	SENT_135	[p10l1137t959r1505b1015],
2	of	IN	O	of	_	0	SENT_135	[p10l1541t958r1608b1015],
3	an	DT	O	a	det	6	SENT_135	[p10l1640t973r1713b1015],
4	ABCB1	NN	O	abcb1	nn	6	SENT_135	[p10l1747t959r1947b1015],
5	gene	NN	O	gene	nn	6	SENT_135	[p10l1993t972r2149b1030],
6	haplotype	NN	O	haplotype	prep_of	1	SENT_135	[p10l146t1052r472b1124],
7	with	IN	O	with	_	0	SENT_135	[p10l511t1052r653b1109],
8	pharmacoresistance	NN	O	pharmacoresistance	prep_with	1	SENT_135	[p10l699t1052r1359b1124],
9	in	IN	O	in	_	0	SENT_135	[p10l1399t1053r1454b1108],
10	temporal	JJ	O	temporal	amod	12	SENT_135	[p10l1498t1052r1797b1124],
11	lobe	NN	O	lobe	nn	12	SENT_135	[p10l1841t1052r1979b1109],
12	epilepsy	NN	O	epilepsy	prep_in	1	SENT_135	[p10l2019t1053r2143b1124, p10l146t1146r323b1218],
13	.	.	O	.	_	0	SENT_135	[p10l2019t1053r2143b1124, p10l146t1146r323b1218],

1	Neurology	NNP	O	Neurology	_	0	SENT_136	[p10l358t1146r702b1218],
2	2004	CD	DATE	2004	num	1	SENT_136	[p10l724t1146r899b1215],
3	;	:	O	;	_	0	SENT_136	[p10l724t1146r899b1215],
4	63	CD	NUMBER	63	dep	1	SENT_136	[p10l911t1146r1013b1203],
5	:	:	O	:	_	0	SENT_136	[p10l911t1146r1013b1203],
6	1	CD	NUMBER	1	number	7	SENT_136	[p10l1029t1147r1048b1202],
7	087-9	CD	NUMBER	087-9	dep	4	SENT_136	[p10l1063t1146r1292b1203],
8	.	.	O	.	_	0	SENT_136	[p10l1063t1146r1292b1203],

1	Tan	NNP	MISC	Tan	nn	2	SENT_137	[p10l143t1241r253b1296],
2	NCK	NNP	MISC	NCK	_	0	SENT_137	[p10l286t1240r436b1308],
3	,	,	O	,	_	0	SENT_137	[p10l286t1240r436b1308],
4	Heron	NNP	ORGANIZATION	Heron	nn	5	SENT_137	[p10l473t1241r663b1296],
5	SE	NN	ORGANIZATION	se	appos	2	SENT_137	[p10l694t1240r787b1308],
6	,	,	O	,	_	0	SENT_137	[p10l694t1240r787b1308],
7	Scheffer	NNP	ORGANIZATION	Scheffer	nn	8	SENT_137	[p10l821t1239r1098b1296],
8	IE	NN	ORGANIZATION	ie	appos	5	SENT_137	[p10l1128t1241r1201b1308],
9	,	,	O	,	_	0	SENT_137	[p10l1128t1241r1201b1308],
10	Pelekanos	NNP	O	Pelekanos	nn	12	SENT_137	[p10l1239t1239r1561b1296],
11	J'	NNP	O	J'	nn	12	SENT_137	[p10l1588t1241r1672b1308],
12	|	NN	O	|	appos	5	SENT_137	[p10l1588t1241r1672b1308],
13	'	''	O	'	_	0	SENT_137	[p10l1588t1241r1672b1308],
14	,	,	O	,	_	0	SENT_137	[p10l1588t1241r1672b1308],
15	McMahon	NNP	PERSON	McMahon	nn	16	SENT_137	[p10l1705t1239r2005b1296],
16	JM	NN	O	jm	appos	5	SENT_137	[p10l2034t1241r2141b1308],
17	,	,	O	,	_	0	SENT_137	[p10l2034t1241r2141b1308],
18	Vears	NNP	O	Vears	nn	19	SENT_137	[p10l143t1334r319b1390],
19	DF	NNP	O	DF	appos	5	SENT_137	[p10l342t1334r427b1402],
20	,	,	O	,	_	0	SENT_137	[p10l342t1334r427b1402],
21	et	FW	O	et	nn	22	SENT_137	[p10l454t1338r521b1390],
22	al.	FW	O	al.	appos	5	SENT_137	[p10l541t1333r619b1390],
23	.	.	O	.	_	0	SENT_137	[p10l541t1333r619b1390],

1	Failure	NN	O	failure	_	0	SENT_138	[p10l648t1333r873b1390],
2	to	TO	O	to	_	0	SENT_138	[p10l894t1338r959b1390],
3	conﬁrm	NN	O	conﬁrm	nn	4	SENT_138	[p10l979t1333r1225b1390],
4	association	NN	O	association	prep_to	1	SENT_138	[p10l1247t1334r1608b1390],
5	of	IN	O	of	_	0	SENT_138	[p10l1631t1333r1697b1390],
6	a	DT	O	a	det	7	SENT_138	[p10l1715t1348r1749b1390],
7	polymorphism	NN	O	polymorphism	prep_of	1	SENT_138	[p10l1772t1333r2143b1405, p10l145t1428r252b1484],
8	in	IN	O	in	_	0	SENT_138	[p10l291t1428r346b1483],
9	ABCB1	NN	O	abcb1	prep_in	7	SENT_138	[p10l383t1427r582b1484],
10	with	IN	O	with	_	0	SENT_138	[p10l628t1427r771b1484],
11	multidrug-resistant	JJ	O	multidrug-resistant	amod	12	SENT_138	[p10l812t1427r1447b1499],
12	epilepsy	NN	O	epilepsy	prep_with	1	SENT_138	[p10l1483t1427r1765b1499],
13	.	.	O	.	_	0	SENT_138	[p10l1483t1427r1765b1499],

1	Neurology	NNP	O	Neurology	_	0	SENT_139	[p10l1809t1427r2152b1499],
2	2004	CD	DATE	2004	num	1	SENT_139	[p10l145t1521r712b1589],
3	;	:	O	;	_	0	SENT_139	[p10l145t1521r712b1589],
4	63:1090	CD	NUMBER	63:1090	num	5	SENT_139	[p10l145t1521r712b1589],
5	—	NN	O	—	dep	1	SENT_139	[p10l145t1521r712b1589],
6	2	CD	NUMBER	2	dep	5	SENT_139	[p10l145t1521r712b1589],
7	.	.	O	.	_	0	SENT_139	[p10l145t1521r712b1589],

1	Sills	NNP	PERSON	Sills	nn	2	SENT_140	[p10l145t1614r273b1671],
2	GJ	NNP	O	GJ	_	0	SENT_140	[p10l298t1614r400b1683],
3	,	,	O	,	_	0	SENT_140	[p10l298t1614r400b1683],
4	Mohanraj	NNP	PERSON	Mohanraj	nn	5	SENT_140	[p10l430t1614r733b1686],
5	R	NNP	PERSON	R	appos	2	SENT_140	[p10l766t1615r823b1683],
6	,	,	O	,	_	0	SENT_140	[p10l766t1615r823b1683],
7	Butler	NNP	PERSON	Butler	nn	8	SENT_140	[p10l858t1614r1058b1671],
8	E	NNP	O	E	appos	5	SENT_140	[p10l1084t1615r1139b1683],
9	,	,	O	,	_	0	SENT_140	[p10l1084t1615r1139b1683],
10	McCrindle	NNP	PERSON	McCrindle	nn	11	SENT_140	[p10l1169t1614r1496b1671],
11	S	NNP	PERSON	S	appos	5	SENT_140	[p10l1522t1614r1575b1683],
12	,	,	O	,	_	0	SENT_140	[p10l1522t1614r1575b1683],
13	Collier	NNP	ORGANIZATION	Collier	nn	14	SENT_140	[p10l1607t1614r1824b1671],
14	L	NNP	ORGANIZATION	L	appos	5	SENT_140	[p10l1850t1615r1902b1683],
15	,	,	O	,	_	0	SENT_140	[p10l1850t1615r1902b1683],
16	Wilson	NNP	PERSON	Wilson	nn	17	SENT_140	[p10l1933t1614r2144b1671],
17	EA	NN	PERSON	ea	appos	5	SENT_140	[p10l148t1708r246b1777],
18	,	,	O	,	_	0	SENT_140	[p10l148t1708r246b1777],
19	et	FW	O	et	nn	20	SENT_140	[p10l294t1713r360b1765],
20	al.	FW	O	al.	appos	5	SENT_140	[p10l402t1708r479b1765],
21	.	.	O	.	_	0	SENT_140	[p10l402t1708r479b1765],

1	Lack	NN	O	lack	_	0	SENT_141	[p10l530t1708r677b1765],
2	of	IN	O	of	_	0	SENT_141	[p10l716t1708r782b1765],
3	association	NN	O	association	prep_of	1	SENT_141	[p10l821t1709r1182b1765],
4	between	IN	O	between	_	0	SENT_141	[p10l1228t1708r1510b1765],
5	the	DT	O	the	det	7	SENT_141	[p10l1553t1708r1660b1765],
6	C3435T	NN	O	c3435t	nn	7	SENT_141	[p10l1701t1708r1944b1765],
7	polymorphism	NN	O	polymorphism	prep_between	1	SENT_141	[p10l1985t1708r2143b1780, p10l147t1802r466b1874],
8	in	IN	O	in	_	0	SENT_141	[p10l504t1803r559b1858],
9	the	DT	O	the	det	16	SENT_141	[p10l597t1802r704b1859],
10	human	JJ	O	human	amod	16	SENT_141	[p10l743t1802r958b1859],
11	multidrug	JJ	O	multidrug	amod	16	SENT_141	[p10l999t1802r1317b1874],
12	resistance	NN	O	resistance	nn	16	SENT_141	[p10l1355t1803r1687b1859],
13	(	CD	NUMBER	(	num	16	SENT_141	[p10l1727t1803r1952b1874],
14	MDR1	NN	O	mdr1	nn	16	SENT_141	[p10l1727t1803r1952b1874],
15	)	NN	O	)	nn	16	SENT_141	[p10l1727t1803r1952b1874],
16	gene	NN	O	gene	prep_in	7	SENT_141	[p10l1991t1816r2147b1874],
17	and	CC	O	and	_	0	SENT_141	[p10l145t1896r260b1953],
18	response	NN	O	response	prep_in	7	SENT_141	[p10l315t1911r601b1968],
19	to	TO	O	to	_	0	SENT_141	[p10l650t1901r716b1953],
20	antiepileptic	JJ	O	antiepileptic	amod	22	SENT_141	[p10l766t1896r1188b1968],
21	drug	NN	O	drug	nn	22	SENT_141	[p10l1238t1896r1383b1968],
22	treatment	NN	O	treatment	prep_to	1	SENT_141	[p10l1433t1901r1791b1953],
23	.	.	O	.	_	0	SENT_141	[p10l1433t1901r1791b1953],

1	Epilepsia	NNP	O	Epilepsia	_	0	SENT_142	[p10l1846t1896r2148b1968],
2	2005	CD	DATE	2005	num	1	SENT_142	[p10l145t1990r673b2058],
3	;	:	O	;	_	0	SENT_142	[p10l145t1990r673b2058],
4	46:643	CD	NUMBER	46:643	num	5	SENT_142	[p10l145t1990r673b2058],
5	—	NN	O	—	dep	1	SENT_142	[p10l145t1990r673b2058],
6	7	CD	NUMBER	7	dep	5	SENT_142	[p10l145t1990r673b2058],
7	.	.	O	.	_	0	SENT_142	[p10l145t1990r673b2058],

1	Weber	NNP	PERSON	Weber	nn	2	SENT_143	[p10l143t2083r356b2140],
2	WW	NNP	O	WW	_	0	SENT_143	[p10l397t2084r536b2140],
3	.	.	O	.	_	0	SENT_143	[p10l397t2084r536b2140],

1	Populations	NNS	O	population	_	0	SENT_144	[p10l591t2083r968b2155],
2	and	CC	O	and	_	0	SENT_144	[p10l1013t2083r1127b2140],
3	genetic	JJ	O	genetic	amod	4	SENT_144	[p10l1176t2084r1419b2155],
4	polymorphisms	NNS	O	polymorphism	conj_and	1	SENT_144	[p10l1466t2083r1976b2155],
5	.	.	O	.	_	0	SENT_144	[p10l1466t2083r1976b2155],

1	Mol	NNP	ORGANIZATION	Mol	nn	2	SENT_145	[p10l2026t2083r2146b2140],
2	Diagn	NNP	O	Diagn	_	0	SENT_145	[p10l145t2178r328b2248],
3	1999	CD	DATE	1999	num	2	SENT_145	[p10l362t2178r919b2246],
4	;	:	O	;	_	0	SENT_145	[p10l362t2178r919b2246],
5	4:299	CD	NUMBER	4:299	num	6	SENT_145	[p10l362t2178r919b2246],
6	—	NN	O	—	dep	2	SENT_145	[p10l362t2178r919b2246],
7	307	CD	NUMBER	307	dep	6	SENT_145	[p10l362t2178r919b2246],
8	.	.	O	.	_	0	SENT_145	[p10l362t2178r919b2246],

1	Ameyaw	NNP	O	Ameyaw	nn	2	SENT_146	[p10l143t2270r421b2342],
2	MM	NN	O	mm	_	0	SENT_146	[p10l436t2271r561b2339],
3	,	,	O	,	_	0	SENT_146	[p10l436t2271r561b2339],
4	Retateiro	NN	O	retateiro	nn	5	SENT_146	[p10l589t2271r893b2327],
5	F	NN	O	f	appos	2	SENT_146	[p10l914t2271r954b2339],
6	,	,	O	,	_	0	SENT_146	[p10l914t2271r954b2339],
7	Li	NNP	PERSON	Li	nn	8	SENT_146	[p10l982t2271r1031b2326],
8	T	NN	PERSON	t	appos	5	SENT_146	[p10l1049t2271r1100b2339],
9	,	,	O	,	_	0	SENT_146	[p10l1049t2271r1100b2339],
10	Liu	NNP	LOCATION	Liu	nn	11	SENT_146	[p10l1128t2271r1218b2327],
11	X	NNP	LOCATION	X	appos	5	SENT_146	[p10l1237t2271r1297b2339],
12	,	,	O	,	_	0	SENT_146	[p10l1237t2271r1297b2339],
13	Tariq	NNP	PERSON	Tariq	nn	14	SENT_146	[p10l1320t2271r1480b2342],
14	M	NNP	PERSON	M	appos	5	SENT_146	[p10l1499t2271r1571b2339],
15	,	,	O	,	_	0	SENT_146	[p10l1499t2271r1571b2339],
16	Mobarek	NNP	O	Mobarek	nn	17	SENT_146	[p10l1594t2270r1876b2327],
17	A	NNP	O	A	appos	5	SENT_146	[p10l1889t2270r1952b2339],
18	,	,	O	,	_	0	SENT_146	[p10l1889t2270r1952b2339],
19	et	FW	O	et	nn	20	SENT_146	[p10l1977t2275r2043b2327],
20	al.	FW	O	al.	appos	5	SENT_146	[p10l2062t2270r2140b2327],
21	.	.	O	.	_	0	SENT_146	[p10l2062t2270r2140b2327],

1	MDR1	NN	O	mdr1	nn	2	SENT_147	[p10l143t2365r311b2421],
2	pharmacogenetics	NNS	O	pharmacogenetic	_	0	SENT_147	[p10l350t2364r970b2436],
3	:	:	O	:	_	0	SENT_147	[p10l350t2364r970b2436],
4	frequency	NN	O	frequency	nsubjpass	14	SENT_147	[p10l1002t2364r1335b2436],
5	of	IN	O	of	_	0	SENT_147	[p10l1359t2364r1425b2421],
6	the	DT	O	the	det	8	SENT_147	[p10l1448t2364r1555b2421],
7	C3435T	NN	O	c3435t	nn	8	SENT_147	[p10l1581t2364r1824b2421],
8	mutation	NN	O	mutation	prep_of	4	SENT_147	[p10l1850t2365r2144b2421],
9	in	IN	O	in	_	0	SENT_147	[p10l145t2459r201b2514],
10	exon	NN	O	exon	prep_in	8	SENT_147	[p10l234t2474r386b2515],
11	26	CD	NUMBER	26	num	10	SENT_147	[p10l419t2459r493b2515],
12	is	VBZ	O	be	auxpass	14	SENT_147	[p10l524t2459r571b2515],
13	signiﬁcantly	RB	O	signiﬁcantly	advmod	14	SENT_147	[p10l601t2458r998b2530],
14	inﬂuenced	VBN	O	inﬂuenced	dep	2	SENT_147	[p10l1026t2458r1368b2515],
15	by	IN	O	by	_	0	SENT_147	[p10l1402t2458r1476b2530],
16	ethinicity	NN	O	ethinicity	agent	14	SENT_147	[p10l1504t2458r1831b2530],
17	.	.	O	.	_	0	SENT_147	[p10l1504t2458r1831b2530],

1	Pharamcogenetics	NNS	O	pharamcogenetic	_	0	SENT_148	[p10l1868t2458r2144b2515, p10l146t2553r498b2623],
2	2001	CD	DATE	2001	num	1	SENT_148	[p10l524t2553r1091b2621],
3	;	:	O	;	_	0	SENT_148	[p10l524t2553r1091b2621],
4	11:217	CD	NUMBER	11:217	number	5	SENT_148	[p10l524t2553r1091b2621],
5	-21	CD	NUMBER	-21	dep	1	SENT_148	[p10l524t2553r1091b2621],
6	.	.	O	.	_	0	SENT_148	[p10l524t2553r1091b2621],

1	leiri	NN	O	leirus	nn	2	SENT_149	[p10l149t2646r271b2702],
2	I	NN	O	i	_	0	SENT_149	[p10l313t2646r347b2715],
3	,	,	O	,	_	0	SENT_149	[p10l313t2646r347b2715],
4	Takane	NN	PERSON	takane	nn	5	SENT_149	[p10l387t2645r617b2702],
5	H	NN	O	h	appos	2	SENT_149	[p10l655t2646r718b2715],
6	,	,	O	,	_	0	SENT_149	[p10l655t2646r718b2715],
7	Otsubo	NNP	PERSON	Otsubo	nn	9	SENT_149	[p10l759t2645r987b2702],
8	K.	NNP	O	K.	nn	9	SENT_149	[p10l1025t2646r1082b2702],
9	The	NNP	O	The	appos	2	SENT_149	[p10l1122t2645r1245b2702],
10	MDR1	NN	O	mdr1	nn	13	SENT_149	[p10l1278t2646r1446b2702],
11	(	CD	NUMBER	(	num	13	SENT_149	[p10l1498t2646r1753b2717],
12	ABCB1	NN	O	abcb1	nn	13	SENT_149	[p10l1498t2646r1753b2717],
13	)	NN	O	)	dep	9	SENT_149	[p10l1498t2646r1753b2717],
14	gene	NN	O	gene	nn	15	SENT_149	[p10l1792t2659r1947b2717],
15	polymorphism	NN	O	polymorphism	dep	2	SENT_149	[p10l1985t2645r2143b2717, p10l147t2739r466b2811],
16	and	CC	O	and	_	0	SENT_149	[p10l500t2739r615b2796],
17	its	PRP$	O	its	poss	19	SENT_149	[p10l650t2740r727b2796],
18	clinical	JJ	O	clinical	amod	19	SENT_149	[p10l758t2739r993b2796],
19	implications	NNS	O	implication	dep	2	SENT_149	[p10l1026t2739r1447b2811],
20	.	.	O	.	_	0	SENT_149	[p10l1026t2739r1447b2811],

1	Clin	NNP	O	Clin	nn	2	SENT_150	[p10l1489t2739r1615b2796],
2	Pharmacokinet	NNP	O	Pharmacokinet	_	0	SENT_150	[p10l1647t2739r2148b2796],
3	2004	CD	DATE	2004	num	2	SENT_150	[p10l145t2834r712b2902],
4	;	:	O	;	_	0	SENT_150	[p10l145t2834r712b2902],
5	43:553	CD	NUMBER	43:553	number	6	SENT_150	[p10l145t2834r712b2902],
6	—	CD	NUMBER	—	dep	2	SENT_150	[p10l145t2834r712b2902],
7	76	CD	NUMBER	76	dep	6	SENT_150	[p10l145t2834r712b2902],
8	.	.	O	.	_	0	SENT_150	[p10l145t2834r712b2902],

1	Sisodiya	NNP	O	Sisodiya	nn	2	SENT_151	[p10l145t2926r407b2998],
2	SM	NNP	O	SM	_	0	SENT_151	[p10l448t2927r554b2983],
3	.	.	O	.	_	0	SENT_151	[p10l448t2927r554b2983],

1	Mechanisms	NNS	O	mechanism	_	0	SENT_152	[p10l599t2926r992b2983],
2	of	IN	O	of	_	0	SENT_152	[p10l1032t2926r1098b2983],
3	antiepileptic	JJ	O	antiepileptic	amod	5	SENT_152	[p10l1137t2926r1558b2998],
4	drug	NN	O	drug	nn	5	SENT_152	[p10l1600t2926r1745b2998],
5	resistance	NN	O	resistance	prep_of	1	SENT_152	[p10l1788t2927r2139b2983],
6	.	.	O	.	_	0	SENT_152	[p10l1788t2927r2139b2983],

1	Curr	NNP	O	Curr	nn	3	SENT_153	[p10l148t3020r294b3077],
2	Opin	NNP	O	Opin	nn	3	SENT_153	[p10l321t3020r471b3092],
3	Neurol	NNP	O	Neurol	_	0	SENT_153	[p10l500t3020r722b3077],
4	2003	CD	DATE	2003	num	3	SENT_153	[p10l751t3020r1357b3090],
5	;	:	O	;	_	0	SENT_153	[p10l751t3020r1357b3090],
6	16:197	CD	NUMBER	16:197	number	7	SENT_153	[p10l751t3020r1357b3090],
7	-201	CD	NUMBER	-201	dep	3	SENT_153	[p10l751t3020r1357b3090],
8	.	.	O	.	_	0	SENT_153	[p10l751t3020r1357b3090],

1	Colhoun	NNP	PERSON	Colhoun	nn	2	SENT_154	[p10l145t3114r408b3171],
2	HM	NNS	O	hm	_	0	SENT_154	[p10l459t3116r575b3184],
3	,	,	O	,	_	0	SENT_154	[p10l459t3116r575b3184],
4	McKeigue	NNP	PERSON	McKeigue	nn	5	SENT_154	[p10l625t3115r935b3186],
5	PM	NNP	O	PM	appos	2	SENT_154	[p10l984t3115r1093b3184],
6	,	,	O	,	_	0	SENT_154	[p10l984t3115r1093b3184],
7	Davey	NNP	PERSON	Davey	nn	10	SENT_154	[p10l1148t3115r1342b3186],
8	Smith	NNP	PERSON	Smith	nn	10	SENT_154	[p10l1387t3114r1570b3171],
9	G.	NNP	PERSON	G.	nn	10	SENT_154	[p10l1618t3115r1685b3171],
10	Problems	NNS	PERSON	problem	appos	2	SENT_154	[p10l1741t3114r2038b3171],
11	of	IN	O	of	_	0	SENT_154	[p10l2083t3114r2149b3171],
12	reporting	VBG	O	report	prepc_of	10	SENT_154	[p10l148t3208r451b3279],
13	genetic	JJ	O	genetic	amod	14	SENT_154	[p10l477t3209r720b3279],
14	associations	NNS	O	association	dobj	12	SENT_154	[p10l746t3208r1140b3264],
15	with	IN	O	with	_	0	SENT_154	[p10l1163t3207r1306b3264],
16	complex	JJ	O	complex	amod	17	SENT_154	[p10l1334t3207r1612b3279],
17	outcomes	NNS	O	outcome	prep_with	12	SENT_154	[p10l1635t3213r1973b3264],
18	.	.	O	.	_	0	SENT_154	[p10l1635t3213r1973b3264],

1	Lancet	NNP	O	Lancet	_	0	SENT_155	[p10l2005t3209r2143b3264, p10l146t3307r249b3359],
2	2003	CD	DATE	2003	num	1	SENT_155	[p10l277t3302r888b3371],
3	;	:	O	;	_	0	SENT_155	[p10l277t3302r888b3371],
4	361:865	CD	NUMBER	361:865	number	5	SENT_155	[p10l277t3302r888b3371],
5	—	CD	NUMBER	—	dep	1	SENT_155	[p10l277t3302r888b3371],
6	72	CD	NUMBER	72	dep	5	SENT_155	[p10l277t3302r888b3371],
7	.	.	O	.	_	0	SENT_155	[p10l277t3302r888b3371],

1	Sakaeda	NNP	O	Sakaeda	nn	5	SENT_156	[p10l145t3395r415b3452],
2	T.	NNP	O	T.	nn	5	SENT_156	[p10l433t3397r483b3452],
3	MDR1	NN	O	mdr1	nn	5	SENT_156	[p10l508t3396r676b3452],
4	genotype-related	JJ	O	genotype-related	amod	5	SENT_156	[p10l708t3395r1279b3467],
5	pharmacokinetics	NNS	O	pharmacokinetic	_	0	SENT_156	[p10l1305t3395r1905b3467],
6	:	:	O	:	_	0	SENT_156	[p10l1305t3395r1905b3467],
7	fact	NN	O	fact	dep	5	SENT_156	[p10l1932t3395r2061b3452],
8	or	CC	O	or	_	0	SENT_156	[p10l2081t3411r2149b3452],
9	ﬁction	NN	O	ﬁction	dep	5	SENT_156	[p10l144t3488r380b3545],
10	?	.	O	?	_	0	SENT_156	[p10l144t3488r380b3545],

1	Drug	NN	O	drug	nn	3	SENT_157	[p10l409t3489r564b3560],
2	Metab	NNP	O	Metab	nn	3	SENT_157	[p10l589t3488r797b3545],
3	Pharmacokinet	NNP	O	Pharmacokinet	_	0	SENT_157	[p10l825t3488r1327b3545],
4	2005	CD	DATE	2005	num	3	SENT_157	[p10l1354t3489r1959b3558],
5	;	:	O	;	_	0	SENT_157	[p10l1354t3489r1959b3558],
6	20:391	CD	NUMBER	20:391	number	7	SENT_157	[p10l1354t3489r1959b3558],
7	-414	CD	NUMBER	-414	dep	3	SENT_157	[p10l1354t3489r1959b3558],
8	.	.	O	.	_	0	SENT_157	[p10l1354t3489r1959b3558],

1	Owen	NNP	PERSON	Owen	nn	2	SENT_158	[p10l145t3583r326b3640],
2	A	NNP	O	A	_	0	SENT_158	[p10l358t3583r421b3652],
3	,	,	O	,	_	0	SENT_158	[p10l358t3583r421b3652],
4	Pirmohamed	NNP	O	Pirmohamed	nn	5	SENT_158	[p10l461t3582r866b3639],
5	M	NNP	O	M	appos	2	SENT_158	[p10l898t3584r970b3652],
6	,	,	O	,	_	0	SENT_158	[p10l898t3584r970b3652],
7	Tettey	NNP	O	Tettey	nn	8	SENT_158	[p10l1005t3584r1217b3654],
8	JN	NN	O	jn	appos	5	SENT_158	[p10l1246t3584r1346b3652],
9	,	,	O	,	_	0	SENT_158	[p10l1246t3584r1346b3652],
10	Morgan	NNP	ORGANIZATION	Morgan	nn	11	SENT_158	[p10l1382t3584r1618b3654],
11	P	NN	ORGANIZATION	p	appos	5	SENT_158	[p10l1654t3584r1696b3652],
12	,	,	O	,	_	0	SENT_158	[p10l1654t3584r1696b3652],
13	Chadwick	NN	ORGANIZATION	chadwick	nn	14	SENT_158	[p10l1734t3582r2049b3640],
14	D	NN	ORGANIZATION	d	appos	5	SENT_158	[p10l2080t3584r2140b3652],
15	,	,	O	,	_	0	SENT_158	[p10l2080t3584r2140b3652],
16	Park	NNP	O	Park	nn	17	SENT_158	[p10l148t3677r288b3734],
17	BK	NNP	O	BK	appos	5	SENT_158	[p10l307t3678r406b3734],
18	.	.	O	.	_	0	SENT_158	[p10l307t3678r406b3734],

1	Carbamazepine	NNP	O	Carbamazepine	nsubj	5	SENT_159	[p10l431t3677r941b3749],
2	is	VBZ	O	be	cop	5	SENT_159	[p10l960t3678r1007b3734],
3	not	RB	O	not	neg	5	SENT_159	[p10l1027t3682r1132b3734],
4	a	DT	O	a	det	5	SENT_159	[p10l1150t3693r1184b3734],
5	substrate	NN	O	substrate	_	0	SENT_159	[p10l1203t3677r1510b3734],
6	for	IN	O	for	_	0	SENT_159	[p10l1527t3677r1622b3734],
7	P-glycoprotein	NN	O	p-glycoprotein	prep_for	5	SENT_159	[p10l1641t3677r2140b3749],
8	.	.	O	.	_	0	SENT_159	[p10l1641t3677r2140b3749],

1	Br	NN	O	br	nn	3	SENT_160	[p11l146t18r218b74],
2	J	NN	O	j	nn	3	SENT_160	[p11l241t19r277b74],
3	Clin	NN	O	clin	_	0	SENT_160	[p11l308t17r434b74],
4	Pharmacol	NNP	O	Pharmacol	dep	3	SENT_160	[p11l462t17r812b74],
5	2001	CD	DATE	2001	num	4	SENT_160	[p11l841t18r1369b86],
6	;	:	O	;	_	0	SENT_160	[p11l841t18r1369b86],
7	51:345	CD	NUMBER	51:345	number	8	SENT_160	[p11l841t18r1369b86],
8	—	CD	NUMBER	—	dep	3	SENT_160	[p11l841t18r1369b86],
9	9	CD	NUMBER	9	dep	8	SENT_160	[p11l841t18r1369b86],
10	.	.	O	.	_	0	SENT_160	[p11l841t18r1369b86],

1	19	CD	NUMBER	19	_	0	SENT_161	[p11l7t111r97b167],
2	.	.	O	.	_	0	SENT_161	[p11l7t111r97b167],

1	Soranzo	NNP	O	Soranzo	nn	2	SENT_162	[p11l145t111r402b167],
2	N	NNP	O	N	_	0	SENT_162	[p11l438t112r500b180],
3	,	,	O	,	_	0	SENT_162	[p11l438t112r500b180],
4	Cavalleri	NNP	ORGANIZATION	Cavalleri	nn	5	SENT_162	[p11l541t110r829b167],
5	GL	NNP	ORGANIZATION	GL	appos	2	SENT_162	[p11l866t111r970b180],
6	,	,	O	,	_	0	SENT_162	[p11l866t111r970b180],
7	Weale	NNP	ORGANIZATION	Weale	nn	8	SENT_162	[p11l1009t110r1209b167],
8	ME	NNP	ORGANIZATION	ME	appos	5	SENT_162	[p11l1242t112r1353b180],
9	,	,	O	,	_	0	SENT_162	[p11l1242t112r1353b180],
10	Wood	NNP	ORGANIZATION	Wood	nn	11	SENT_162	[p11l1393t110r1570b167],
11	NW	NNP	ORGANIZATION	NW	appos	5	SENT_162	[p11l1609t112r1728b180],
12	,	,	O	,	_	0	SENT_162	[p11l1609t112r1728b180],
13	Depondt	NNP	ORGANIZATION	Depondt	nn	14	SENT_162	[p11l1772t110r2044b182],
14	C	NNP	ORGANIZATION	C	appos	5	SENT_162	[p11l2078t111r2140b180],
15	,	,	O	,	_	0	SENT_162	[p11l2078t111r2140b180],
16	Marguerie	NNP	O	Marguerie	nn	17	SENT_162	[p11l143t206r473b277],
17	R	NNP	O	R	appos	5	SENT_162	[p11l508t206r564b275],
18	,	,	O	,	_	0	SENT_162	[p11l508t206r564b275],
19	et	FW	O	et	nn	20	SENT_162	[p11l603t210r670b262],
20	al.	FW	O	al.	appos	5	SENT_162	[p11l702t205r779b262],
21	.	.	O	.	_	0	SENT_162	[p11l702t205r779b262],

1	Identiﬁcation	NN	O	identiﬁcation	nn	2	SENT_163	[p11l823t205r1256b262],
2	candidate	NN	O	candidate	_	0	SENT_163	[p11l1291t205r1618b262],
3	causal	JJ	O	causal	amod	4	SENT_163	[p11l1649t205r1852b262],
4	variants	NNS	O	variant	dep	2	SENT_163	[p11l1883t206r2147b262],
5	responsible	JJ	O	responsible	amod	4	SENT_163	[p11l148t298r519b370],
6	for	IN	O	for	_	0	SENT_163	[p11l540t298r634b355],
7	altered	JJ	O	altered	amod	8	SENT_163	[p11l655t298r891b355],
8	activity	NN	O	activity	prep_for	5	SENT_163	[p11l916t299r1165b370],
9	of	IN	O	of	_	0	SENT_163	[p11l1185t298r1251b355],
10	the	DT	O	the	det	14	SENT_163	[p11l1271t298r1378b355],
11	ABCB1	NN	O	abcb1	nn	14	SENT_163	[p11l1398t299r1597b355],
12	multidrug	JJ	O	multidrug	amod	14	SENT_163	[p11l1633t298r1951b370],
13	resistance	NN	O	resistance	nn	14	SENT_163	[p11l1975t299r2143b355, p11l145t398r328b449],
14	gene	NN	O	gene	prep_of	8	SENT_163	[p11l358t406r534b463],
15	.	.	O	.	_	0	SENT_163	[p11l358t406r534b463],

1	Genome	NNP	O	Genome	nn	2	SENT_164	[p11l571t393r843b449],
2	Res	NNP	O	Res	_	0	SENT_164	[p11l872t393r984b449],
3	2004	CD	DATE	2004	num	2	SENT_164	[p11l1011t393r1617b461],
4	;	:	O	;	_	0	SENT_164	[p11l1011t393r1617b461],
5	14:1333	CD	NUMBER	14:1333	number	6	SENT_164	[p11l1011t393r1617b461],
6	—	CD	NUMBER	—	dep	2	SENT_164	[p11l1011t393r1617b461],
7	44	CD	NUMBER	44	dep	6	SENT_164	[p11l1011t393r1617b461],
8	.	.	O	.	_	0	SENT_164	[p11l1011t393r1617b461],

